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2Foreword
First Edition of Textbook of Urogynaecology
Urogynaecology is an exciting and dynamic subspecialty. The last decade 
has seen a rapid advance in the management options available to the 
gynaecologist in treating women with pelvic floor dysfunction. Stress 
incontinence surgery was revolutionised by the development of the TVT 
and exciting long term data has confirmed this device as a gold standard 
in the management of SUI. Overactive bladder has seen the launch of 
a number of new anticholinergic drugs with better side-effect profiles 
and dosing schedules. We also now have some alternatives to the drugs 
including Botulinum Toxin A and neuromodulation. We are developing 
a greater understanding of the role of childbirth and pregnancy in pelvic 
floor dysfunction. The last three years has seen the launch of intriguing 
pelvic floor replacement  systems and although we are some way off from 
achieving long term data on these devices, this is no doubt an important 
step in the evolution of pelvic floor surgery.
This book has been written by a number of authors from different parts 
of South Africa. The field of urogynaecology is still in its infancy and we 
therefore have many unanswered questions. In this volume, the reader 
will therefore encounter varying opinions. There is a significant amount 
of overlap and difference of opinion and we hope this will stimulate the 
reader to read widely and formulate his or her own opinion.
The electronic format of this text has made it possible to offer it to the 
reader at an affordable price. We trust that this book will contribute to 
a better understanding and management of South African women with 
pelvic floor dysfunction. We dedicate it to the women of South Africa.
A special thanks to Robertha and Anthea Abrahams for secretarial work, 
and Dr Julie van den Berg for assistance with proof reading.
The Editors  
3Pelvic floor dysfunction is 
associated with multiple 
symptoms including bladder, 
bowel and sexual complaints. In 
addition, women may present 
with neurological symptoms, 
psychological issues and 
relationship dysfunction. It is 
therefore imperative that the 
history and examination are 
performed in a comprehensive 
fashion. 
Urogynaecological symptoms 
are never life-threatening but 
they can have a profound impact 
on the women’s quality of life. 
Clinical assessment therefore 
aims to determine the extent of 
the impairment on quality of life 
and thereby institute the most 
appropriate route of investigation 
and management. 
Clinicians use the traditional 
approach of history and 
examination. Symptoms as elicited 
by the traditional interview by 
Chapter 1
The Urogynaecological History
Stephen Jeffery
the doctor have been shown to be 
fraught with subjective influences. 
A number of questionnaires are 
now available which are able to 
elicit symptoms in a standardised 
form and quantify them. This is 
particularly useful in a research 
setting but these instruments 
are now increasingly being 
used in day-to-day practice. 
Similarly, the examination of the 
urogynaeological patient has 
become more scientific with the 
advent of more detailed and 
scientific prolapse scoring systems. 
  
History
Urinary Symptoms
Frequency
This is defined as the number of 
voids during waking hours. Normal 
frequency is considered to be 
between four and seven voids a 
day. 
4Nocturia
This is the number of times a 
woman has to awake from sleep to 
pass urine. This varies with the age 
of the woman, with an increase 
reported in woman above the age 
of 70 years where normal would 
be considered to be twice at night, 
three times for women over 80 
and four times for women over 90 
years of age. 
Incontinence
Symptoms of Urinary Incontinence 
are notoriously difficult to 
evaluate. The International 
Continence Society defines 
this as the “involuntary loss 
of urine which is a social or 
hygienic problem and objectively 
demonstrable”.
Stress Incontinence
This is the involuntary loss of urine 
with a rise in intra-abdominal 
pressure. Factors that commonly 
elicit stress incontinence include 
running, laughing, coughing, 
sneezing and standing up from a 
seated position. 
Urinary urgency
This is the compelling desire to 
void which is difficult to defer. 
It must be differentiated from 
urinary urge which is a normal 
desire to void which can be 
comfortably deferred by the 
woman. 
    
Urgency Incontinence
Here, the women describes the 
symptoms of urgency and she is 
unable to get to the toilet in time 
and develops incontinence as a 
result. 
Determining the severity of 
Incontinence
It is important to make a clinical 
attempt to determine the severity 
of the incontinence symptoms. The 
woman could be asked to quantify 
the symptoms on a  scale of 0 to 
I0. When this is done using a chart 
it is called a visual analogue scale 
(VAS). Many women present with 
mixed symptoms of both stress and 
urge incontinence and by asking 
them to quantify each symptom 
using the visual analogue score, 
we are able to determine which is 
more severe. 
The patient should also be asked 
about the use of continence aids 
such as pads and how often she 
changes her underwear. The 
number of incontinence episodes 
per day can also be indicative of 
the severity of the condition.
Symptoms of voiding 
dysfunction
5These symptoms are not as 
common in women as in men 
but if present, should prompt 
the appropriate investigation of 
urinary residual and flow rate. 
These symptoms include:
•	 Hesitancy
•	 Straining to void
•	 Incomplete Emptying
•	 Post- Micturition dribbling
•	 Poor Stream
•	 Double Voiding 
Bladder pain
Women with bladder pain should 
be questioned in detail regarding 
the nature and occurrence 
of the symptoms. Pain that is 
relieved with passing urine may 
be associated with Interstitial 
Cystitis/ Painful Bladder Syndrome. 
Women with pain as a significant 
symptom should be evaluated 
with cystoscopy and biopsy since 
pain may also be associated with 
tumours and stones.
Urethral Pain
This may be associated with 
infections or urethritis.
Haematuria
Women with urinary symptoms 
should always be questioned 
regarding the presence or 
absence of blood in the urine and 
investigated appropriately.
Prolapse symptoms
Women with prolapse have a 
broad range of symptoms. Studies 
have shown that the symptoms 
increase significantly with stage 2 
prolapse or greater. Most women 
will complain of a bulge or a lump, 
whilst others will describe either 
discomfort or a burning sensation. 
Still others will describe associated 
voiding or defaecatory difficulty, 
needing to reduce the prolapse to 
void or completely evacuate their 
bowels.
 
Bowel symptoms
Evaluation and questioning 
regarding bowel symptoms is an 
essential part of the evaluation of 
the pelvic floor. 
Anal Incontinence
This is the involuntary passage of 
flatus.
Faecal Incontinence
This is defined as the involuntary 
passage of liquid or solid stool. 
This should be quantified by asking 
the women about the frequency, 
severity, use of continence aids  
and impact on quality of life.
Faecal urgency and urge 
incontinence
This is an important symptom 
6which is often underreported and 
seldom elicited by the clinician. 
Defaecatory dysfunction
Women should be asked about 
any difficulty in completing 
defaecation including digitation, 
splinting or manual evacuation.
Constipation
A record should be made of 
frequency of stools and any 
symptom of constipation.
Sexual History
A detailed history of sexual 
function is vital to a thorough 
assessment of pelvic floor 
disorders. Women should be 
asked if they are sexually active. 
Any problems should be noted 
including dyspareunia, vaginal 
slackness, vaginal tightness, 
anorgasmia, coital faecal or urinary 
incontinence during intercourse.
Other relevant parts 
of the history
Neurological history
Women should be questioned 
regarding symptoms of limb 
weakness and sensory fallout. 
Any history of multiple sclerosis, 
parkinsonism, spinal cord injury, 
stroke or spina bifida should also 
be recorded. 
Medications
A note should be made of 
medications that may be 
worsening the symptoms, including 
diuretics and alpha –blockers.
Medical History
Diabetes Mellitis and Insipidus are 
usually associated with polyuria. 
Cardiac failure can present 
with nocturia as a result of the 
redistribution of fluid when the 
patient is lying down.  
Fluid Intake
The amount and type of fluid 
consumed on a daily basis should 
be recorded. Caffeine and alcohol 
can exacerbate symptoms of 
overactive bladder significantly 
and these products in particular 
should be enquired about.
Obstetric History
The number and type of deliveries 
are important as well as any history 
of perineal or anal sphincter injury. 
Surgical History
Previous pelvic surgery, including 
prolapse and incontinence surgery, 
should be noted. 
  
   
7   
Causes of Incontinence
I. Stress Incontinence
    Sphincter Dysfunction
    Abnormal Bladder neck support
2. Detrusor Overactivity
    Idiopathic
    Neurogenic
3. Mixed incontinence
4. Overflow Incontinence
5. Functional Incontinence
    Confusion
    Dementia
6. Pharmacologic
7. True incontinence
    Fistulae
8. Transient Incontinence
    UTI
    Restricted Mobility
    Constipation
    Atrophic Urethritis
9. Congenital Abnormalities
I0. Excessive urine production
    Diabetes Mellitis and Insipidus
    Diuretics
    Cardiac failure
Adapted from Textbook of Female 
Urology and Urogynaecology Eds 
Cardozo and Staskin.
8 Definitions of Symptoms
Lower urinary tract symptoms, 
(LUTS) are equally bothersome 
to men and women, and greatly 
affect the quality of life (QOL).
The term “Lower urinary tract 
symptoms” is used to describe 
a patient’s urinary complaints 
without implying a cause. Lower 
urinary tract symptoms were 
defined by the standardization sub 
– committee of the International 
Continence Society.
LUTS are the subjective indicators 
of a disease or change in 
conditions as perceived by the 
patients, carer or partners and may 
lead her to seek help from health 
care professionals. Symptoms may 
either be volunteered or described 
during the patient interview. They 
are usually qualitative.
In general, lower urinary tract 
Chapter 2
Lower urinary tract symptoms 
and urinary incontinence: an 
overview
Peter de Jong
symptoms cannot be used to make 
a definitive diagnosis. However 
LUTS can also indicate pathologies 
other than lower urinary tract 
dysfunction, such as urinary 
infection. The clinician will make 
his/her best efforts to exclude 
other causes of LUTS.
Lower urinary tract symptoms are 
categorized as storage, voiding 
and post micturition symptoms. 
(Table 1)
Storage Symptoms are experienced 
during the storage phase of the 
bladder, and include daytime 
frequency and nocturia.
Increased daytime frequency is 
the complaint by the patient who 
considers that he/she voids too 
often by day. The average person 
voids 6 times a day.
Nocturia is the complaint that the 
9individual has to wake at night 
one or more times to void.
Urgency is the complaint of a 
sudden compelling desire to pass 
urine, which is difficult to defer.
Urinary incontinence is the 
complaint of any involuntary 
leakage of urine.
In each specific circumstance, 
urinary incontinence should be 
further described by specifying 
relevant factors such as type, 
frequency, severity, precipitating 
factors, social impact, effect 
on hygiene and quality of life, 
measures used to contain the 
leakage, and whether or not the 
individual seeks or desires help 
because of urinary incontinence.
Stress urinary incontinence is the 
complaint of involuntary leakage 
on effort or exertion, or on 
sneezing or coughing.
Urgency urinary incontinence is the 
complaint of involuntary leakage 
accompanied by or immediately 
preceded by urgency.
Mixed urinary incontinence is the 
complaint of involuntary leakage
associated with urgency and also 
with exertion, effort, sneezing or 
coughing.
Enuresis means any involuntary 
loss of urine. If it is used to denote 
incontinence during sleep, it 
should always be qualified with 
the adjective “nocturnal”.
Table 1 LUTS
FILLING / STORAGE EMPTYING / VOIDING POST VOIDING SYMPTOMS
Frequency Hesitancy Post – micturition dribbling
Urgency Straining to void Feeling of incomplete 
emptying
Nocturia Poor stream
Urgency Incontinence Intermittency
Stress Incontinence Dysuria
Nocturnal Incontinence Terminal dribbling
Bladder / Urethral Pain
Absent or Impaired Sensation
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Nocturnal enuresis is the complaint 
of loss of urine occurring during 
sleep.
Continuous urinary incontinence 
is the complaint of continuous 
leakage and may denote urinary 
fistula.
Bladder sensation can be defined, 
during history taking, into four 
categories.
Normal: the individual is aware 
of bladder filling and increasing 
sensation up to a strong desire to 
void.
Increased: the individual feels an 
early first sensation of filling and 
then a persistent desire to void.
Reduced: the individual is aware 
of bladder filling but does not feel 
a definite desire to void.
Absent: the individual reports 
no sensation of bladder filling or 
desire to void.
Voiding symptoms are experienced 
during the voiding phase.
Slow stream is reported by the 
individual as the perception 
of reduced urine flow, usually 
compared to previous performance 
or in comparison to others.
Intermittent stream or Double 
voiding (Intermittency) is the term 
used when the individual describes 
urine flow which stops and starts, 
on one or more occasions, during 
micturition.
Hesitancy is the term used when 
an individual describes difficulty 
in initiating micturition resulting 
in delay in the onset of voiding 
after the individual is ready to pass 
urine.
Straining to void describes the 
muscular effort used to initiate, 
maintain or improve the urinary 
stream.
Terminal dribble is the term used 
when an individual describes a 
prolonged final part of micturition, 
when flow has slowed to a trickle 
or dribble.
Post micturition symptoms are 
experienced immediately after 
micturition.
Feeling of incomplete emptying 
is a self – explanatory term for 
a feeling experienced by the 
individual after passing urine.
Post micturition dribble is the term 
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used when an individual describes 
the involuntary loss of urine 
immediately after passing urine, 
usually after leaving the toilet.
Frequency – Volume Chart 
(Bladder Diary)
Frequency – volume charts (FVC) 
have become an important 
part of the evaluation of LUTS. 
Most experts would agree that 
these charts provide invaluable 
information about a number 
of symptoms including urinary 
frequency, urgency, incontinence 
episodes, and voided volume. In 
fact some symptoms, like nocturia, 
cannot be properly evaluated 
without a chart. Frequency – 
volume charts are critical for the 
distinction between nocturnal 
overactive bladder and nocturnal 
polyuria, two common causes 
of nocturia. Despite this the 
structure, content and duration 
of chart keeping for evaluation 
has not been standardised. There 
are a number of parameters 
that can be assessed by the FVC, 
including: total number of voids 
per 24 hours, total number of 
daytime (awake) voids, total 
number of night time voids, 
total fluid intake, total voided 
volume, maximum, minimum and 
mean voided volume, number of 
urgency episodes, and number of 
incontinence episodes.
FVC’s have been shown to be 
reproducible and more accurate 
when compared with the patient’s 
recall. The optimal length of 
a diary varies according to the 
parameter assessed and precision 
and sensitivity required. In 
addition, if one is trying to assess 
change, the baseline parameter 
(e.g number of voids, incontinence 
episodes) will affect the length 
of the diary needed to detect 
a certain change. A 7 day diary 
is a reasonable option for most 
patients with incontinence. If 
record keeping for 7 days increases 
a patient’s burden the number of 
days required to evaluate voiding 
symptoms should be reduced.
The majority of information 
collected on FVC’s or bladder 
diaries has been used to establish 
baselines or to study patients with 
OAB or incontinence.
Physical examination
A general physical examination 
of the patient is mandatory, since 
many co–morbid conditions are 
likely to impact on the symptoms 
of LUTS (Table 2)
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Table 2 Comorbid conditions 
causing LUTS
•	 Medical disorders 
 › Hypertension / heart failure
 › Mulitple sclerosis
 › Diabetes Mellitus
•	 Reduced mobility
•	 Alzheimers
•	 Medical therapy, i.e diuretics
•	 Neurological disorders
A detailed gynaecological 
assessment is important, with 
particular attention to pelvic 
floor disorders, and prolapse. A 
full neurological examination 
is also required. Digital rectal 
examination is useful to evaluate 
the possibility of co – existent anal 
/ faecal incontinence.
Special investigations
Urinalysis
Urinalysis is not a single test 
- complete urinalysis includes 
physical, chemical, and microscopic 
examinations. Dipstick urinalysis 
is certainly convenient but false 
positive and false negative results 
may occur. It is considered an 
inexpensive diagnostic test able to 
identify patients with urinary tract 
infection (UTI) as indicated by the 
presence of leucocyte esterases 
and nitrites, although infection 
may exist in the absence of pyuria 
and, in the elderly population, 
pyuria may develop in the absence 
of UTI. Microscopic haematuria can 
be easily identified by dipsticking 
because of the presence of 
haemoglobin. The detection of 
haematuria is important because 
the condition is associated with 
a 4 – 5% risk of diagnosing a 
urological disorder or malignancy 
within 3 years. Because of the 
high prevalence of urinary tract 
infection (UTI) and the increase 
of LUTS in the presence of UTI, all 
guidelines on the management 
of patients with LUTS and urinary 
incontinence, endorse the use 
of urinalysis in primary care 
management.
Urodynamic 
Investigations
What is meant by the term 
Urodynamic investigations?
In 1970 Bates coined the expression 
that ‘the bladder often proves to 
be an unreliable witness’, meaning 
that the presenting symptoms 
of the patient and the eventual 
diagnosis of the problem are often 
at variance. In 1972 Moolgaoker 
stated that ‘urinary symptoms in 
the female do not form a scientific 
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basis for treatment’.
Urodynamic tests have been 
developed to confirm the 
underlying diagnosis in a patient 
complaining of symptoms of 
urinary incontinence. These 
tests identify the etiology of 
the problem and elucidate its 
pathophysiological mechanism. 
Their use is sometimes debatable, 
since grade A evidence supporting 
the general use of urodynamics in 
the investigation of incontinence, 
is not available.
The most basic form of urodynamic 
testing which is used in present 
day practice consists of:
1. Uroflowmetry (otherwise 
known as a ‘free flow 
measurement’
2. Multichannel urodynamics 
which involve filling and 
voiding cystometry (the latter 
being a so – called ‘pressure – 
flow’ study).
Depending on the sophistication of 
the apparatus used, either a leak 
– point pressure measurement, or 
urethral pressure profilometry may 
be performed additionally as a test 
of urethral function. Urodynamic 
testing can either be static or 
ambulatory.
Videocystourethrography is used 
in advanced centres and is the 
gold standard of the investigation 
of female urinary incontinence. 
It involves contrast media and 
screening radiology superimposed 
upon conventional cystometry to 
provide an accurate diagnosis. This 
modality is not widely available.
Increasingly, ultrasound imaging is 
also being used to measure both 
bladder neck descent and bladder 
wall thickness. Electromyography 
and cystoscopy are adjuncts to 
urodynamics in complex patients 
with atypical pathology.
The measurement of urethral 
resistance pressure has recently 
been pioneered. This does have 
potential as a diagnostic tool of 
the future. However, at present 
its widespread use as a routine 
urodynamic tool is questionable 
and it should only be used in 
research studies aimed at clarifying 
its value.
Basic tests which should be 
performed on patients prior to 
urodynamic testing include a 
urine microscopy and culture, 
and a measurement of residual 
urine volume, either by catheter 
or ultrasound. A bladder diary 
(frequency / volume chart) is 
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also a necessary aid to diagnosis. 
The latter has been shown to 
provide valuable information on 
the patient’s voiding pattern and 
functional bladder capacity, as well 
as giving an indication of leakage 
episodes.
It can be said that most 
urodynamic tests are expensive, 
time consuming and invasive 
(involving catheterization of 
the patient). They also require 
considerable expertise and access 
to sophisticated equipment. 
There should therefore be sound 
motivation for their use as a 
diagnostic tool.
Clinical Indications for 
Urodynamics Investigations
There are many etiological factors 
leading to urinary incontinence 
in women. Certainly the most 
common problems are urodynamic 
stress incontinence due to 
urethral sphincter weakness or 
bladder neck hypermobility, and 
detrusor overactivity leading to 
incontinence (in most cases ‘urge 
incontinence’). Other causes of 
incontinence include fistulae, 
urethral diverticulae, urethral 
instability, the urethral syndrome 
and also the contributory effect 
of urinary tract infection. It 
must be emphasized that many 
of these conditions may mimic 
the symptoms associated with 
stress incontinence and destrusor 
overactivity.
A cough – induced bladder 
contraction causing leakage 
may be confused with stress 
incontinence (so called ‘stress – 
induced instability’).
There may be serious sequelae if 
a patient suffering from urinary 
incontinence is not adequately 
evaluated and an incorrect 
diagnosis is made. The most serious 
of these is inappropriate surgery. 
Failure to recognize concomitant 
detrusor overactivity and / or 
voiding dysfunction may also 
affect the outcome of appropriate 
surgery.
Table 1 lists the most important 
indications for urodynamic studies.
Table 1: Indications for 
urodynamic studies
1. Prior to surgery
2. Failed medical or surgical treatment
3. Complex symptomatology
4. Neurological dysfunction
5. Voiding dysfunstion
6. Medico – legal cases
15
Clinical Diagnosis versus 
urodynamic diagnosis
Over the past 35 years there have 
been ongoing discussions in the 
literature on how best to evaluate 
patients with incontinence. The 
accurate identification of patients 
with SUI has received considerable 
attention
The accuracy of history alone
Most of the early papers looked 
at the discriminatory value of 
a pure history of either stress 
incontinence or detrusor instability. 
Symptoms alone were used to 
make a diagnosis before patients 
were subjected to confirmatory 
cystometry. Most of the earlier 
studies had relatively low numbers 
of patients. In summary, it is clear 
from the majority of studies that 
a history of incontinence alone is 
not enough to enable a clinician 
to make an accurate diagnosis 
for a decision on whether or not 
to embark on stress incontinence 
surgery. The symptom of stress 
incontinence may be very sensitive, 
but is so nonspecific as to render it 
of little diagnostic value.
History is best used as a guide to 
the subsequent evaluation process 
and to serve as a measure of 
disease severity.
History, clinical examination 
and basic tests
In the ongoing search for an 
uncomplicated and cost – effective 
approach to the pre – operative 
evaluation of a patient for 
stress incontinence surgery, 
several authors looked at other 
parameters which could prove 
useful.
In summary the addition of other 
clinical parameters and simple 
office tests do enhance the 
sensitivity of a history. However, 
the various authors still found 
the combination inadequate for 
a reliable diagnosis and most 
felt that additional research was 
warranted.
In South Africa, Urogynaecology as 
a subspeciality is still in its infancy. 
Treatment decisions in female 
urinary incontinence management 
are mostly made on clinical 
judgment. There are very few 
management protocols in place 
and this is an area which urgently 
requires development, particularly 
at specialist level.
Medical practice is increasingly 
becoming dogged by litigation and 
practitioners have to be able to 
show that they have their patient’s 
best interest at heart by backing 
16
up clinical diagnosis with special 
investigations.
In the larger centres in SA 
there are facilities available for 
performing urodynamic studies 
but these are mostly underutilised. 
They are often also run by staff 
who are not properly trained to 
provide good quality results and 
interpretation.
There is an increasing number of 
practitioners in SA who have a 
special interest in Urogynaecology 
and who manage female patients 
with urinary incontinence. It is 
these practitioners who should 
be at the forefront of attempts 
to develop mechanisms which are 
aimed a providing the best possible 
service for their patients. “Best 
practice’ therefore also means 
a move away from ‘preference 
– based’ to ‘evidence – based’ 
medicine.
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All women presenting with 
pelvic floor dysfunction should 
be thoroughly examined  in 
the supine, left lateral and 
standing positions. Where a 
surgical intervention is planned, 
the responsible surgeon should 
determine exactly what may 
be required at operation – so 
that the appropriate consent 
can be obtained and the correct 
intervention planned. 
General
The women’s mobility and general 
condition should be noted. 
Neurological 
examination
The spinal segments S2,3.4 should 
be assessed by testing the tone, 
strength and sensation in the 
Chapter 3
Physical Examination and the 
POP-Q
Peter de Jong, Stephen Jeffery
lower limbs. The anal sphincter 
tone should be tested.  
Gynaecological 
Examination
It is impossible to perform an 
adequate urogynaecological 
examination without using a 
Sims speculum and in some 
circumstances two Sim’s speculae 
are required.  The examination 
begins with the woman in the 
dorsal position. The vulva and 
vagina are inspected for any 
lesions, atrophy or excoriation. 
The woman is then asked to 
cough or valsalva while the 
clinician observes for any stress 
incontinence. She is then asked 
to turn onto her left side and the 
Sims speculum is used to inspect 
the anterior and posterior vaginal 
walls for prolapse. It is imperative 
that the middle compartment is 
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also adequately assessed for any 
uterine or vaginal vault descent. 
This can be difficult, but if one 
uses two Sims speculae placed 
anteriorly and posteriorly, while 
the women strains down, it 
is relatively easy to assess this 
compartment. The prolapse should 
be graded using either the Baden- 
Walker or POP-Q systems (see 
below). If the women’s symptoms 
are not adequately explained by 
the findings at examination, it may 
be useful to perform an additional 
assessment with her standing. This 
is accomplished by asking her to 
stand with her legs apart while 
the examiner bends in front of 
the patient and gently palpates 
the anterior, middle and posterior 
compartments. She is then asked 
to cough again in the standing 
position. 
Classification and 
grading of prolapse
Grading and classification of pelvic 
organ prolapse enables clinicians 
to communicate with each other 
and is also useful in a research 
setting. The most commonly used 
grading system is the Baden-
Walker halfway system which 
grades prolapse as follows:
Grade I: Descent halfway to the 
introitis
Grade 2: Descent down to the 
vaginal introitis 
Grade 3: Descent beyond the 
introitis but not maximal
Grade 4: Maximal descent   
This grading system is useful in day 
to day clinical practice but it has a 
number of shortcomings. It does 
not give a quantitative impression 
of the severity of the prolapse. 
It does not address the vaginal 
length, perineal body size or the 
length of the urogenital hiatus. 
The POP-Q (Pelvic Organ Prolapse 
Quantification System) was 
developed by the International 
Continence Society to address 
these issues  and it supercedes the 
previous systems used to describe 
POP. The new objective assessment 
allows a clear and unambiguous 
description of prolapse, facilitating 
better objective assessment, 
management and surgical 
comparison. Precise staging made 
gynaecological oncology an 
objective progressive disciple, and 
it is hoped that introduction of 
POP – Q will allow similar advances 
in the management of prolapse. 
Terms used in the past such as for 
example small, medium or large, 
cystocoele or rectcoele, are no 
longer applicable. At first glance, 
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the system appears complicated 
and difficult to master but 
once it is understood, it can be 
performed in less than 30 seconds 
while performing a routine 
gynaecological examination.  It 
is based on measurements that 
are taken using the introitis as 
reference. Any measurement 
above this is negative and 
anything below this is positive. 
The measurements are taken using 
a marked Pap smear spatula. Six 
specific vaginal sites (points Aa, Ba, 
C, D, Bp and Ap) and the vaginal 
length (tvl) are assessed using 
centimeters of measurement from 
the introitus. The length of the 
genital hiatus (gh) and perineal 
body (pb) are measured. 
The points are defined as follows, 
with the ranges as suggested in 
the following table.
All measurements are made to the 
nearest 0.5cm
Consensus and validation of the 
new system has been extensive. 
The clinical examination is 
performed and the measurements 
recorded on the “POPQ grid”. 
(Table 2)
TABLE 1: POP - Q DEFINITION AND RANGES
Point Measurement Range
Aa Anterior vaginal wall 3cm proximal to the hymen -3 to +3
Ba Leading – most point of anterior vaginal wall prolapse -3 to +tvl
C Most distal edge of cervix or vaginal cuff (if cervix is absent) -/+ tvl
D Most distal portion of the posterior fornix -/+ tvl
Ap Posterior vaginal wall 3cm proximal to the hymen -3 to +3
Bp Leading – most point of posterior vaginal wall prolapse -3 to +tvl
gh Perpendicular distance from mid – urethral meatus to posterior hymen No limit
pb Perpendicular distance from mid – anal opening to posterior hymen No limit
tvl Posterior fornix or vaginal cuff (if cervix is absent) to the hymen No limit
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TABLE 2:  The POPQ Grid – Used 
to Record Examination Results.
anterior
wall             
Aa
anterior 
wall
Ba
anterior 
wall
C
genital
hiatus
gh
perineal
body
pb
total vaginal
length
tvl
posterior
wall
Ap
posterior
wall
Bp
posterior
fornix
D*
*Measurement D is not taken in 
the absence of a cervix
The measurement of prolapse 
is performed in accordance 
with certain measurement 
fundamentals. (Table 3)
Table 3: POPQ Measurement 
Fundamentals
All measurements are made to the nearest 
0.5cm
All measurements are made relative to the 
hymen
Points proximal to the hymen are negative 
(inside the body)
Points distal to the hymen are positive (out-
side the body)
The hymen is assigned a value zero
gh, pb, and tvl measurements will always 
have a positive value
All measurements, except for tvl, are made 
while patient is bearing down
Both the patient’s position during 
the examination (lithotomy, 
birthing chair, or standing) and the 
state of her bladder and rectum 
(full or empty) should be noted
Staging of the grade of pelvic 
support is objectively done on a 
five – stage system. (Table 4)
Table 4: The five stages of 
Pelvic Organ Support
Stage 0: No descent of any compartments
Stage 1: Descent of the most prolapsed 
compartment between perfect 
support and – 1cm, or 1cm                 
proximal to the hymen
Stage 2: Descent of the most prolapsed 
compartment between -1cm and 
+1cm.
Stage 3: Descent of the most prolapsed 
compartment between +1cm 
and (tvl -2cm)
Stage 4: Descent of the most prolapsed 
compartment from (tvl -2cm) to 
complete prolapse
Explanation of 
individual points
Points Aa, Ab, Pa and Pb are the 
most difficult to understand. They 
represent the extent of prolapse, 
be it above the introitis ( ie 
negative) or below the introitis ( ie 
positive) 
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Point Aa 
If an imaginary small man walked 
from the introitis up the anterior 
vaginal wall and made a mark once 
he had covered 3 cm this would be 
point Aa. The distance this point 
descends on the vertical plane can 
therefore be either -3, -2, -1 if it 
is above the introitis,   0 at the 
introitis and +1,+ 2 or +3 below the 
introitis.   This point is therefore 
never more than 3 and represents 
the bottom 3cm of the vagina.
Point Ba
This point describes additional 
prolapse of the anterior vaginal 
wall that goes beyond the first 
3 cm. It is the most distal part of 
the prolapse. It can therefore be 
greater than the +3 described for 
point Aa. For the milder prolapse, 
it often equates to that of Aa. 
Because it essentially defines more 
extensive prolapse, when there 
is no prolapse, by convention we 
make it the same as Aa.  
Point Ap
Again our imaginary man makes 
the 3cm trip up the posterior wall 
where he marks off point Ap. The 
distance this point descends can 
again be therefore either -3, -2, -1 
if it is above the introitis,   0 at the 
introitis and +1,+ 2 or +3 below the 
introitis.  
Point Bp
Again, this point describes more 
extensive prolapse beyond the 
3 cm mark of Ap similar to Ba. 
Again if there is no prolapse, by 
convention it is -3. 
Point  C
This describes the prolapse of the 
cervix or vaginal vault. If the cervix, 
for example, is 7cm above the 
introitis, this point is then -7, if it is 
4 cm below C is +4. 
Point D
This describes the descent of the 
posterior fornix again similar to 
the cervix.
Total vaginal Length
This is the measurement of 
the length of the vaginal tube 
from top to bottom. It is usually 
measured with the marked spatula 
inserted to its maximum into the 
vagina.
Urogenital hiatus
The measuring spatula is placed 
anteroposteriorly along the 
introitis and measures from the 
urethral meatus to the midline of 
the posterior hymen.
Perineal body
Again the perineum is measured 
from the posterior hymen to the 
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anus in the midline.
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Urodynamics
Whole books have been written 
on Urodynamic practice and 
technique. The diagnosis in women 
with urinary incontinence based 
on clinical findings is correct in 
only 65% of cases. There is a large 
overlap between symptoms and 
examination and urodynamic 
findings. 55% of women with 
stress incontinence will have a 
mixed picture. The cystometrogram 
becomes essential, in a number 
of women, to enhance diagnostic 
accuracy and therefore enable us 
to institute treatment. 
The equipment
The Urodynamics system comprises 
two catheters, one placed in the 
bladder and another in the rectum, 
a computer and the urodynamics 
software and pressure transducers, 
a pump system, and a flowmeter. 
The catheter that is placed in the 
Chapter 4
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bladder is has a double lumen, one 
to measure the bladder pressure 
(Pves) and the other lumen is used 
to fill the bladder with water via 
the pump system. Sometimes, 
two separate catheters are used 
for filling and pressure recording. 
The rectal probe measures the 
intra-abdominal pressure (Pabd) 
and this pressure could therefore 
also be obtained by inserting the 
line into the vagina or even into 
a colostomy. A Urodynamic report 
usually gives 3 pressure tracings: 
Pves (bladder pressure), Pabd 
(abdominal) and Pdet (detrusor 
pressure). The detrusor pressure is 
obtained by the following formula 
Pdet = Pves-Pabd. Urodynamics is 
therefore often called Subtracted 
Cystometry.
The Procedure
The test comprises three 
phases.
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1. Free flow phase
The woman is asked to arrive 
at the investigation with a full 
bladder. She is then asked to 
void on the flowmeter, which is 
usually mounted on a commode, in 
privacy. It should be noted that this 
part of the test differs from the 
voiding cystometry, which is done 
after the filling phase once the 
bladder is full and the lines are in 
situ to measure the pressures. 
Flow Meter Commode
2. Filling phase
The bladder and rectal lines are 
inserted with the patient supine 
and any urinary residual is noted. 
The lines are flushed and the 
system is zeroed. The women 
is asked to cough to check that 
the Pdet measurement is correct. 
For example, if the Pabd is not 
measuring correctly, the Pdet will 
not be accurately calculated. If 
both the vesical and rectal lines 
are measuring appropriately, 
when  the women coughs, there 
should be no deviation of the 
Pdet – only on the vesical line and 
the abdominal line since these 
are both under the influence 
of abdominal pressure. In other 
words, when there is a rise in 
abdominal pressure with coughing, 
the same pressure is transferred 
to the bladder. The Pdet will 
therefore be zero since Pves minus 
Pabd is zero and the detrusor line 
will be flat with deviations only in 
the Pabd and Pves. 
Bladder filling is commenced 
once the operator is satisfied that 
the tracing is technically correct. 
The patient is asked to report 
on her first desire as well as the 
moment she has a strong desire to 
void. Any urgency and associated 
incontinence is noted. Provocative 
measures through the filling phase 
include asking the woman to heel 
bounce, wash hands and cough. 
This will also hopefully elicit any 
stress incontinence which is usually 
also occasionally recorded on the 
trace by a flowmeter but if this 
modality is not available on the 
filling phase, is usually observed  
by visual inspection of the vulva.    
When the patient is unable to 
tolerate any more filling, the pump 
is stopped, this is the maximum 
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cystometric capacity. 
3. Voiding Cystometry
This is done by asking the patient 
to void while the pressures are 
recorded. 
Possible Diagnoses
During Free Flow
Flow rate is abbreviated as Q. A 
normal flow curve is bell-shaped. 
An obstructive pattern is flat or 
with intermittent sections of flow.  
The maximum flow is denoted 
as Qmax. A normal flow rate is 
defined as less than I5ml/s.
During Filling phase
Any contractions of the detrusor 
tracing suggest a diagnosis 
of detrusor overactivity (DO). 
One should always look at the 
abdominal tracing and this 
should be flat during a detrusor 
contraction to diagnose DO. If the 
abdominal curve is also elevated, 
this would suggest possible poor 
subtraction and a diagnosis of 
DO should not be made. If the 
Detrusor pressure curve  rises 
slowly during the filling phase, this 
would suggest poor compliance. If 
one notes both stress incontinence 
and DO during filling, a diagnosis 
of mixed incontinence is made.  
During voiding Cystometery
Pressures are measured during 
the voiding cystometry phase 
and therefore parameters such 
as PdetQmax, the detrusor 
pressure during maximum flow, 
is measured.  A pressure greater 
than 20cmH2O would suggest an 
obstruction.
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Introduction
The term “overactive bladder” 
was proposed as a way of 
approaching the clinical problem 
from a symptomatic rather than 
a urodynamic perspective. The 
overactive bladder syndrome 
(OAB) has been defined by the 
International Continence Society 
as urinary urgency with or without 
urge incontinence usually with 
frequency and nocturia. It is a 
diagnosis based on lower urinary 
tract symptoms alone. While not 
life threatening, it can have a 
considerable adverse impact on 
the quality of lives of those who 
suffer from it, and it is highly 
prevalent within society. Recent 
epidemiological studies have 
reported the overall prevalence 
of OAB in women to be 16%, 
suggesting that there could be 
Chapter 5
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17.5 million women in the USA 
who suffer from the condition. 
The prevalence increases with 
increasing age being 4 percent in 
women younger than 25 years and 
30 percent in those older than 65 
years. The overall prevalence of 
OAB in individuals aged 40 years 
and older is 16%. Frequency, the 
most common symptom, occurs in 
85% of respondents, while 54% 
complain of urgency and 36% of 
urge incontinence.
Initial management of OAB should 
take into account the individual’s 
lifestyle and any appropriate 
interventions that can be 
employed to minimize symptoms. 
For example, reducing excessive 
fluid intake (25ml / kg / day is 
sufficient) and minimising caffeine 
and alcohol consumption may 
be helpful, as well as reviewing 
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any medication that may have 
an impact on lower urinary tract 
function, such as diuretics.
Behavioral therapies and, 
particular, bladder retraining 
may help a person regain central 
control of micturition and can be 
highly effective in well – motivated 
individuals, although there is a 
recognized high relapse rate. 
Drug therapy is the mainstay of 
treatment for OAB, and from 
the number of preparations that 
have been studied, it is clear 
that there is no ideal drug for all 
people. In the past, clinical results 
of treatment have often been 
disappointing due to both to poor 
efficacy and unacceptable adverse 
effects. Earlier preparations were 
not subjected to the current 
rigorous randomised controlled 
trials and, therefore, lack evidence 
– based data. Comparison of 
drug therapies for this condition 
is difficult due to the placebo 
effect of 30 – 40%, and since the 
response to any of the available 
drugs is only in the region of 60%, 
any differences that are detected 
are likely to be small, and thus 
require large – scale studies to 
show efficacy.
The drugs that are currently 
prescribed for OAB have an 
antimuscarinic component, and 
this limits compliance with the 
treatment because of a lack of 
acceptability to some people. 
Recent advances have included 
sustained release preparations of 
existing compounds, innovative 
routes of administration and 
newer antimuscarinic preparations. 
While many people will be 
considerably improved and even 
cured of their symptoms by drug 
therapy, there are always those 
who do not respond and for them, 
it is most important that further 
investigations are undertaken to 
ensure that the correct problem 
is being addressed. Urodynamic 
studies will confirm (or otherwise) 
a diagnosis of detrusor overactivity 
in which case, further trials 
of different antimuscarinic 
preparations would be desirable, 
whereas in the absence of 
proven detrusor overactivity, 
an alternative diagnosis should 
be sought to avoid further 
ineffectual treatment and, hence 
disillusionment and a waste of 
resources.
Definition of OAB 
syndrome
OAB is a clinical diagnosis and 
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comprises the symptoms of 
frequency (>8 micturitions / 
24 hours), urgency and urge 
incontinence, occurring either 
singly or in combination, which 
cannot be explained by metabolic 
(e.g diabetes) or local pathological 
factors (e.g urinary tract infections, 
stones, interstitial cystitis).
In clinical practice, the empirical 
diagnosis is often used as the 
basis for initial management 
after assessing the individual’s 
lower urinary tract symptoms, 
physical findings and the 
results of urinalysis, and other 
indicated investigations. Thus, the 
International Continence Society in 
its Standardisation of Terminology 
report from 2002 defined the 
OAB syndrome as urgency with or 
without urge incontinence, usually 
with frequency and noctuira. 
These symptom combinations 
are suggestive of urodynamically 
demonstrable detrusor overactivity, 
but can be due to other forms of 
urethro – vesical dysfunction. The 
term “overactive bladder” can be 
used if there is no proven infection 
or other obvious pathology.
In the current International 
Continence Society (ICS) definition 
of the OAB syndrome, urgency 
is an obligatory component. This 
is in line with current opinion 
regarding the importance of 
urgency as the driving force behind 
the other components, frequency, 
nocturia and incontinence, 
which are also mentioned in the 
definition. Urgency is, however, 
difficult to measure and in many 
of the clinical trials assessing the 
pharmacological treatment of OAB 
syndrome, micturition frequency 
has often been used as the primary 
endpoint as it is easier to quantify.
The OAB – how 
common is it?
There are at present only a few 
population – based studies that 
have assessed the prevalence 
of OAB. The prevalence of OAB 
symptoms was estimated in a large 
European study involving more 
than 16 000 individuals. Data were 
collected using a population – 
based survey of men and women 
aged ≥ 40 years, selected from 
the general population in France, 
Germany, Italy, Spain, Sweden and 
the UK using a random, stratified 
approach. The main outcome 
measures were prevalence of 
urinary frequency (>8 micturitions 
/24 hours), urgency and urge 
incontinence; proportion of 
participants who had sought 
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medical advice for OAB symptoms; 
and current previous therapy 
received for these symptoms. 
The overall prevalence of OAB 
symptoms in this population of 
men and women aged ≥ 40 years 
was 16%. About 79% of the 
respondents with OAB symptoms 
had experienced symptoms for 
at least 1 year and 49% for 3 
years. Sixty – seven percent of 
the women and 65% of the men 
with OAB symptoms reported that 
their symptoms had an impact 
on daily living. The prevalence 
of OAB symptoms increased with 
age in both men and women. 
OAB symptoms were relatively 
more common in younger women 
compared with men, while the 
opposite was found for the older 
age groups where symptoms were 
more common in men. However, 
when comparing the total 
population of men and women, 
there was little difference in the 
overall prevalence reported in 
women and men.
The prevalence of OAB symptoms 
has also been assessed in a 
large population based survey 
from the USA. The National 
Overactive Bladder Evaluation 
(NOBLE) was designed to assess 
the prevalence and burden of 
OAB. A sample of 5204 adults ≥ 
18 years and representative of 
the US population by sex, age, 
and geographical region was 
assessed. The overall prevalence 
of OAB was similar between men 
(16.0%) and women (16.9%) and 
was similar to the results reported 
earlier from Europe. The impact 
of OAB symptoms on quality of 
life was assessed in a subset of the 
participants from the NOBLE study. 
In individuals who reported OAB 
symptoms, these symptoms had a 
clinically significant negative effect 
on quality of life, quality of sleep, 
and mental health.
Impact of OAB 
symptoms on 
employment, social 
interactions, and 
emotional wellbeing
Symptoms suggestive of an OAB 
often have a profound negative 
influence on quality of life. It 
is not only episodes of leakage 
that effect wellbeing but also 
urgency and frequency have 
considerable detrimental effects 
on daily activities. Constant worry 
about when urgency is going to 
strike results in the development 
of elaborate coping mechanisms 
to enable people to manage 
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their condition (e.g voiding 
frequently in an effort to avoid 
leakage episodes, mapping out 
the location of toilets, drinking 
less, or the use of incontinence 
pads). It is not difficult to see how 
these troublesome symptoms may 
disrupt people’s daily lives and 
occupations. Despite the negative 
impact of these symptoms on 
quality of life, many affected 
individuals fail to report this 
condition to their physicians of 
symptoms for many years. This 
may be due to embarrassment or 
possibly because of the mistaken 
opinion that effective treatment is 
not available.
The management of 
overactive bladder
Incontinence occurs in 
approximately a third of people 
presenting clinically with OAB, 
and approximately a third of them 
have a mixed picture of combined 
sphincteric weakness and detrusor 
overactivity. The prevalence of 
OAB is higher among the elderly 
population (age 64 and above); it 
is estimated to be approximately 
30 – 40% among persons older 
that 75 years, and this may have 
additional ramifications as both 
urinary urgency, associated 
incontinence and noctuira have 
been shown to be associated with 
an increased incidence of falls and 
fractures among elderly.
The intensity of urinary urgency 
has a significant association 
with other symptoms of OAB. 
Urgency is the ‘driving’ symptom 
in OAB, those experiencing OAB 
frequently experience urgency at 
inconvenient and unpredictable 
times and consequently, often 
lose control before reaching the 
toilet. This adversely affects their 
physical and psychological state by 
limiting daily activities, intimacy, 
compromising sexual function 
and worsening self – esteem. 
It is no surprise therefore that 
improvements in urgency are often 
stated by people to be the most 
noticeable response to therapy.
Urgency is a sensory symptom 
and as such is difficult to define, 
to communicate to both patients 
and colleagues alike and the 
measure and quantify. Despite 
the difficulties,  urgency and the 
other symptoms of OAB result 
in a significant deterioration in 
HRQL. To date, patient diaries have 
been shown to be a reliable way 
to collect various OAB symptoms, 
including urgency episodes, and 
diary entry remains the most 
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accurate and sensitive method 
for evaluating changes in urgency 
with pharmacotherapy. Data 
obtained on the basis of 3 – or 4 
– day diaries suggest that short – 
duration diaries are just as reliable 
as those recorded for 7 days, and 
because they impart less patient 
burden, may be an acceptable 
method of assessing the symptoms 
of OAB. Apart from increases 
in cystometric capacity, invasive 
pressure flow studies have failed to 
show positive results with existing 
antimuscarinic therapy.
Initial assessment must include 
a thorough history and physical 
examination. A complete 
pelvic and neurological exam 
is mandatory, to exclude other 
conditions that may mimic OAB 
symptoms. Urine analysis, and 
microscopy and culture will exclude 
urinary infections. Further special 
investigations are not required.
Treatment for all forms of 
incontinence should commence 
with conservative methods before 
progressing to more complex 
surgical procedures if these do not 
work. A multidisciplinary approach 
is important in its management. 
In addition to urologists and 
gynaecologists, continence nurse 
specialists, physiotherapists 
and healthcare professionals in 
community based primary care 
services play a pivotal role in 
the management of incontinent 
patients.
Behavioural therapy and 
pharmacotherapy are the 
mainstay of treatment, and there 
is continuing search for more 
effective and selective drugs 
with minimal adverse effects 
(AEs). About 50% of people 
gain satisfactory benefit from 
pharmacotherapy. The role of 
physiotherapy in the treatment of 
urge incontinence remains unclear 
as evidenced by systematic review 
of clinical trials. 
Treatment of OAB is multifaceted. 
Effective treatment modalities 
include lifestyle modifications, 
medications, bladder retraining, 
and exercises to strengthen the 
pelvic floor (Kegel Exercises)
1. Lifestyle modifications
•	 The patient should limit 
intake of foods and drinks 
that may irritate the bladder 
or stimulate the production 
of urine e.g alcohol, caffeine, 
coffee, tea and fizzy drinks, 
and aspartate sweeteners.
•	 Drink 25ml / kg / day of 
fluids
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•	 Maintain healthy bowel 
actions. Eat high fibre foods 
such as wholewheat bread 
and pastas.
•	 Stop smoking
•	 Lose weight (if obese)
2. Bladder retaining
The patient should -
•	 Gradually increase the time 
between voids
•	 Increase the time intervals by 
15 minutes until she reaches 
an optimal time which is 
comfortable for her.
3. Pelvic floor muscle exercises 
(Kegel Exercises) (See 
elsewhere)
Surgical options (some still 
experimental) have been added 
in recent years and these include, 
neuromodulation and botulinum 
toxin injection therapy, but these 
interventions are reserved for cases 
where medical therapy fails.
Drug therapy
There are a number of 
antimusarinic agents in 
contemporary use. Oxybutynin 
chloride is the most commonly 
prescribed anticholinergic for OAB 
worldwide. It has antimuscarinic 
activity acting primarily on the 
M1 and M3 receptor over the M2 
receptor. Two oral formulations 
of this drug are now available on 
our market and include immediate 
– release (IR) and extended – 
release (ER) forms. More recently, a 
transdermal formulation has been 
introduced. Several randomised 
placebo controlled trials have 
shown oybutynin IR to be 
effective in producing subjective 
improvement in patients (at least 
50% improvement in incontinence 
episodes) as well as objective 
parameters. Dose begins at 2.5mg 
bd, going up to a maximum of 
5mg tds. Adverse effects include 
dry mouth, blurred vision, 
constipation, urinary retention, 
gastro – oesophageal reflux, 
dizziness and central nervous 
system (CNS) effects. The AEs, 
particularly dry mouth, can lead to 
a high (up to 80%) dropout rate 
within 6 months of commencing 
treatment.
In an attempt to reduce the 
incidence of these AEs, a new 
formulation, allowing a more 
controlled release of the drug over 
a 24 – hour period (oxybutynin 
ER) was introduced. The sustained 
release produces a more sustained 
plasma concentration when 
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compared with the IR preparations 
and, hence, a much more stable 
steady – state concentration for 24 
hours. Tablet doses between 5 and 
10 mg are available, and several 
randomized controlled studies 
have shown that oxybutynin ER 
is as effective as IR preparations 
with the additional benefit 
of a reduction in dry mouth. 
Other modes of oxybutynin 
delivery include intravesical and 
transdermal administration. 
Intravesical therapy was developed 
to increase the balance in 
favour of efficacy over AEs in 
those patients routinely using 
intermittent self – catheterisation. 
Oxybutynin (typically 5mg) is 
mixed with normal saline and 
administered twice a day via a 
urethral catheter. Several small 
open – label studies have shown 
that intravesical administration of 
oxybutynin can reduce subjective 
and objective detrusor overactivity. 
Clearly, the main limitation of this 
route of administration, associated 
with the use of intermittent self 
– catheterisation, is the increased 
risk of developing cystitis due to an 
irritant effect of the solution, and 
a higher risk of developing urinary 
tract infections with subsequent 
high dropout rates.
Following the hypothesis that 
oxybutynin metabolites are 
the principal cause of AEs, 
alternative delivery routes have 
been sought that would avoid 
oral administration and first 
pass metabolism. Consequently, 
a transdermal preparation of 
oxybutynin has been developed. 
At the present time, this agent has 
not yet been licensed for use in 
SA. An initial short – term study of 
transdermal verus oral oxybutynin 
IR in adults with urinary urge 
incontinence reported that both 
treatment options had similar 
efficacy, but the transdermal 
route produced significantly less 
dry mouth. A double – blinded 
randomised controlled trial (RCT) 
of transdermal oxybutynin at 3.9 
mg administered twice weekly 
versus placebo, reduced the 
number of weekly incontinence 
episodes, reduced average daily 
urinary frequency increased 
average voided volume and 
significantly improved quality of 
life (QOL) compared with placebo. 
The incidence of dry mouth 
was similar in both the groups, 
and the main AEs associated 
with transdermal delivery were 
erythema and pruritis at the site of 
application.
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Propiverine hydrochloride is a 
tertiary amine with a half – life 
of approximately 20 hours, 
showing peak levels in serum 
after approximately 2.3 hours 
after ingestion. Like oxybutynin 
it exhibits a mixed action, 
exhibiting both anticholinergic 
and musculotropic effects (calcium 
channel blocking activity). Doses 
vary between 15 and 30 mg 
daily. The clinical trials and data 
with this agent are limited to 
a month’s duration or less. In a 
double – blinded randomized 
placebo – controlled trial of people 
Different anticholinergics available in RSA
Drug Name Brand Name Licensed dose
Tolterodine tartrate ER Detrusitol XL 4mg o.d
Darifenacin hydrobromide Enablex 7.5 – 15mg tds
Oxybutynin hydrochloride Ditropan 2.5mg b.i.d – 5mg tds
Oxybutynin hydrochloride ER Lyrinel XL 5 – 20mg o.d
Oxybutynin hydrochloride tds Kentera 1 patch twice weekly
Trospium chloride Uricon 20mg b.i.d
Solifenacin succinate Vesicare 5 – 10mg o.d
Propiverine hydrochloride Detrunorm 15mg o.d. – tds
Propiverine hydrochloride ER Dertrunorm XL 30mg o.d.
Key:
o.d. = once daily
b.d. = twice daily
tds = three times daily
with OAB, propiverine 15 mg 
three times daily was compared 
with oxybutynin 5 mg twice 
daily and placebo. Both drugs 
produced objective and subjective 
improvements compared with 
placebo at 4 weeks compared 
with baseline. Propiverine was as 
effective as oxybutynin in reducing 
urgency and urge incontinence, 
but was associated with a lower 
incidence of dry mouth.
Tolterodine was launched in 
1998 and was the first modern 
anticholinergic on the market. 
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The ER formulation was released 
as a once – daily preparation 
aimed at producing a stable serum 
concentration over 24 hours. ER 
has peak serum concentration at 
2 – 6 hours post administration. 
Therapy with tolterodine ER 4mg 
appears to be efficacious in both 
older and younger people with 
OAB; it is useful for at least up to 
12 months with improvement in 
voiding diary parameters including 
urgency, and patient perception of 
their condition with a benefit of 
HRQL based on the King’s health 
questionnaire. The ER formulation 
is more effective than placebo in 
different degrees of incontinence 
severity. It has been shown to be 
effective in treating women with 
mixed urinary incontinence with a 
predominance of urge symptoms 
over stress.
Trospium chloride, a quaternary 
amine, is purported to lack 
CNS effects as it does not cross 
the blood – brain barrier. Its 
half – life is between 12 – 18 
hours and reached peak plasma 
concentrations between 4 and 
6 hours. The usual dose is 20mg 
twice daily. Trospium 20 mg twice 
daily has shown similar results 
when compared with oxybutynin 
5 mg twice daily, with significant 
reduction in urodynamic and 
voiding diary parameters 
(frequency, urgency and urge 
incontinence) for up to 52 weeks 
after trospium 20 mg twice – daily 
treatment.
Two new anticholinergic agents 
have been released in recent 
years, namely solifenacin and 
darifenacin. Solifenacin has a 
mean time to maximum plasma 
concentration of 3 – 8 hours and 
long elimination half – life of >45 
– 68 hours. Solifenacin produces 
a significant reduction in voiding 
frequency and a significant 
increase in volume voided/void in 
people with OAB and urodynamic 
evidence of detrusor overactivity. 
The recommendation is for 
an initial 5 mg dose with the 
possibility of dose flexibility by 
increasing the dose to 10 mg as 
required. The long term efficacy 
of solifenacin has been reported 
in an open – label extension of 
randomised placebo – controlled 
trials. The efficacy seen in the 
initial trials was maintained for 
up to 52 weeks. About 85% of 
the study population was satisfied 
after 24 weeks of flexible dosing, 
and with regard to efficacy, 74% of 
the population were satisfied after 
24 weeks of flexible dosing.
Darifenacin is a tertiary amine 
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derivative and is the most selective 
M3 receptor antagonist. It has 
been shown to have a higher 
degree of selectivity for the M3 
over the M2 receptor compared 
with other anticholinergics, with 
marginal selectivity for the M1 
receptor. In healthy volunteers 
after oral administration of 
darifenacin, peak plasma 
concentrations are reached after 
approximately 7 hours with 
multiple dosing, and steady – 
state plasma concentrations 
are achieved by the sixth day 
of dosing. In a double – blind, 
radomised, crossover study 
comparing darifenacin with 
oxybutynin in people with 
proven detrusor overactivity and 
associated symptoms of OAB, 
darifenacin was as effective 
as oxybutynin in terms of the 
ambulatory urodynamic variables 
tested but darifenacin 15 and 
30 mg controlled release was 
significantly better in salivary flow 
compared with oxybutynin 5 mg 
three times daily.
The introduction of darifenacin has 
fuelled debate over the potential 
importance of pharmacological 
selectivity as related to the AE 
profile. M1 and M3 receptor have 
been attributed to dry mouth, 
M1 to cognitive impairment, M2 
to cardiac effects and M3 and 
M5 to visual effects. Certainly, in 
this population, this would be of 
greater significance due to the 
existence of comorbidity and the 
susceptibility to impaired cognitive 
function and nervous system 
effects. Definitive comment on 
this subject will inevitably await 
adequately powered head – to – 
head comparative studies. Dose 
flexibility has been explored with 
darifenacin and clearly showed 
that some people who do not 
respond to a lower dose of drug 
(7.5mg) will do so at higher 
doses (15mg), but will develop 
more pronounced AEs inevitably, 
however, they may accept this as 
part of the ‘trade – off’ for the 
greater efficacy experienced
It is clear that among the many 
drugs tried for the treatment 
of OAB, acceptable efficacy, 
documented in RCT’s of good 
quality, has only been shown 
for a limited number. The 
anitmuscarinics tolterodine, 
trospium, solifenacin and 
darifenacin, the drugs mixed 
actions, oxybutynin and 
propiverine, and the vasopressin 
analogue, demopressin, were 
found to fulfill the criteria 
for level1 evidence according 
to the Oxford assessment 
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system and were given grade 
A recommendations by the 
International Consultation on 
Incontinence. All antimuscarinics 
apart from oxybutynin IR were 
found to be well tolerated. Dry 
mouth was the most commonly 
reported adverse event and no 
drug was associated with an 
increase in any serious adverse 
event. 
Generally there is little or no good 
evidence to choose between the 
anticholinergics
Oestrogen
Whilst the use of oestrogen in the 
treatment of women with stress 
incontinence is controversial, its 
use in women with the irritative 
symptoms of OAB is more 
established. Postmenopausal 
women with genital atrophy or 
OAB symptoms may receive oral 
or topical therapy provided no 
contra – indications exist, but at 
present, oestrogen therapy for 
stress incontinence is unwise. As 
we wallow in post “Women’s 
Health Initiative” hype, we must 
remember the negative impact 
of withholding the beneficial 
effects of oestrogen on the pelvic 
floor, and not precipitate a host 
of symptoms caused by significant 
genital atrophy. Oestrogen is 
not useful for treating urinary 
incontinence, but may reduce the 
incidence of UTI’s.
MIXED 
INCONTINENCE
Ethipramine
Tricyclic anti – depressants have 
been used widely for symptoms 
of frequency, urgency, urge 
incontinence and especially 
nocturia for many years. Although 
grade 1 evidence justifying their 
use is lacking, many patients 
are satisfied with the results. 
Ethipramine is inexpensive and 
widely available, with a multitude 
of effects – and side effects.
Its actions are anticholinergic 
in nature, with an adrenergic 
effect on the bladder neck. 
Theoretically at least, this makes 
it ideal for mixed incontinence, 
but its side – effects are often 
troublesome. It causes cardiac 
conduction defects and this has 
caused the WHO to warn against 
its use. Dry mouth and drowsiness 
are the most bothersome side 
effects, limiting its use. The drug 
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is available in 10mg and 25mg 
tablets, and the usual starting 
dose is 10mg in the mornings, 
with 25mg or 50mg at night. The 
soporific effect of ethipramine may 
be used to advantage, allowing 
increased evening dosage. Contra 
– indications are as for other anti – 
cholinergics. If clinicians prescribe 
ethipramine, they must be aware 
of its cardiac effects especially in 
elderly women.
Imipramine
The use of imipramine is parallel 
to that of ethipramine – with the 
proviso that it remains untested 
as a pure anticholinergic for use 
in incontinence. Imipramine is 
primarily, with amytriptyline, an 
antidepressant, and its useful 
anticholinergic effects are purely 
fortuitous. Clinicians must be 
aware that these agents are of 
limited use as niche agents, and 
that ethipramine is perhaps more 
clinically useful.
Pharmcotherapy remains the 
mainstay of therapy for the 
treatment of OAB, and the 
contemporary literature shows that 
antimuscarinic agents are used 
as a first line therapy for OAB. To 
gain a better understanding of the 
overall benefits of OAB treatment, 
it is critical that RCTs use validated 
instruments to assess HRQL and to 
relate these changes to changes in 
OAB symptoms. The International 
Continence Society advocates the 
use of HRQL measures in clinical 
research has provided increasing 
evidence for the HRQL benefits 
conferred by effective OAB 
treatments.
The future emphasis of work in 
this field must also incorporate 
patient – perceived outcomes using 
existing tools to assess bother and 
QOL.
The future
There is an overall trend towards 
development of once daily 
extended release preparations for 
existing anticholinergics, such as 
extended release oxybutynin and 
propiverine. Multiple strengths 
are now available in certain once 
daily agents such as solifenacin, 
allowing more flexible therapeutic 
options. Urinary urgency does not 
always arise within the bladder, 
and that when investigating OAB 
we should consider a variety of 
pathological causes. With the 
exception of botulinum toxin 
and neuromodulation for failed 
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medical therapy for OAB, there 
have been no new important 
surgical innovations. These last 
two options have superceded 
bladder augmentation by bowel 
interposition, since they are far less 
invasive, are reversible, and have 
fewer side effects.
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Introduction
The mainstay of treatment 
for Overactive Bladder is fluid 
management, bladder retraining 
and anticholinergic drug therapy.  
There are, however, a subset of 
women who do not respond to 
these standard treatment regimens 
and remain incontinent, their 
symptoms having a profound 
impact on their quality of life. 
Studies have shown that only 
18% of women stay on their 
drug treatment for longer than 
6 months. This appears to be as 
a result of inadequate efficacy 
and not side effects. Morris et al 
performed one of the only trials 
on long –term outcomes of women 
treated for OAB with a standard 
care package of anticholnergics 
and bladder retraining.  Looking 
at the same subjects a mean of 
eight years following discharge 
from the incontinence clinic, only 
7% of the cohort reported being 
cured, with 65% still suffering 
significant symptoms. Previously, 
the only therapeutic option for 
these patients was surgery in the 
form of bladder augmentation. 
These operations, however, 
carry a high morbidity with 
most having voiding dysfunction 
requiring clean intermittent self 
catheterization, and troublesome 
mucus production. 
A number of newer promising 
treatment options have  been 
developed, including Botulinum 
Toxin and nerve stimulation 
techniques.  
1. Botulinum Toxin
Botulinum Toxin, which is 
produced by the bacterium, 
Clostridium Perfringens, is the 
most potent toxin known to man. 
It is a Gram positive, anaerobic 
Chapter 6
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bacteria which is commonly found 
in the soil and 1g of the toxin can 
kill 1 million people.  It blocks the 
release of acetylcholine at the 
neuromuscular junction in the 
detrusor muscle. Amongst those 
who have contributed to the 
science of Botulinum Toxin, credit 
must be given to Schantz who 
purified the toxin and enabled its 
mass production. Its first clinical 
use was in 1980 when it was 
used to treat strabismus.  There 
are 7 subtypes, A, B, C, D, E, F , 
G, however only Toxins A and B 
are available commercially. The 
Botulnum A Toxin preparation, 
Botox® (Allergan Inc.) is probably 
the most well known, but there 
is an alternative called Dysport® 
(Ipsen Pharma).   Botulinum Toxin 
B is marketed by Solstice. 
Botox®  has been more extensively 
evaluated in the literature than 
Dysport®, but there are now 
a number of studies that now 
confirm its efficacy. Botox® is 
three times more potent than 
Dysport and most reports use 
300u for Neurogenic DO and 200u 
for Idiopathic DO. Exact dosages 
for Dysport are less clear and  
ranges from 500u to 1000u are 
administered.  
The toxin is usually administered  
using either a flexible or rigid 
cystoscope using a flexible 26 
gauge needle that is threaded 
through the working channel of 
the scope. The toxin is diluted 
into 20 ml of normal saline and 
injected in 1ml aliquots under 
local or general anaesthesia. 
Most practitioners avoid injecting 
the bladder trigone because of 
the theoretical risk of reflux. 
Recent work has, however, shown 
that trigonal injections are not 
associated with reflux and have 
equivalent efficacy to the extra-
trigonal administration. When a 
flexible cystoscope is used, the 
Botox can be given using local 
anaesthetic gel but sedation or 
general anaesthesia is usually 
necessary when using a rigid scope.
Schurch et al  were the first to use 
intradetrusor Botox injections for 
the treatment of severe detrusor 
overactivity in spinal cord injured 
patients. Profound improvements 
were demonstrated, with 17 of 19 
patients achieving continence. A 
large amount of data has emerged 
since then suggesting excellent 
efficacy in Neurogenic DO. Schurch 
et al reported again in 2005 on 
59 NDO patients. This was double 
blind placebo controlled parallel 
group study. They gave patients 
either placebo, Botox 200u or 
42
Botox 300u. Up to six months 
follow-up, they reported a 50 % 
reduction in incontinence episodes 
with 49% of the cohort reporting 
being dry. The urodynamic findings 
compared to placebo were 
remarkable with highly significant 
increases in maximum cystometric 
capacity at two, six and 24 weeks 
compared to placebo.  
Following the success in NDO a 
number of studies began looking 
at the treatment of Idiopathic 
DO. The problem with IDO is the 
risk of voiding dysfunction – since 
unlike in NDO, most of these 
patients have normal voiding 
function. Popat et al  published 
the first data on IDO using Botox, 
achieving continence rates of 
57%. The incidence of de novo 
voiding dysfunction was 19%. In 
a further randomized controlled 
trial, Sahai et al report profound 
improvements in multiple 
outcomes following the injection 
of Botox when compared to 
placebo.
The main adverse event following 
Botulinum injections is temporary 
urinary retention, with a reported 
incidence of between 19% to 
35%.  Women who develop 
this complication are required 
to perform clean intermittent 
self catheterization or have a 
suprapubic catheter inserted.  
The Botulinum Toxin effect on the 
detrusor lasts for approximately 
six to nine months and it usually 
requires repeat administration 
following this. As the urgency and 
urge incontinence return, normal 
voiding is also regained in those 
women who developed urinary 
retention.
An important factor to take into 
consideration is the cost of the 
Botulinum Toxin product. Botox is 
sold in vials of 100u and a single 
course of 300u would have a cost 
in excess of R6000. Dysport has 
only recently been launched in 
South Africa and would have a 
comparable price tag. One would 
need to add to this the costs of 
administration, including surgeons 
fees, theatre time and disposables.
2. Sacral Nerve Stimulation 
(SNS)
This device works by implanting a 
pacemaker-like neurostimulator 
in the lower back that sends mild 
electrical impulses to electrodes 
that are usually placed adjacent 
to the third sacral nerve root. 
The device received European 
Union approval in 1994 and USA 
FDA approval in 1999 and more 
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than 35000 devices having been 
implanted worldwide to date. In 
patients with OAB, SNS restores 
the balance between inhibitory 
and excitatory control systems 
at various sites in the peripheral 
CNS. This involves stimulation of 
somatosensory ascending tracts 
projecting from the bladder into 
the pontine micturition centre 
in the brain stem. The electrical 
impulses also activate the pelvic 
efferent hypogastric sympathetic 
nerves, which promotes 
continence.   
The device is inserted in two 
phases. The test phase includes the 
temporary insertion of a needle 
into the sacral foramen under 
local anaesthetic and the electrical 
stimulation is derived from an 
externally placed battery and 
generator. If the subject reports a 
satisfactory response after three to 
four weeks, defined as more than 
50% improvement in symptoms, 
a permanent device is sited. 
This involves the implantation 
of a long-term battery and 
neurostimulator in the buttock and 
lower back. 
A RCT reported continence 
outcomes of 47% at six month 
follow up, with a further 29% 
reporting more than 50% 
reduction in leakage episodes. 
A further systematic review 
confirmed these findings with 
67% of patients reporting being 
dry or having a more than 50% 
improvement in symptoms. 
Another trial that followed 
patients up for a mean of more 
than 5 years reported continued 
success in 76% of the cohort. 
Despite these success rates, this 
therapeutic option is not accessible 
to the majority of women largely 
due to the cost of the device and 
the expertise required to place and 
maintain the neurostimulator. It is 
available in South Africa, supplied 
by Medtronic, but retails for 
approximately R55000.
There are also significant adverse 
events associated with this 
equipment including pain and 
discomfort, seroma formation, 
disturbed bowel function and 
wound dehiscence. 
3. Posterior Tibial Nerve 
Stimulation
Because of the technical and 
cost implications of SNS, indirect 
neuromodulation of S2,3 and 4 
via stimulation of the posterior 
tibial nerve, was developed.  The 
technique is performed by passing 
an electric current between a 
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small acupuncture needle 4cm 
above the medial malleoulus and 
an electrode on the sole of the 
patient’s foot. The device has 
only recently become available 
and marketed by Manta Surgical 
under the name of “Urgent PC” in 
South Africa. There is a significant 
disposable component to the 
equipment, including a single use 
electrode and needle and this 
unfortunately drives up the cost of 
using this device. The treatment 
regime consists of up to 12 weekly 
sessions of 30 minutes although 
it may be efficacious after shorter 
treatment periods, it does not last 
indefinitely and it needs to be 
repeated after a few months. 
It has been shown to be efficacious 
in two trials with one reporting 
more than 50% reduction in 
leakage episodes in 70% of 
their cohort, 46% of the subjects 
reporting  being dry. 71% of the 
cohort of 53 patients in another 
trial reported treatment success.
4. Surgical Therapy
Clam ileocystoplasty and 
augmentation procedures are 
usually reserved for patients 
with neurogenic detrusor 
overactivity and high pressure 
bladders with the potential of 
upper tract damage. The advent 
of neuromodulation and Botox 
has provided us with additional 
options prior to resorting to 
surgery. Augmentation procedures 
also have a high incidence of 
urinary retention requiring 
catheterization.
    
5. Alternative therapy
A number of studies have shown 
acupuncture to be a useful 
adjunct to therapy.  A study 
performed in the late 1980’s 
reported a 77% reduction  in 
urgency and frequency in 77% of 
their patients  versus only  20% 
in placebo.  These findings have 
been confirmed by Bergstrom et 
al who also demonstrated reduced 
incontinence episodes.  The most 
interesting data have emerged 
from a trial where women were 
randomised  to acupuncture in 
bladder specific points versus 
relaxation point acupuncture. 
They demonstrated significant 
improvements in quality of life 
and frequency episodes in the 
group receiving bladder specific 
acupuncture. Acupuncture is 
readily available, is inexpensive 
and can be performed by many 
physiotherapists- and hence should 
be kept in mind for those women 
who do not want medication.  
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Stress Urinary Incontinence is 
defined as the complaint of 
involuntary leakage on effort 
or exertion, or on sneezing or 
coughing.
Stress incontinence occurs when 
one coughs, sneezes or jumps, 
resulting in a few drops or urine 
leaking out. It is caused by vaginal 
childbirth, aging and genetic 
factors.
Where do we begin? 
– Physiotherapy
The first step in therapy is to have 
the sufferer visit a physiotherapist 
with a special interest in pelvic 
floor rehabilitation. The physio will 
assess the strength of the patient’s 
pelvic floor, and suggest exercise 
to enhance the muscle power of 
the Levator muscles. She will need 
to have a programme of daily 
Chapter 7 
The Treatment of Stress 
Incontinence
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exercises extending over a number 
of weeks.
Pelvic Muscle Exercises
Do 45 pelvic muscle exercises every 
day, 15 at a  time, 3 times a day:
15 lying down in the morning
15 standing up in the afternoon
15 sitting down in the evening
For each exercise:
Squeeze the pelvic muscles for 
10 seconds (start at 1 second and 
build up)
Relax for 10 seconds
Remember to relax at the muscles 
in your abdomen when you do 
these exercises, and continue to 
breathe normally.
Test the power and effectiveness of 
your exercises by placing 2 fingers 
in the vagina, and squeezing. The 
physio will assist in assessing pelvic 
muscle tone. 
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The physiotherapist may 
also choose to employ the 
following:
Weighted vaginal cones, which 
are placed in the vagina while 
the patient actively squeezes the 
pelvic muscles to prevent the 
vaginal cones from falling out. The 
weights begin at 20g, and increase 
until the woman can manage to 
retain a cone of 100g, for 30min 
twice daily.
Faradism, where tiny electric 
impulses are sent through an 
electrode placed in the vagina. 
The current stimulates the correct 
muscles to contract, and so build 
Levator power.
Bio feedback, where the patient 
squeezes a balloon placed in the 
vagina, reflecting on an indicator 
the power of the pelvic muscle 
contractions.
If a woman persists in 
physiotherapy, there is no doubt 
that the technique will result in 
better muscle strength and control, 
with a corresponding improvement 
in bladder control.
Bear in mind that physiotherapy 
is without side effects, may be 
done at home, and empowers 
the sufferer to take charge of her 
recovery.
Physiotherapy is also useful in the 
management of the overactive 
bladder, when exercises are known 
as the “urge strategy”, and help 
in the management of urge 
incontinence
When Is Surgery 
Indicated?
When the relief obtained by 
physiotherapy is unsatisfactory, 
then other options may be 
explored.
For women with significant 
symptoms (for example, they need 
to wear a pad daily), some form of 
surgical option may be indicated.
The Surgical 
Management Of 
Stress Incontinence
Vaginal birth and aging are 
important causes of urinary 
stress incontinence. Ingenious 
operations to cure this common 
and distressing symptom in women 
have been devised. As a better 
understanding of the mechanisms 
of continence have evolved, 
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operations to cure the condition 
have improved.
Over the years there have been 
many operations for the treatment 
of urinary incontinence, suggesting 
no single procedure is effective 
in the management of this 
common and distressing condition. 
Recently new procedures have 
become available, being safer, 
and more effective, than previous 
interventions.
Historical Perspective
Traditionally the anterior repair 
of a cystocoele using Kelly 
plication sutures have been useful 
in the management of stress 
incontinence. However the effect 
is transient, and while it cures 
anterior compartment prolapse, 
the anterior repair is not an 
authentic continence operation. 
Meta analyses of heterogenous 
studies suggest a continence rate 
of 67% - 72%, but generally the 
success is around 66%. Long term 
results are poor, and at 5 years 
success falls to 37%. The major 
indication for a bladder buttress 
in contemporary practice is for the 
woman who prefers to sacrifice 
continence for a reduced chance 
of complication – the incidence of 
long – term voiding complication 
following this procedure 
approaches zero.
One of the first effective 
procedures to gain acceptance 
was the Burch colposuspension. 
John Burch described his 
operation in the 1950’s and it 
became the accepted benchmark. 
Several sutures plicate the 
peri – urethral fascia to elevate 
the anterior vaginal wall and 
bladder. Colposuspension is still 
applicable today, if the patient 
requires a continence procedure 
and is fortuitously undergoing 
laparotomy. 
While the Burch procedure is as 
effective as modern sub – urethral 
slings, a prospective randomized 
trial showed higher morbidity 
than the sling so it is nowadays 
probably best reserved for women 
subject to serindipidous pelvic 
surgery. Several drawbacks attend 
the operation, chief of which is 
subsequent enterocoele formation. 
Voiding dysfunction, detrusor 
overactivity and uterovaginal 
prolapse are consistently reported 
sequelae to colposuspension. 
The widespread adoption of the 
modern TVT has been primarily 
driven by the reduced surgical 
morbidity of such procedures. In 
48
a recent randomized controlled 
trial between the TVT and 
colposuspension, analysis after 2 
years reported an objective success 
rate for the Burch of 51% versus 
63% for the TVT group.
In the 1960’s needle suspension 
procedures were popularized by 
Stamey, Pereyra, Raz and others, 
but time has shown that while 
short – term cure was reasonable, 
they were insufficiently robust 
to maintain continence. Needle 
suspensions are now perhaps 
only indicated in the less – mobile 
elderly where a quick gentle 
procedure will suffice. Efficacy in 
the long term is poor, with only 
50% - 60% cure at 4 years. Needle 
suspensions do not produce a 
lower complication rate than 
the colposuspension, and there 
is little evidence to support their 
continued use.
Having been described and used 
more than a century previously, the 
rectus sheath sling was all the rage 
in the 1970’s. While this effectively 
cures stress incontinence, the 
procedure suffers considerable 
morbidity, and comes with the 
high price of voiding difficulty 
and irritative storage bladder 
symptoms. The mean cure rate 
is a pleasing 86% but long term 
voiding dysfunction (refractory 
urge incontinence, the need for 
clean intermittent catheterisation, 
and sling revision) occur in 10% of 
cases. Rectus fascia procedures are 
safe, with good longterm results 
and have became the benchmark 
for this form of sling surgery. 
Autologous slings can be used to 
provide effective long term cure of 
stress incontinence, but allograft 
and xenograft slings should only 
be used in the context of well 
constructed research trials.
In the 1980’s the laparoscopic 
Burch was introduced, riding the 
crest of the endoscopic revolution. 
This sporting procedure was the 
province of the laparoscopic 
affecionado, but showed no 
advantage over the other 
procedures of the time. There is a 
higher cure rate with the “open” 
Burch procedure, and the evidence 
on laparoscopic Burch is limited 
by short – term follow – up, small 
numbers, poor methodology and 
its technical difficulty.
Peri - urethral injectable agents 
have been used for the treatment 
of SI for the past century, but 
newer agents have caused a 
re – focus on these methods. A 
variety of substances have been 
reported to be safe including GAX 
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10mm sub – urethral sling placed 
without tension mid – urethrally, 
afforded remarkable results with 
little morbidity. The original 
retropubic approach (TVT-R) has 
now in the new millennium been 
superceded by the transobturator 
slings – safer, easier vaginal 
procedures with the same tension 
– free sub – urethral principle, but 
avoiding the pelvic cavity and its 
viscera completely.
Long term data suggested that (at 
least until recently) the retropubic 
TVT-R had become the benchmark, 
with excellent cure rates in a 
well described, standardized 
procedure, easily reproduced 
by  most urogynaecologists with 
predictable outcomes. The Burch 
colposuspension, conversely, 
had many modifications and 
variations of sutures, approaches 
and methods, yielding variable 
outcomes as a result.
With progress in minimally 
invasive surgery, and the idea 
instead of using trochars attached 
to synthetic slings instead of 
open incision, the retropubic 
midurethral sling (MUS) was 
developed.  
For descriptive purposes, the term 
MUS will be used to describe 
collagen, Teflon, zirconium beads, 
hyaluronic acid, and autologous 
fat and cartilage. But the ideal 
agent remains elusive. Agents 
are applied without general or 
regional anaesthesia, but there 
is no agreed method, technique, 
location, volume or equipment 
for the procedure. Although short 
term efficacy in some agents is 
satisfactory, evidence shows that 
long term durability of more than 
4 years is poor, and no agent is 
superior to another in terms of 
efficacy, durability or safety. A 
recent report suggests that stem 
cells may be injected adjacent 
to the urethral sphincter. No 
data is available suggesting how 
stem cells obtain innervation, or 
functional potential. This form 
of therapy is for now at least, 
still very experimental.  Para – 
urethral injections can be offered 
to women with SI on the basis of 
low operative morbidity – if they 
are prepared to accept a poor long 
term success rate.
In the 1990’s the concept of urinary 
continence being maintained by 
sub – urethral fascial support was 
mooted by Petros and Ulmsten in 
their “Integral Theory” of female 
continence. From this came the 
Tension- Free Revolution, with the 
realization that an open – weave 
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the group of synthetic slings 
placed under the midurehtra 
with a small incision using various 
trochar devices. This is in contrast 
to the traditional slings which 
typically were placed under the 
proximal urethral through larger 
incisions without trochars. The 2 
general categories of MUS are the 
retropubic and transobturator
Cede  
The Retropubic TVT 
(TVT-R)
The classic retropubic tension 
– free vaginal tape (TVT-R) is 
a safe and well – tolerated 
procedure with an 81% cure 
at 7 years follow – up, and an 
improvement rate of 94%. Some 
fatalities have occurred due to 
bowel damage and uncontrolled 
retropubic haemorrhage. A 
few small, retrospective, non – 
randomized studies comparing 
retropubic to the newer 
transobturator procedures show 
similar cure rates, but these 
studies are too underpowered 
to show meaningful differences 
in complications rates. Review 
papers suggest the obvious, that 
obturator approaches are safer 
because of avoidance of pelvic 
cavity viscera – but no hard 
evidence exists to support this 
notion. Given that transobturator 
approaches are probably safer and 
equally as effective as retropubic 
TVT, the thoughtful continence 
practitioner must consider if the 
“inside – out” route is safer, or 
otherwise, than the “outside – in” 
transobturator approach.
The New 
Transobturator 
Approach
Transobturator “outside – in” 
procedures
This concept was first described 
in 2001, and represented a 
completely different approach 
for placement of the tension – 
free mid – urethral tape. Initially 
a welded semi – rigid tape of 
non – woven monofilament 
polypropylene was used, with 
5% elasticity and 70% porosity 
(Obtape TOT device). This tape is 
now obsolete. Women are placed 
in the Lithotomy position, and the 
10mm tape passes sub – urethrally 
through the obturator fossa to exit 
the skin through a small incision 
on the medial aspect of the inner 
thigh. The introducer passes from 
the obturator fossa medially 
inwards towards the vagina, hence 
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the “outside – in” appellation.
The manufacturers (Mentor – 
Porges) have since introduced the 
ArisR type 1 light weight superior 
mesh, being woven in such a 
manner as to have low elasticity. 
Since 2002 more than 25, 000 TOT 
procedures have been performed, 
giving a reported success rate 
of 80% - 90%, improvement 
in continence of 7% – 9%, 
and a failure rate of up to 7%. 
Complications include bladder 
injuries in 0.7% of cases, and a 
3% – 5% incidence of voiding 
dysfunction.
Post – operative retention occurs in 
around 0.5% of cases, with other 
complications including thigh pain, 
haematomas, vaginal and urethral 
erosions. The overall Obtape 
complication rate is around 3.6%. 
These results have been carefully 
collated by a French Multicenter 
Registry with ObtapeR surveillance, 
comprising 9 centres and including 
data from some 730 women. 
In a recent study of 117 women, 
the ObtapeR afforded a 92% 
cure (defined as complete or 
partial satisfaction), with a 5% 
complication rate. Tape erosions 
over the 22 month follow – up 
period, occurred in 3 cases.
Another popular “outside – in” 
device is the MonarcR tape, and 
one – year data shows similar 
results. The objective cure rate is 
82%, with adverse events including 
mesh erosions, urinary retention 
and urinary tract infections. 
Data are very difficult to interpret 
and care must be taken when 
comparing studies. Since no “head 
to head” prospective randomized 
comparative trials of methods have 
been presented, it is impossible 
at this point to claim superiority 
or safety of one product over 
another.
Transobturator “inside – out” 
procedures
The Transobturator “inside – 
out” approach was first mooted 
by de Leval in 2003. The device 
is introduced through a 10mm 
suburethral vaginal skin incision, 
and passed laterally through the 
obturator fossa to the medial thigh 
area, and hence the “inside - out” 
moniker. This novel approach 
was developed after extensive 
cadaveric dissection and one 
year data suggest a 91% cure 
rate, with 5% of cases showing 
improvement. Post operative 
complications include voiding 
dysfunction in 5% of women, 
with a 12% incidence of transient 
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inner thigh pain and a few cases 
of vaginal healing defects. In a 
2004 prospective series, Waltregny 
found a cure rate of 94% with no 
reported complications. Procedures 
typically take around 20 minutes 
to perform, and may be done as 
day case procedures if the patient 
prefers. Although general or 
regional anaesthesia is the norm, 
they may be done under local 
anaesthetic. Intra – operative 
cystoscopy is not generally 
required.
It is difficult to draw conclusions 
from these data, and clinical trials 
will show comparative success rates 
and the incidence of perioperative 
complications. It has become 
common to measure the  “passing 
distance” of the different devices 
to vital anatomical structures 
in preserved or fresh cadaver 
specimens, but once again this 
does not necessarily translate to 
clinical safety or otherwise.
Transobturator 
“Outside In” Vs 
“Inside Out” – Which 
Is Best?
The “Outside in” approach of 
Delorme
The original technique of Delorme 
is intuitive and uncomplicated, 
even in obese subjects. 
Theoretically the passage of the 
vaginal finger may cause some 
tissue destruction because of 
the more extensive dissection, 
particularly in the atrophic 
vagina with thinner vaginal skin, 
leading to infection, erosion 
or tape displacement. With 
the introduction of the new   
improved type 1 mesh (ARISTM), 
a lower erosion rate is expected. 
Complications involving the 
urethra, bladder and vagina have 
been described.
The “Inside out” approach of de 
Leval
This dissection is less extensive 
without the need for digital 
control, and the mesh used is 
extra - ordinarily well tolerated 
with long – term clinical data 
available. Whilst the urethra and 
bladder may be at less risk than in 
the original outside - in technique, 
clinical trials will need to confirm, 
or refute the notion of increased 
safety using the newer operation.
Hysterectomy during a 
continence procedure
Hysterectomy is a commonly 
performed operation in 
gynaecology, and SI is a common 
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condition. Should hysterectomy 
be combined with a prophylactic 
continence procedure? Is the 
efficacy of either procedure 
affected by concomitant surgery? 
Assuming that SI is a symptomatic 
and demonstrable problem, 
evidence suggests that abdominal 
hysterectomy performed at the 
time of a Burch colposuspension 
has no adverse effect on the 
cure rate of stress incontinence, 
but complications are increased 
significantly. However vaginal 
hysterectomy at the time of a TVT 
has no adverse effect on surgical 
outcome. Bear in mind that when 
performing an anterior repair 
procedure, a significant percentage 
of cases will develop de – novo 
SI because urethral obstruction 
is relieved. It is very difficult to 
predict which cases will develop de 
novo SI, and no predictive tests are 
currently available to determine 
which cases should be offered 
“prophylactic” incontinence 
procedures.
The Future
Recently the “mini – sling” 
products have become available, 
consisting of shorter lengths of 
mesh introduced vaginally below 
the subpubic arch, with no exit 
points. The mini – sling type 
operations work on a different 
principle to the conventional 
obturator approach, and are 
placed with the mesh adjacent to 
the urethra. At this stage no long 
term comparative data regarding 
efficacy are available. Stem cells 
injected para – urethrally remain 
an interesting possibility, but are 
still, at this stage, experimental.
Conclusion 
The obturator approach to the 
treatment of stress incontinence 
offers many advantages over 
previous operations, especially 
ease of surgery, safety and good 
predictable cure rates. Apologists 
for each method have preferences 
that should be respected – but at 
the present time there is no sound 
clinical evidence comparing the 
“outside – in” to the “inside – out” 
transobturator approach, and 
this data is awaited with interest. 
Theory and opinion do not 
translate to clinical evidence. While 
the retropubic approach is still 
popular, the obturator approach 
has many probable advantages to 
recommend this technique, and 
make it the treatment of choice. 
A multitude of sling products are 
now available on the South African 
54
market, many being fake copy – 
cat counterfeits of the originators. 
While the ersatz knock – offs 
may be slightly cheaper (since no 
development costs were involved), 
the originators have the advantage 
of published clinical trials proving 
good outcomes. Fake products are 
seldom an improvement on the 
originals and must be used with 
caution.
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Introduction
Incomplete bladder emptying 
and urinary retention can lead 
to severe urinary tract infection 
and upper urinary tract disease 
as a consequence of retrograde 
infection and hydronephrosis.  
Obviously these problems all carry 
quite a significant morbidity and 
even mortality if unrecognised 
and untreated. Undiagnosed 
problems related to voiding will 
often be diagnosed only when 
one encounters the troublesome 
complication of urinary retention 
following pelvic floor surgery.  It is 
therefore essential that anybody 
practicing gynaecology, urology 
or uro-gynaecology should have 
an understanding of the causes, 
diagnosis and management of 
voiding disorders.
Aetiology
There are essentially only 3 reasons 
that an individual will experience 
difficulty with voiding:  
•	 Inefficient or absent detrusor 
contractility.  Impaired detrusor 
contractility (IDC) and detrusor 
areflexia (DA).
•	 Obstruction to urinary flow 
often called bladder outlet 
obstruction in males. (BOO)
•	 Lack of co-ordination between 
detrusor contraction and 
relaxation of the urethral 
sphincter, known as detrusor-
sphincter dyssynergia (DSD).  
It would seem quite simple to now 
present a trainee in gynaecology, 
urology or uro-gynaecology with 
a set of tables giving the causes 
of the three different types 
of dysfunction.  The problem 
however is that neurological 
pathology can often be a cause 
Chapter 8
The Management of Voiding 
Disorders
Peter Roos
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of these dysfunctions and various 
neurological conditions can cause 
overactive bladder symptoms, 
impaired detrusor contractility 
and incontinence.  A good starting 
point therefore is to list the various 
neurological factors which can 
affect the lower urinary tract 
(Table I)
Table I: Neurological Disorders 
Affecting Voiding
•	 Cerebrovascular accidents  
Brain tumours
•	 Cerebral Palsy
•	 Parkinsons disease
•	 Shy-Drager Syndrome
•	 Multiple sclerosis
•	 Spinal cord injuries – suprasacral 
and sacral
•	 Infectious conditions (tabes 
dorsalis, poliomyelitis, transverse 
myelitis, herpes zoster)
•	 Skeletal abnormalities of the 
spine (disc problems, ankylosing 
spondylitis)
•	 Peripheral nerve damage 
(radical surgery, diabetes 
mellitus)
Neurological disorders often 
overwhelm the average clinician, 
who probably slept through 
neurology lectures at university.  
These are just a few important 
things to remember.
Most conditions of the central 
nervous system can produce the 
full range of bladder symptoms, 
varying sometimes from one stage 
of the disease to another.
Sacral spinal injuries, lumbar-sacral 
nerve route compression and 
peripheral nerve damage usually 
cause DA.
Important causes of DSD are spinal 
cord injuries and multiple sclerosis.  
These conditions can cause high 
pressures within the bladder 
of above 40cmH20 without the 
urethral sphincter opening.  This 
causes severe back pressure and 
upper urinary tract damage.
Fortunately most neurological 
conditions causing bladder 
pathology will be perfectly 
obvious. It is however important 
in the patient with atypical or 
mixed urinary symptoms to be 
on the lookout for more subtle 
neurological changes before 
instituting treatment, especially 
surgical treatment.
Table 11: Other Causes Of 
Voiding Dysfunction
Obstructive
•	 Urethral stenosis
•	 Urethral sphincter hypertrophy
•	 Pelvic masses
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•	 Uterine prolapse
•	 Anterior vaginal wall prolapse
•	 Foreign bodies
•	 Post surgical, especially surgery 
for urinary stress incontinence
Inflammatory
•	 Severe vulvo vaginitis (genital 
herpes, severe vulvo-vaginal 
candidiasis)
•	 Urethritis and cystitis
Pharmacological
•	 General anaesthesia
•	 Regional anaesthesia
•	 Analgesics (Morphine) 
•	 Anti depressants
•	 Anti cholinergics
Detrusor Muscle Abnormalities
•	 Detrusor myopathy
•	 Over distention
Psychogenic
Post Partum Voiding Difficulty
Idiopathic
Surgical
•	 Will be discussed later in this 
chapter
Diagnosis
History
A good history is usually the most 
important aspect of making a 
diagnosis for any condition.  Until 
recently, however, the correlation 
between history, clinical findings 
and special investigations has 
shown poor correlation in women 
and been more extensively and 
better defined in men.
The following urinary symptoms 
are however important in making 
the diagnosis of suspected voiding 
abnormalities.  Be aware however 
that different studies have linked 
these symptoms differently to 
confirmed voiding disorders
•	 Hesitancy
•	 Straining to void
•	 Feeling of incomplete emptying
•	 Terminal dribble
•	 Post micturition dribble
•	 Splitting and spraying of urine
•	 Changing position to void
The above urinary symptoms 
may also be associated with 
overactive bladder symptoms and 
incontinence.
Further important questions in 
the history would be careful 
questioning about the usage 
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of medications, recent pelvic or 
abdominal surgery, neurological 
symptoms and symptoms of utero-
vaginal prolapse.
Examination
A good general examination 
looking for systemic causes of 
urinary symptoms is vital.
Abdominal and pelvic 
examinations should concentrate 
on detecting local lesions and 
anomalies, which might cause 
urinary obstruction, such as pelvi-
abdominal tumours, utero-vaginal 
prolapse, vulvo-vaginitis, urethritis 
and evidence of pelvic floor spasm 
or relaxation.
In difficult cases, with mixed 
urinary symptoms, or where 
symptoms have had sudden onset, 
careful neurological examination 
including inspecting the lumbar 
spine, assessing sensory and 
motor function in the pelvic area 
and checking peripheral reflexes 
are all important features of the 
examination.
Special Investigations
•	 Mid stream urine examination 
for infection and haematuria
•	 Post micturition residual 
volume.  For a long time, a 
residual volume of 100ml was 
considered to be cut off point 
for normality, however more 
recently it has been suggested 
that any residual volume over 
30ml might be associated with 
urinary tract infection.  Residual 
volumes can be measured either 
by catheterisation or ultrasound 
scanning. Ultrasound scanning 
is less invasive and causes 
less discomfort than urinary 
catheterisation. It is important 
to remember however that the 
accuracy of this measurement 
depends on the time since the 
last passage of urine until the 
time of the measurement of the 
residual volume.
•	 Uroflowmetry is an excellent 
non invasive screening test 
for voiding dysfunction.  A 
flow rate of less than 15ml per 
second would be considered 
to be abnormal.  This flow 
rate however also needs to be 
compared to the voided volume 
and the Liverpool Nomogram, 
plotting flow rate against 
voided volume, is used for this 
purpose.
•	 Uro-dynamic studies.  If the 
diagnosis of voiding dysfunction 
has been made, uro-dynamic 
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studies are important for 
confirmation of this diagnosis 
and to assess whether the 
voiding dysfunction is associated 
with poor detrusor contractions 
or obstruction, associated with 
high bladder pressures of more 
than 20cm H2O with maximum 
flow of less than 15ml/sec.
•	 Imaging of the bladder 
and lower urinary tract by 
means of ultrasound or 
videocystourethrography can 
also be used.
•	 Other simple non invasive 
investigations could include 
voiding diaries and frequency 
and volume charts kept by the 
patient.
Treatment Of Voiding 
Disorders
(Excluding Voiding Difficulty 
After Incontinence Surgery)
The treatment of voiding 
disorders obviously is dependant 
on the underlying cause.  If the 
underlying cause is obstructive, 
such as in pelvic swellings, utero-
vaginal prolapse, constipation or 
foreign bodies, these problems 
should obviously be attended to. 
Treatment of vulvo-vaginitis and 
urethritis goes without saying.  
In consultation with the medical 
practitioners taking care of this 
particular patient, changes in 
medication, which might be 
causing the problem should be 
considered as well as attention to 
the psychological and psychiatric 
health of the individual.
If the condition is untreatable or 
chronic, such as in neurological 
disorders, the following options 
are recommended:
•	 Timed voiding with assistance in 
increasing abdominal pressure, 
such as the Valsalva manoeuvre 
or Crede’s manoeuvre, where 
the patient or an assistant 
increases the abdominal 
pressure by pushing supra-
pubically.
•	 Intermittent clean 
catheterisation.  This has 
proven to be a very useful and 
safe method of emptying the 
bladder without continuous 
catheterisation. This can be done 
at 2-4 hourly intervals and can 
be performed by the patient 
themselves if they have the 
necessary motor co-ordination 
to do it.  In spinal injuries 
below C7, most patients can 
manage this themselves.  Clean 
catheterisation as opposed 
to sterile catheterisation is 
quite acceptable in the home 
environment, however in 
hospital, it might be more 
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appropriate to use sterile 
techniques to prevent cross 
infection.
•	 Continuous catheterisation.  
This can either be done by 
trans-urethral catheter or 
supra-pubic catheterisation. 
These patients need careful 
surveillance for urinary tract 
infection, stone formation and 
regular cystoscopy to exclude 
the development of bladder 
carcinomas.
•	 Medical therapy.  Medical 
therapy should be aimed at 
treating urinary tract infections 
and reducing the risks of high 
pressure bladders with a closed 
urethra by using anti cholinergic 
agents. Medical therapy to 
increase detrusor contractions 
has been disappointing.
•	 Neuromodulation with 
stimulators might be used in 
some of these conditions.
Voiding Difficulty 
After Incontinence 
Surgery
Voiding difficulty and retention of 
urine following surgery for urinary 
stress incontinence is becoming 
less common, but is nevertheless 
a stressful and uncomfortable 
complication for both patient and 
surgeon.  Having said that, the 
incidence is probably becoming 
less with the use of mid urethral 
tapes, this condition probably also 
remains under diagnosed and 
under reported.
The two major issues concerning 
post operative urinary retention 
are:
1. Can it be predicted and 
therefore prevented 
2. What to do about the problem 
once it arises.
Causes Of Post Operative 
Voiding Dysfunctions
•	 Undiagnosed pre-existing 
condition.
•	 Factors related to anaesthesia 
e.g general anaesthesia, 
regional anaesthesia, atropine, 
anaesthetic reversal agents and 
analgesics
•	 Post operative pain.
•	 Oedema and swelling around 
the urethra and bladder neck.
•	 Constipation.
•	 Operative technique e.g over-
elevation of the bladder neck 
with colpo-suspension and 
urethral compression with mid-
urethral tapes.
•	 Other possible causes of post 
operative voiding dysfunction 
are previous incontinence 
61
surgery, age and post 
menopausal status
Incidence
The reported incidence of post 
operative voiding difficulty and 
retention of urine varies greatly 
in the literature and is frequently 
thought to be under reported.
Comparative studies between 
colpo-suspension and tension free 
vaginal tapes suggest that the 
incidence is approximately 7% in 
both of these procedures.  The 
reported incidence of voiding 
dysfunction following mid urethral 
tapes, either by the retro-pubic 
or trans-obturator route seems to 
settle between 4 and 6 % but has 
been reported as high as 10%.  
Reported incidence of voiding 
dysfunction in previously used 
procedures such as Burch colpo-
suspension, Marshall Marchetti 
Krantz procedures, slings and 
needle suspensions have varied 
between 5 and 22%.
Voiding dysfunction following the 
injection of bulking agents, does 
not seem to have been a major 
problem.
Prediction Of Post Operative 
Urinary Retention
•	 Although there is no universal 
agreement, it is important to 
pay attention to the symptoms 
of voiding dysfunctions listed 
above.
•	 History of age, menopausal 
status and previous surgical 
history should be taken into 
account.
•	 The presence of a raised residual 
urine.
•	 Uroflowmetry of less than 15ml/
second.  
•	 Abnormalities of uro-
dynamic studies, particularly 
those suggestive of outflow 
obstruction and poor detrusor 
activity for whatever cause.
•	 Inexperienced surgeon not 
following recommended 
techniques
Management
•	 Prevention.  Attention should be 
given to the above predisposing 
factors. In the care of a trained 
uro-gynaecologist after careful 
assessment, these factors do not 
necessarily preclude the use of 
surgery for the treatment of 
urinary stress incontinence.
•	 Counselling. Patients having 
surgery for urinary stress 
incontinence should all be 
counselled that urinary 
retention and voiding difficulty 
might be a complication in up 
to 10% of cases. Furthermore, 
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in cases where voiding difficulty 
might be anticipated, it might 
be worthwhile teaching clean, 
intermittent self catheterisation 
pre-operatively.
•	 Temporary causes of voiding 
dysfunction and retention 
should be treated expectantly. 
Within a few days, swelling, 
bruising and oedema should 
disappear and various drugs 
contributing to the problem 
should be excreted.  The 
treatment of pain and 
constipation are important.
Post operative voiding difficulty 
with high residual volumes 
and urinary retention might 
occur either in the immediate 
post operative period or much 
later, even after years.  The 
management of the problem 
related to the surgical procedure 
itself, particularly with the use of 
mid urethral tape, is according 
to whether the diagnosis is made 
in the immediate post operative 
period or much later
•	 Early post operative voiding 
difficulty, particularly with the 
presence of a mid urethral tape, 
which persists beyond the time 
when the reversible causes 
have disappeared, is usually 
treated early in the first 7-10 
days before tissue ingrowth has 
taken place.  This can be done 
as a simple surgical procedure 
with local anaesthesia. The 
vaginal epithelium over the tape 
is opened and the tape itself is 
pulled down 1-2 cm.
•	 Later diagnosis of voiding 
difficulty in the presence of 
mid urethral tapes, when tissue 
ingrowth has already taken 
place, needs to be done as a 
more formal surgical procedure 
either cutting or removing a 
portion of the tape underneath 
the urethra.
•	 Other forms of surgical release 
include transvaginal and 
retropubic urethrolysis. 
A very nice description of the 
methods of releasing post surgical 
obstruction can be found in the 
Textbook of Female Urology 
and Uro-gynaecology, Volume 
2 Chapter 68 by Huckabay and 
Nitti, Editors Cardozo and Staskin, 
Publishers Informa Healthcare, 
2006
The early and late release of mid 
urethral tapes is very successful 
in the management of voiding 
difficulties and interestingly, up 
to more than 60% of patients will 
remain continent despite cutting 
or removing the tape, however in 
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some of these patients, overactive 
bladder symptoms might persist.
There is some difference of opinion 
as to whether when removing a 
tape for obstruction, one should 
replace it immediately with a 
new tape.  There are some who 
recommend removing the tape 
and then doing a cough test to 
assess whether there is stress 
incontinence, before putting a new 
tape in.  It would seem however 
appropriate to adopt a wait and 
see policy in view of the fact that 
so many people, particularly with 
late release of tapes will remain 
continent after the tape cutting or 
removal.
In the event of planning 
conservative management for the 
above problems, it is frequently 
necessary to perform intermittent 
catheterisation and pay special 
attention to the treatment of 
overactive bladder symptoms with 
anti cholinergics.  With the easy 
access to changing tension and 
removing and cutting mid urethral 
tapes, conservative management 
with prolonged catheterisation 
and the use of anti cholinergics is 
becoming less popular.
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Introduction
Urinary incontinence and pelvic 
organ prolapse can adversely affect 
almost every aspect of a woman’s 
life, including her sexuality. 
Sexual function is complex and 
impacts the woman to affect the  
perception of her own image and 
the formation of relationships with 
others. 
Sexuality and urinary incontinence 
are often considered to be 
taboos in the minds of many 
people, but recently the fields 
of urogynaecology and female 
urology have focused attention 
on female sexual function to align 
it with the extensive research 
performed in male sexuality.
At present, there is no consensus 
regarding the definition of normal 
sexual function. In 1992 the World 
Health Organization International 
Classification of Diseases-10 
defined female sexual dysfunction 
(FSD) as “the various ways in 
which an individual is unable to 
participate in a sexual relationship 
as she would wish”. In1998, Basson 
et al received consensus on the 
classification of sexual dysfunction 
and divided it into four major 
categories including dysfunction 
of desire, arousal and orgasm 
with a fourth category for sexual 
pain disorders. The final category 
included other sexual pain 
disorders not associated with coitus 
(Table1). The American Foundation 
for Urologic Diseases classification 
system includes personal distress in 
each category and therefore the 
general opinion is that in order to 
make a diagnosis of FSD, it must be 
associated with personal distress.
The focus of this chapter will be 
directed towards the impact of 
urinary incontinence on female 
sexuality.
Chapter 9
Sexual function in women with 
urinary incontinence 
Kobus van Rensburg
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Prevalence 
i) FSD
According to the National Health 
and Social Life Survey FSD is 
common, with a prevalence of 
43% in women between the ages 
of 18 and 54 years.  Lack of desire 
is the most common category with 
32% of patients describing this as 
reason for their dysfunctional sex 
lives. (Table 2) 
ii) FSD and urinary incontinence
Coital urinary incontinence (CUI) 
occurs in 24- 34% of women. 
Thirty-two percent of women 
reported urinary incontinence 
at intercourse in a recent South 
African study, with 31% avoiding 
intercourse altogether due to their 
urinary leakage. In the same study, 
stress urinary incontinence (SUI) 
was more commonly associated 
with leakage during penetration 
(32%) when compared to urge 
urinary incontinence (UUI) (7.8%). 
However, women with urge urinary 
incontinence leaked more often 
during orgasm (15.4%) compared 
to women with SUI (6.6%). This 
confirms then the commonly 
held notion that SUI occurs more 
commonly during penetration and 
UUI during orgasm.
Etiology of sexual 
dysfunction 
i) FSD
The etiology of FSD is multi 
dimensional including 
physiological and psychological 
factors, and interpersonal and 
sociocultural influences. (Table 3)
Physiological factors, such as 
medical condition involving the 
urogenital tract, contribute to 
the complex etiology of FSD. 
Psychological factors such as mood 
disturbances, stress and substance 
abuse are also etiological factors. 
Interpersonal relationship such as 
partner illness or lack of privacy 
might also contribute to FSD. 
Finally, sociocultural influences, 
such as cultural and religious 
Table I. Categories of sexual dysfunction
Low sexual desire Difficulty with 
Arousal
Difficulty with 
orgasm
Sexual pain 
disorder
Hypoactive sexual 
desire disorder
Sexual aversion
Female arousal 
disorder
Dyspareunia
Vaginismus
Other non-sex causes
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beliefs have an important impact 
on sexual function.
Table III: Etiology of female 
sexual dysfunction (FSD) 
(Bachman et al.  In CD:  Insights 
in FSD (2004)
•	 Physiol                           
•	 Psycol
•	 Urogenital           
•	 Depression / Anxiety
•	 Neural                          
•	 Prior abuse
•	 CVS                          
•	 Stress
•	 Medication              
•	 Alcohol / Substances
•	 Hormonal loss
•	 FSD
•	 Interpersonal Sociocultural 
influences
•	 Inadequate education
•	 Conflict family, religious
•	 Societal taboos
ii) FSD and urinary incontinence
Urinary incontinence can be 
associated with FSD for a number 
of reasons, including physical and 
psychological factors, performance 
anxiety, pain and an unsympathetic 
reaction from the partner.  Other 
issues contributing to a sense 
of reduced sexuality include a 
poor self-esteem, mood changes 
associated with decreased libido, 
the use of protective underwear 
and reduced spontaneity.  The fear 
of leaking urine and a concern 
about odour also induce a sense 
of anxiety. Women who leak and 
have developed a vulval dermatitis 
as a result may occasionally present 
with Dyspareunia.
Looking at the overall impact of 
Table II Prevalence of female sexual dysfunction 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stress, urge and mixed urinary 
incontinence, it would appear 
that a mixed picture has the 
most significant impact on sexual 
function in women.
Coital incontinence should always 
be evaluated in the context of the 
women’s age since this has also 
been identified as an independent 
risk factor for a decline in 
sexual activity. Specifically, the 
menopause is known to be 
significantly associated  with a 
decrease in libido, sexual activity 
and responsiveness. Caution should 
therefore always be exercised 
when evaluating a woman with 
FSD, where coital incontinence 
is occasionally blamed for sexual 
problems which pre-existed. 
Evaluation of FSD
Currently there are no completely 
reliable instruments available 
to measure or diagnose sexual 
dysfunction. It is essential that a 
women’s sexual function causes 
personal distress before the 
clinician makes a diagnosis of FSD. 
Sexuality is only one aspect of 
quality of life (QOL). The World 
Health Organization defines QOL 
as not only the absence of disease, 
but also complete physical, social 
and mental wellbeing.
Different methods of evaluating 
of QOL are available. Validated 
questionnaires represent a more 
objective assessment and have 
become an essential tool used 
to standardize and collect data. 
Two types of questionnaires are 
available, including a general 
questionnaire and a condition 
specific questionnaire. The general 
questionnaire is insensitive 
to a condition such as urinary 
incontinence, whereas a condition 
specific questionnaire is more 
surgery sensitive to the effect of 
lower urinary tract symptoms on 
QOL, but in turn does not evaluate 
other health related issues.
Questionnaires are often intrusive 
and ask very intimate questions. 
However, in a study that was 
used to develop and validate a 
questionnaire looking at urinary 
incontinence and sexual function 
(SF-IUIQ), 82.2% of the women did 
not report feeling too embarrassed 
to complete the questionnaire.  
The short form of the pelvic organ 
prolapse/urinary incontinence 
sexual questionnaire (PISQ-12) 
is a useful condition specific 
questionnaire.  In the clinical 
setting this short form of the PISQ 
provides a template for clinicians 
68
to discuss sexuality and helps to 
evaluate outcome before and 
after treatment intervention which 
could be conservative or surgical.
Treatment of Urinary 
incontinence and 
Female sexual 
dysfunction
In most studies looking at the 
outcomes of treatment for urinary 
incontinence, objective measures 
of continence outcomes are usually 
the primary aims and sexual 
function is usually assessed as a 
secondary outcome.  
Conservative treatment
These measures usually reduce 
urinary incontinence and 
improve QOL and sexuality. The 
International Continence Society 
(ICS) includes pelvic floor muscle 
training (PFMT) as first line therapy 
for stress urinary incontinence, 
urge urinary incontinence and 
mixed urinary incontinence. A 
number of small studies have been 
done to evaluate the impact of 
PFMT on coital incontinence. In a 
RCT of 59 women  with SUI , Bo 
et al reported a 50% decrease in 
coital incontinence in the group 
receiving PFMT compared to a 
reduction of only 10% in the 
placebo group.  Admittedly,  this 
was a small study but it certainly 
supports the role of PFMT as 
a first line in reducing coital 
incontinence. 
For some patients, simple advice 
such as emptying the bladder 
prior to intercourse or a change in 
position are effective in reducing 
coital urinary incontinence.   
Women with overactive bladder 
find the symptoms particularly 
more bothersome compared to 
those patients complaining of 
stress urinary incontinence since 
urinary leakage is not the only 
symptom. Bladder training and 
anticholinergic drugs are the 
treatments of choice, but the cure 
rates and the impact on sexuality 
remain unclear.                
                                                                            
Surgical treatment and sexual 
function
When surgery is planned the risk 
of post-operative dyspareunia 
related to each type of operation, 
should always be considered. An 
increasing number of papers have 
raised the issue of FSD in women 
who undergo urogynaecological 
surgery but conflicting data have 
been reported.    
In the past the Burch 
colposuspension was most 
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commonly performed operation 
for the surgical treatment of stress 
urinary incontinence. During 
the last decade, however, the 
mid-urethral tapes, employing 
polypropylene monofilament 
mesh, have become the gold 
standard. Baessler et al were the 
first to report, in a retrospective 
study on Burch colposuspension, 
on a 70% decrease in coital 
incontinence following surgery. 
It decreases incontinence at 
penetration by 80% and during 
orgasm by 75%. 
A review of vaginal surgery for 
SUI and female sexual function 
reports that the retropubic TVT 
does not appear to adversely affect 
overall sexual function. Other 
retrospective and prospective 
studies have reported varying 
results ranging from deterioration 
to equivocal with some reporting 
improvement in outcomes. (Table 
IV) Mesh erosion is an important 
cause of dyspareunia for both 
sexual partners. In a prospective 
study looking at urodynamic stress 
incontinence treated with either 
retropubic TVT or transobturator 
TVT, overall scores as measured 
by the  PISQ sexual questionnaire 
improved significantly with specific 
improvements in the physical and 
partner related domains. The 
behavior/emotive domain showed 
no significant improvement. 
Other treatment
Estrogen treatment requires 
further research, but currently 
it does not appear  to be of 
value in the treatment of urinary 
TableI V: Sexual function after tension-free vaginal tape procedure
Sexual 
function %
Reference: 
Study type Number 
of 
Patients
Unchanged Improved Worsened
Maaita et al 
(2002)
Retrospective 43 72 5 14
Yeni et al (2003) Prospective 32 No pre- and postoperative difference
Elzevier et al 
(2004)
Retrospective 65 72 26 1.6
Glavind and 
Tetche (2004)
Retrospective 48 60 25 6
Mazouni et al 
(2004)
Prospective 55 74 2 24
Ghezzi et al 
(2006)
Prospective 53 62 34 4
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incontinence.
Conclusions
Sexuality is complex and the 
etiology of female sexual 
dysfunction is multidimensional.  
FSD is common and the taboo 
nature of sexuality and urinary 
incontinence is a challenge for the 
clinician. Coital incontinence and 
urinary incontinence can cause 
FSD. Validated questionnaires, 
evaluating sexuality will render 
more reliable and objective data in 
the future. These instruments also 
have a role in assessing FSD pre- 
and post treatment. The use of 
pelvic floor muscle training should 
be considered as the first line of 
treatment for coital incontinence. 
Simple advice to empty the 
bladder prior to intercourse should 
also be offered. Surgical treatment 
for stress urinary incontinence 
does not adversely affect female 
sexual function but further 
research, specific to mixed urinary 
incontinence, is required.  Sexuality 
should be an essential outcome 
measure with intervention studies 
on the surgery for SUI.                                              
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Incidence
Urinary Tract Infections are 
extremely common in women 
of all ages. 25-30% of women 
aged 20-40 years have had a UTI 
and  40% of patients with UTIs 
will have a recurrence within one 
year. The prevalence of UTIs in 
young women is thirtyfold that 
of young men but with increasing 
age this ratio decreases due to 
high incidence of BPH in men. 
The elderly (20% of women) 
have a significant incidence of 
bacteriuria (predisposing factor to 
development of UTI). 
Pathogenesis
The urinary tract is normally sterile 
above the level of distal urethra. In 
the majority of UTIs, the organism 
ascends to the urinary tract via 
the ascending route. The female 
urethra is short and close to the 
faecal reservoir (source of most 
organisms causing UTIs) hence 
the higher incidence of UTIs in 
females compared to males. The 
main defence mechanism against 
infection is the hydrokinetic 
effect of regular effective voiding. 
For a significant infection to 
develop, an organism needs to 
gain access to the urinary tract, 
adhere to the urothelium and 
multiply in numbers. Virulent 
bacteria can overcome normal 
host defence mechanisms whereas 
less virulent bacteria result in 
significant infections in patients 
with abnormal urinary tracts or 
those with compromised immunity. 
During sexual intercourse the 
faecal organisms causing UTIs 
colonise the vagina and thus sexual 
activity encourages ascending 
infection. 
Chapter 10
Urinary Tract Infections (UTIs) 
in Women
Dick Barnes
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The microbiology of UTI is as 
follows:
•	 Escherichia coli (E coli) 
responsible for:
 › 85% of community acquired 
} UTIs
 › 50% of hospital acquired }
•	 other common Gram-negative 
organisms:
 › Klebsiella
 › Proteus
 › Pseudomonas
•	 Gram-positive organisms can 
also cause UTIs:
 › Strep. faecalis
 › Staph. aureus
 › Staph. epidermidis
 › Staph. saprophyticus
•	 In diabetics and 
immunocompromised patients 
fungi (Candida) and viruses 
(adenovirus, cytomegalovirus) 
cause a significant proportion of 
UTIs
Predisposing Factors
General Factors
•	 Females
•	 Elderly
•	 Diabetes mellitus: The glucose 
in urine is a good culture 
medium for organisms. Diabetes 
also impairs the function of 
white blood cells and diabetic 
autonomic neuropathy may 
cause a lower motor neuron 
neuropathic bladder with poor 
bladder emptying.
•	 Immunocompromised patients:
	› malnutrition
	› HIV/AIDS
	› cancer
	› chemotherapy
	› immunosuppression
•	 Analgesic abuse
	› can cause papillary necrosis
Local Factors
Any condition that impairs the 
normal flow of urine, or interferes 
with normal emptying can 
predispose to infection.
•	 Obstruction of upper tracts 
(kidneys and ureters)
	› stones
	› PUJ obstruction
	› sloughed papillae (diabetics)
•	 Bladder outflow obstruction 
	› urethral stricture
	› post mid-urethral tape surgery
•	 Neuropathic bladder
•	 Vesico-ureteric reflux
•	 Foreign bodes in urinary tract
	› bladder catheter
	› double J ureteric stent
•	 Urological “procedures”
	› cystoscopy
	› urodynamics
•	 Vesico colic fistula
•	 Pregnancy
•	 Vaginal infections
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•	 Blood Culture
	› NO imaging (i.e. U/S) is 
needed in the acute phase 
UNLESS:
	» diabetic
	» immunocompromised
	» history of stone disease
	» no response to antibiotics 
within 72 hours
Treatment
•	 General Measures
	› admission to hospital if toxic, 
vomiting
	› intravenous fluids if 
inadequate hydration
	› blood culture if high 
temperature
•	 Antibiotics
	› Goals of treatment
	» eradicate infection
	» prevent complications
	› Ideal antibiotic
	» bactericidal
	» broad spectrum
	» high penetration and 
concentration in urine and 
renal tissue
	› Antibiotics most frequently 
used:
	» Aminoglycosides
	» Fluoroquinolones
	» Cephalosporins
	» Co-amoxiclav (Augmentin)
	» Amoxycillin and Co-
Trimoxazole are not useful 
agents for empirical 
Acute Pyelonephritis
Acute pyelonephritis is an acute 
bacterial infection of the renal 
parenchyma and is the commonest 
disease of kidney.
Complications of Acute 
Pyelonephritis
•	 Septicaemia and septic shock
•	 Abscess 
	› intra-renal
	› perinephric
•	 Chronic pyelonephritis
	› healing with scarring
•	 Renal failure
	› if bilateral chronic 
pyelonephritis
Clinical Presentation
•	 History
	› fever and rigors
	› loin or back pain
	› nausea and vomiting in some 
patients
	› LUT symptoms (frequency, 
dysuria) often absent
•	 Examination
	› ill and pyrexial
	› loin tenderness
•	 Urine
	› Dipstick: WBCs ++ Nitrite test 
positive
	› Microscopy: pus cells ++ 
organism +
	› Culture: send specimen before 
starting antibiotics
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therapy because of high 
incidence of resistance to 
E coli
	» antibiotics should be given 
for 7-14 days and whichever 
agent is used, cure rate = 
90%
•	 Urological Investigation (once 
acute infection has resolved)
	› All women with recurrent UTIs
	› Associated haematuria
	» patients with recurrent 
acute pyelonephritis in 
the absence of urinary 
tract abnormality should 
have long-term continuous 
low dose antimicrobial 
prophylaxis (see below)
Cystitis
Clinical Presentation
•	 frequency and urgency
•	 suprapubic and back pain
•	 dysuria
•	 no pyrexia
•	 elderly patients may present 
with sudden onset of 
incontinence and/or smelly urine
Treatment
Three day course of treatment 
is sufficient to eliminate 
uncomplicated cystitis completely
Single dose therapy only 70% 
effective. 
Agents used:
•	 Fluoroquinolones
•	 Co-amoxiclav
•	 Cephalosporins
•	 Nitrofurantoin
Recurrent Cystitis
•	 recurrent cystitis in females is 
very common and is usually re-
infection
General Measures
•	 good fluid intake
•	 local hygiene
•	 sexual intercourse
•	 void before and after 
intercourse
•	 avoid spermicidal creams and 
diaphragm contraceptives
 › topical oestrogens for 
atrophic vaginitis
 › treat constipation
Specific Measures
Three options:
1. Continuous low dose 
chemoprophylaxis 
Nitrofurantoin, Cephalosporin 
nocte dose for 6-9 months
2. Post intercourse single dose 
therapy if UTIs related to 
intercourse. Antimicrobials as 
above
3. “Self-start” Therapy. Patient 
has supply of treatment (usually 
Fluoroquinolone), when 
symptoms of cystitis begin send 
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urine specimen for culture and 
initiate therapy, attend doctor 
few days later when culture 
result available
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Introduction
In a normal urogynecology 
practice, physicians might from 
time to time see patients with 
underlying neurologic diseases.  
These women may present to the 
clinic with symptoms of lower 
urinary tract dysfunction including 
incontinence, incomplete bladder 
emptying or recurrent bladder 
infections.  It is important to have 
a basic knowledge of possible 
underlying neurological conditions 
that might cause these symptoms.  
It is not the aim of this chapter to 
include all neurologic conditions 
and give a complete overview 
of all the possible treatment 
modalities.  It is, however, 
important to understand the basic 
concepts and therefore a proper 
knowledge of the physiology and 
anatomy of bladder function is 
essential.  The physician will then 
be able to localize the site of the 
lesion and adjust the treatment.  
It is also important to know of 
treatment modalities so that the 
patient can have access to different 
options if necessary.
NLUTD (neurogenic lower urinary 
tract dysfunction) is a condition 
where diagnosis and treatment 
needs to be tailored to the 
individual patient and underlying 
disease. It is often the most 
challenging as well as the most 
gratifying condition to treat and 
care for.
Physiology
Normal voiding is a complex 
interaction of supraspinal and 
spinal control.  This will cause 
relaxation of the urethra and 
sustained contraction of the 
detrusor to facilitate complete 
empting of the bladder.
Neural control of normal 
Chapter 11
Neurogenic Bladder
Frans van Wijk
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micturition is a complicated system. 
A simplified summary is as follows:
The supra-pontine control centres 
in the frontal cortex of the limbic 
area and the cerebellum have an 
inhibitory effect on the function 
of the bladder.  The pons has 
two regions, the M- region for 
stimulation and the L- region 
for inhibition.  The spinal cord 
will relay the sympathetic, 
parasympathetic and somatic fibers 
to the lumbar and sacral areas 
and the parasympathetic system 
will stimulate the detrusor muscle 
whereas the sympathetic system 
will increase outflow resistance.  
The somatic system has control of 
the rhabdo muscle of the urethra 
as well as control of the pelvic 
floor muscles. All 3 systems must 
work in balance to create normal 
storage and voluntary voiding of 
the bladder.
A neurogenic bladder can 
be described as the effect of 
neurological disease on lower 
urinary tract function.
To understand the function better 
the different systems will be 
discussed separately.
Central nervous system (CNS)
The cortical pathways originate 
in the pre central gyrus, lateral 
prefrontal cortex and anterior 
cingulate gyrus.  These centers 
mainly inhibit the midbrain area, 
the so-called pontine micturition 
center (PMC). CNS control of 
micturition centers around the 
middle pons.  Barrington showed 
in cats that the motor tone of the 
bladder arises in this region.  The 
Pontine Micturition Centre (PMC) 
is called the M-region and causes 
stimulation of detrusor muscle 
and relaxation of the sphincter. 
Stimulation of this center will 
lower urethral pressure, inhibit 
pelvic floor contraction and 
stimulate detrusor contraction.
Stimulation on the same level as 
the M-Region but more lateral, the 
so called L-region, will stimulate 
Onuf’s nucleus to contract the 
urethra.  Thus the midbrain will 
control either storage or emptying 
function of the bladder through 
the M and L pontine micturition 
regions.
CNS control centers around the 
middle pons, where Barrington 
showed in cats that the motor tone 
of the bladder arises, is the most 
important. 
The midbrain gets inhibitory and 
stimulatory control from many 
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different regions in the brain 
namely frontal cortex, cerebellum, 
and hypothalamus.
The main neurotransmitters in the 
CNS are glutamate for stimulation 
and GABA and glycine for 
inbibition.
A central concept in the 
development and organization of 
the brain is plasticity. This means 
that the brain can adjust its hard-
wiring through conditioning or 
external stimuli.
This is mainly achieved by 
the organization of the 
interconnections through the 
white matter. It is now understood 
that the white matter is an 
extremely dynamic part of brain 
development.
The changes of aging on the 
brain have a variable effect and 
may cause abnormal sensory 
perceptions or reduced inhibition 
of bladder function.
Parasympathetic System
Parasympathetic stimulation 
will start in the M-regions of the 
pontine micturition center to the 
intermedial grey matter of the 
spinal cord at level S2-4.These 
fibres will then emerge from the 
piriformis muscle overlying the 
sacral foramina and form the 
pelvic plexus which in turn supplies 
the pelvic organs.  The fibres 
terminate in ganglia in the wall of 
the bladder making it vulnerable 
to injuries of the bladder e.g. over-
stretching, infection or fibrosis.
In the ganglia, the nerves 
are stimulated by nicotinic 
acetylcholine receptors.  Other 
neurotransmitters are also active at 
ganglia level but not as important.
Postganglionic parasympathetic 
fibres diverge and store 
neurotransmitters in synaptic 
vesicles. On electrical impulse 
the vesicle binds to the synaptic 
membrane and deposits the 
acetylcholine in the synapse to 
stimulate muscarinic receptors 
on the muscle fibres stimulating 
muscle contraction through 
intracytoplasmic calcium release.
Sympathetic system
Sympathetic stimulation 
reaches the bladder through 
preganglionic fibres from 
thoracolumbar spinal segments 
that synapse in paravertebral 
and paravertebral sympathetic 
pathways.  Postganglionic neurons 
reach the upper vagina, bladder, 
proximal urethra and lower ureter 
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through the hypogastric and 
pelvic plexuses. The sympathetic 
preganglionic neurotransmitter 
is mainly acethylcholine, acting 
on nicotinic receptors and post 
ganglionic transmitters, primarily 
norepinephrine.  Stimulation of 
B-adrenergic receptors in the 
bladder causes relaxation of the 
smooth muscle and stimulation 
of alpha-one receptors in the 
bladder base and smooth muscle 
of the urethra causing muscle 
contraction.
Norepinephrine also suppress 
secretion of the presynaptic 
parasympathetic cholinergic 
neurotransmitter. Urine storage 
is thus attained by detrusor 
relaxation, urethral muscle 
contraction and inhibition of 
parasympathetic stimulation all 
through sympathetic stimulation.
Somatic innervation
Skeletal muscle is present in the 
distal portion of the urethra 
and pelvic-floor muscles.  The 
innervations come from Onuf’s 
somatic nucleus in the anterior 
horn of S2-4 segments.  This 
nucleus gives rise to the pudendal 
nerve, which supplies the rhabdo 
urethral sphincter.  Important 
neurotransmitters include 
serotonin and norepinephrine. 
These increase the effect of the 
excitatory neurotransmitter, 
glutamate, on pudendal motor 
neurons.  The effects on the 
rhabdo sphincter are achieved 
by acetylcholine stimulation of 
nicotinic cholinergic receptors.
Sensory pathways
The two important sensory 
feedbacks are transported to the 
central nervous system through the 
parasympathetic and sympathetic 
system.  They have a contra and 
ipsilateral supply.
Proprioceptive endings are present 
in collagen bundles in the bladder 
and these are responsible for 
stretch and contraction sensations.
Free nerve endings (C fibres) are 
in the mucosa and submucosa 
and stimulated through pain 
and temperature.  The sensory 
endings contain acetylcholine and 
substance P.
Urethral sensation is transmitted 
mainly through pudendal nerve.
Central areas that receive bladder 
and urethral sensation are the 
periaqueductal grey matter (PAG), 
insula and anterior cingulate gyrus. 
An area in the frontal cortex is 
also activated at times of filling.  
A study of both normal patients 
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and those with overactivity of the 
bladder showed different areas 
of predominant activity. Using 
functional magnetic resonance 
imaging (fMRI)4), the insula is 
stimulated to a greater extent 
anteriorly with unpleasant bladder 
sensations.  These sensations are 
received by the PAG and mapped 
in the insula. It would therefore 
seem that  not only normal sensory 
impulses but also abnormal 
impulses or abnormal mapping are 
responsible for overactivity of the 
bladder.  It is easy to understand 
that diffuse neurologic disorders 
might have an effect on the 
perception of sensory impulses of a 
normal LUT.
Epidemiology
There are no exact figures on the 
prevalence  of neurologic disease 
of the lower urinary tract.  It is 
important, however, to recognize 
that patients with neurological 
disease should be evaluated for 
lower urinary tract function.  Any 
patient with unexplained lower 
urinary tract symptoms should be 
evaluated for possible neurologic 
abnormality.  It is even more 
important that, before invasive 
surgery, including prolapse 
and incontinence operations, 
that neurological conditions 
are considered, especially if the 
symptoms do not fit together.
Classification
It is clear from the previous 
physiologic description that 
a simple classification is not 
possible.  Therefore, the physician 
should evaluate detrusor and 
sphincteric function as separate 
entities.  Both of these can be 
either normal, hyperactive or 
hypoactive in function.  It is also 
important to make sure that 
there is co-ordination between 
the detrusor and sphincteric 
function.  Sphincteric function has 
an autonomic (sympathetic) and 
a somatic control.  Incoordination 
is described as detrusor-sphincter 
dyssynergia.  The diagnosis of 
detrusor-sphincter-dyssynergia will 
not state which system causes the 
outflow obstruction (sympathetic 
or somatic). These can, however, 
be differentiated by proper 
examination.  A distinction should 
be made between detrusor-smooth 
muscle sphincter dyssynergia 
or detrusor-striated muscle 
dyssynergia.
The higher the lesions, the 
more hyperactivity we find and 
the lower the lesion, the  more 
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hypofunction.
The evaluation of the patient 
should include:
•	 Detrusor function
•	 Urethral function
•	 Co-ordination between the two
Neurologic 
Conditions
Supra-pontine lesions
Supra pontine lesions e.g. 
 
This classification will give a good description of the pathophysiology as 
well as guide further treatment
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Alzheimer or stroke patients.  
These conditions will lead to less 
inhibition of bladder control.  It 
is important to understand that 
aging will cause atrophy of the 
cortex and can therefore also 
cause less control of the bladder 
function.  This might not directly 
be associated with pathology but 
occur as part of the normal aging 
process.  High lesions will mostly 
cause over activity of the bladder 
but coordinated voiding with 
normal urethra.
Diverse neurologic conditions:
Parkinson’s disease
Parkinson’s disease gives a diffuse 
dysfunction of the neurologic 
system  because of degeneration 
of primarily the dopaminergic 
neurons. Dopamine deficiency 
in the substantia nigra accounts 
for the classical motor features 
of the disease.  This leads to 
resting tremors and slow onset 
of movements.   This condition 
will only cause lower urinary tract 
dysfunction after many years and 
there is a slow progression in the 
disease.   Treatment must always 
take into consideration that 
the condition might deteriorate 
and that the patient might lose 
proper motor activity of the hands 
and later not be able to self-
catheterize.  Treatment decisions 
must take into account the 
progression of the disease.
If lower urinary tract symptoms 
develop early then Multiple System 
Atrophy (MSA) must be considered.
Voiding dysfunction occurs in 
35-75% of patients. It normally 
consists of frequency, urgency, 
nocturia and urge incontinence. 
Urodynamically they normally have 
detrusor overactivity. Generally 
they have coordinated sphincters 
although sporadic involuntary 
activity of the striated muscle 
might occur as shown by EMG 
measurements without any true 
obstruction.
 
Multiple Sclerosis (MS)
Multiple Sclerosis is a progressive 
disease affecting young and 
middle aged people with 
twofold predilection for 
females. The primary lesion is 
neural demyelination with axon 
sparing and it is possibly immune 
mediated. Demyelination often 
affects the corticospinal and 
reticulospinal columns of the 
spinal cords. Therefore voiding and 
sphincteric dysfunction is common.
Voiding symptoms will be present 
in 50-90% of patients. Detrusor 
overactivity with striated sphincter 
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dyssynergia is the most common 
finding. Detrusor areflexia might 
also be present. Up to 15% of 
patients might present with the 
urinary symptoms before the 
primary neurologic diagnosis of 
Multiple Sclerosis is made.
Multiple System Atrophy (MSA) 
This is a progressive degenerative 
neurologic disease that is 
characterized by combination of 
Parkinsonism, cerebellar ataxia 
and autonomic failure.  In this 
condition the lower urinary 
tract function will be affected 
fairly soon after the start of the 
disease.  Therefore, aggressive 
rehabilitation for the urinary 
tract dysfunction is often not 
indicated and not very satisfactory.  
The cause of the disease is 
unknown and it is a progressive 
neurodegenerative condition with 
a life expectancy of a mere 9 years. 
The so called Shy-Drager syndrome 
is possibly the end stage of the 
disease.
Spinal cord damage
Spinal cord damage, as in spinal 
cord injuries, spina bifida patients 
and compression of the spinal cord 
due to disc compression, tumors 
or cysts as well as cauda equina 
lesions can all lead to different 
types of fallout of the bladder and 
sphincter control. 
These patients will normally end 
up having treatment in a center 
for neurologic rehabilitation.  It 
is important to have a high index 
of suspicion for cauda equina 
lesions or spinal cord compression 
in patients that develop new 
symptoms of lower urinary tract 
dysfunction, especially if it is 
associated with fallout in the lower 
extremities. It is normally caused 
by central disc compression at the 
level of L5 or S1 where the cauda 
equina is central in the spinal 
space before it exits through the 
foramina. Cauda Equina syndrome 
is characterized by perineal 
sensory loss, loss of both anal 
and bladder voluntary sphincters 
and sexual responsiveness. They 
have acontractile detrusor muscle 
and no bladder sensation.   These 
patients will have to be evaluated 
urgently to prevent permanent 
damage. Even with emergency 
decompression, permanent 
detrusor areflexia is common.
Complete spinal cord lesions below 
T6 will normally give detrusor over 
activity with smooth sphincter 
synergia and striated sphincter 
dyssynergia. Sensory loss will also 
be present below the lesion.
 
Lesions above T6 might have 
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smooth muscle sphincter 
dyssynergia as well, because of 
sympathetic damage.
 
Treatment of spinal cord injuries 
should aim to create a low-
pressure system and emptying with 
clean intermittent catheterization.
A complication of the above T6 
lesions is Autonomic Hyperreflexia. 
This is characterized by an acute 
autonomic response (primarily 
sympathetic) causing headache, 
hypertension and flushing of the 
body above the lesion. Avoidance 
of stimuli in susceptible patients 
is important and sublingual 
nifedipine either as prophylactic 
or therapeutic treatment seems 
very effective. Dosage of 10- 20 
mg might be used as it prevents 
smooth muscle contraction 
through calcium channel blockade.
 
Transverse myelitis is a rapidly 
developing condition affecting 
motor, sensory and sphincter 
function. It will mostly stabilize in 
2-4 weeks and recovery is usually 
complete.
Peripheral Nerve Damage 
Peripheral nerve damage is 
normally associated with diseases 
like diabetes, herpes virus 
infection, Guillain-Barre Syndrome 
and surgical trauma to pelvic 
plexus during radical surgery to 
the pelvic organs.    In obstructed 
labor, minor damage can happen 
to the innervation of the lower 
urinary tract.  This will normally 
lead to atonic or hypoactive 
function of the detrusor or 
sphincter muscle. Fortunately, 
damage to the pelvic plexus is 
often transient and temporary 
measures are strongly advised in 
the initial period. The condition 
will stabilize and function will 
return spontaneously to the pelvic 
plexus.  Correction of the under 
lying neurologic damage is almost 
never possible.
Diverse
HIV
The true incidence of lower urinary 
tract symptoms in the acquired 
immunodeficiency syndrome is 
not known. The whole spectrum 
of dysfunctions can be present in 
these patients but seems to be in 
the more advanced stages of the 
disease. Treatment principles are 
the same as other neurological 
conditions.
Fowler Syndrome
This syndrome presenting in young 
women below 30 presenting 
with acute retention and often 
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have polycystic ovarian disease. 
A classical EMG finding of the 
sphincter was described by 
Fowler characterized by the 
inability to relax the sphincter. It 
is in the absence of demonstrable 
neurologic disease and very 
susceptible to neuromodulation 
therapy. 
 
Clinical Evaluation
The evaluation of the neurologic 
patient includes the normal 
physical, biochemical and dynamic 
testing that is important in all 
patients with lower urinary tract 
symptoms.  The only difference 
is that special attention must be 
taken to include the state of the 
upper tract and neuromuscular 
evaluation.  EMG measurements 
will give a better understanding of 
the exact lesion.  
History and physical 
examination
Thorough history and physical 
examination is necessary with care 
to evaluate perineal sensation, 
sphincter tone and lower extremity 
reflexes and sensation. Abdominal 
examination will sometimes detect 
a full bladder.
Remember that the neurogenic 
patient might have the normal 
anatomic abnormalities of the 
urogynae patient and good pelvic 
floor examination must be carried 
out.
Knowledge of the dermatomes 
and reflexes will help to localize 
the lesion. 
Special investigations
Ultrasound of the bladder, urine 
dipstick and serum creatinine is 
indicated.  If any abnormality is 
picked up with these screening 
tests, the necessary workup must 
be done.
Urodynamic evaluation
Standard Urodynamic testing 
gives information on bladder and 
urethral function. To evaluate 
co-ordination between bladder 
contraction and urethral relaxation 
cystometogram and EMG or 
video urodynamics will give more 
information.  
In the neurogenic patients, 
urodynamic studies are very 
important to evaluate the precise 
function of the lower urinary 
tract. Urodynamic studies should 
be performed in a specialized unit 
where good studies will be done 
as well as EMG measurements 
of the pelvic floor if needed. 
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Video urodynamics or ultrasound 
visualization of the bladder and 
the bladder outlet might enhance 
the information available on 
normal urodynamic studies. In a 
high-pressure bladder system with 
detrusor pressures reaching more 
than 40 cm of water, especially in 
the presence of detrusor sphincter 
dyssynergia, it might lead to 
upper tract deterioration.  The 
physician must make sure that 
proper knowledge of bladder 
function as well as urethral and 
pelvic floor activity is known after 
a full urodynamic evaluation. 
Specific attention should be given 
to sensation of the bladder at the 
time of    urodynamic study to plan 
further treatment.  Urodynamic 
evaluation must always try to 
mimic the real life symptoms 
during the study.
Specialized tests
1. Ice water test might give 
information on the difference 
between reflex and areflexic 
neurologic bladders, but is 
controversial.
2. Betanecol super sensitivity 
test might also give more 
information on the difference 
between neurologic or miogenic 
a contractile bladders.  The 
current recommendation is that 
it has to be used with care and 
only as part of a full evaluation.
3. EMG of the sphincter.  It is 
recommended that EMG of the 
urethral sphincter can be used 
in the diagnosis of neurologic 
bladder dysfunction.  There is 
not a good correlation between 
anal sphincter activity and 
urethral function.
4. The following tests are currently 
still experimental and there is 
no clear clinical proof that it will 
add to the information on the 
specific patient.
EMG of the detrusor muscle
Dynamic bulbocaverneus reflex
Nerve conduction studies
Somatosensory evoke potentials
Electro sensitivity of the low 
urinary tract
Sympathetic skin response
More research is necessary before 
these specific tests can prove to be 
useful as a clinical tool.
Treatment   
                                                                                                                                
AIMS: 
•	 Protect renal function, prevent 
infection
•	 Restore continence
•	 Restore emptying
•	 Controlled collection of urine 
if restoration of function not 
possible
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Planning of treatment is important 
as the underlying disease and 
the effect on the lower urinary 
tract symptoms is almost never 
stable and neither is the physical 
condition of the patient.  These 
patients are therefore better 
cared for in a team situation or 
with close interaction with the 
neurologist.
Underlying condition should be 
stable.
E.g. - The spinal cord injury patient 
needs to be over the shock phase.  
The Parkinson patient, on effective 
treatment.  
The stroke patient rehabilitated 
and stable, etc.
Mobility of the patient
The next component of decision 
making is the mobility of the 
patient.  Both in their ability to 
get to the toilet as well as good 
hand function and mobility.  
Treatment like timed voiding, self 
intermittent catheterization and 
catheter care might be impossible 
for certain patients.  In other cases 
the patient might have access 
to support like nurses, family or 
institutions that can help with 
care of basic body functions, the 
decision making might  differ 
according to circumstances.
Kidney Function
It is very important for the 
treating physician to remember 
the effect of the lower urinary 
tract symptoms on kidney function 
before decisions on treatment 
are made. Unstable bladder with 
detrusor sphincter dyssynergia 
(DSD) will lead to impairment of 
kidney function. If augmentation 
or diversion procedures are 
considered, kidney function and 
upper tract anatomy should be 
evaluated.  Absorption of urea 
and electrolytes by the intestinal 
interposition can cause metabolic 
changes.
Conservative treatment
Conservative treatment entails 
triggered reflex voiding, bladder 
expression through crede or 
valsalva maneuver, timed voiding 
and fluid restriction.  This 
treatment is normally given for 
supra-spinal lesions because of 
balanced bladder function.  In the 
spinal lesions, diffuse neurologic 
conditions and lower lesions it 
must only be considered if the 
bladder is a low-pressure system.  
The reason is that there may 
be D-S-D with a risk to kidney 
function.
Conservative treatment must 
always form part of the total 
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treatment of the patient, even 
in cases where more invasive 
treatment is indicated.  It is 
difficult in the neurologic patient 
to completely restore normal 
function, therefore measures like 
timed voiding, fluid restriction and 
effort to empty completely need 
to be emphasized constantly. Pelvic 
floor exercise are normally not 
indicated in neurologic conditions 
but might give some improvement 
in patients with MS.  Electric 
stimulation or biofeedback have 
the same limitations.
Catheters
Catheters are used to drain 
the bladder in patients where 
retention or incomplete voiding is 
present.  They can also be used in 
incontinent patients, especially if 
cognitive function is impaired.
Intermittent catheterization can 
be used if the storage pressures 
are low, the bladder has a good 
capacity and there is good hand 
control.  Clean self-intermittent 
catheterization is still the best 
way to empty the bladder.  It is 
important to motivate the patient 
to start doing it.  Once they are 
used to it the result is usually good. 
The recommended frequency is 
4-6 times per day with a bladder 
capacity of not more than 400ml 
and a 12-14-size catheter is used.
Indwelling catheters are inserted 
either suprapubically or trans-
urethrally for patients where 
there is either a high-pressure 
system or the possibility of self-
catheterization is not available, 
or in cases where patients lose 
mobility or cognitive function.  
There are significantly more 
risks with indwelling catheters 
compared to CISC and Silicone 
catheters should be used.
Catheters normally need changing 
every 3 months but there are some  
patients that might need more 
frequent changing.  Crystallization 
and blocking are the biggest 
problems
Recommendations On The Use 
Of Catheters
Self clean intermittent 
catheterization is superior to any 
of the other techniques as long as 
the bladder is not a high-pressure 
system.
Indwelling catheters are safe 
and sufficient for short-term 
management of urinary retention.  
The use of indwelling catheters 
routinely for the management 
of the neurologic bladder is not 
recommended.
Complications of supra-pubic 
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catheters are similar to those of 
urethral indwelling catheters.  
Apart from insertion, that has a 
higher risk, supra-pubic catheters 
have the possibility of bowel 
perforation and urethral catheters 
cause urethral incompetence over 
time.
Protective pads and diapers, 
protective clothing or pads for the 
incontinent patient is sometimes 
the only way to protect the patient 
from skin reactions and a bad 
odour.
Pharmacotherapy
Pharmacotherapy is mainly used 
for overactivity of the bladder.  
There are practical options for 
improving of bladder emptying.   
Again, as  with the previous 
treatments, the detrusor function, 
as well as the urethral function 
have to be seen as separate 
entities and a decision on which 
pharmacotherapeutic  agent 
will work best in each specific 
instance is important.  Only broad 
guidelines will be given on which 
treatment modalities will work 
better for a specific condition.
Drugs Available For Treatment 
Of Neurologic Lower Urinary 
Tract Overactivity:
Detrusor muscle relaxing drugs:
•	 Oxybutynin
•	 Darifenacin
•	 Solifenacin 
•	 Tolterodine
•	 Properverine
•	 Trosium
•	 Propantholene
•	 Flavoxate
•	 Tri-cyclic anti-depressants
Discussion
Drugs to reduce over activity of 
the bladder and increase the 
storage function of the detrusor.  
The mainstay of treatment in this 
group are the   anticholinenrgic 
drugs.  The newer anticholinergic 
drugs as in Oxybytinin, Darifenacin, 
Tolterodene and Solifenacin are 
all available as a long acting 
preparations.  This gives better 
long-term effects and less side 
affects.  The side effect profile of 
the different medications is well 
known as in central nervous system 
effects, cardio vascular effects, 
dry mouth and constipation.  
There are specific advantages 
and disadvantages of each of 
the long acting anticholinergic 
medications.  It is important to 
decide which ones will work 
best in a specific case and it is 
important to make sure the 
patient complies with the intake of 
the medication and that the long 
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term effect thereof is measured.  
With proper care and information 
the side effect profile is limited. 
Oxybutynin is also available as 
an intravesical installation as 
well as a transdermal absorption 
application.  There is no clear 
recommendation that any of these 
drugs is superior in all cases of 
detrusor over activity.
Drugs work on nerve function
•	 Valinoïds eg. Capcacin and 
Resinoferatoxin blocks sensory 
nerves for afferent sensation to 
the brain.
•	 Botulinum toxin
 
Vaniloids
The study showed that 
Resinoferatoxin is a much more 
potent sensory antagonist than 
Capcacin and is superior in terms 
of efficacy.  In studies it has 
been shown that the maximum 
cystometric capacity increased 
significantly but it did not change 
detrusor pressure significantly.  It 
is currently recommended that 
further randomized trials must 
be done to determine the exact 
place for this treatment modality.  
It has been studied in neurogenic 
bladders and compared to Botox 
but shown to be less effective.
Botulinum toxin A
Botulinum toxin A is the most 
potent biologic toxin known 
to man.  It binds the snap 33 
docking protein in the nerve 
terminal.  Inhibiting acetylcholine 
release from the nerve terminal 
and thus preventing muscle 
contraction.  This can give clinical 
improvement for six to nine 
months in neurologic patients by 
lowering detrusor contraction and 
increasing bladder capacity. 
Numerous studies have been 
done which shows efficacy of 
the Botulinum toxin, starting 
within the first six days and 
has an optimum effect after six 
weeks.  The individual response is 
fairly specific for a patient.  If the 
effect lasts for six months the first 
time, the follow up injection will 
normally also last about that long.   
The current use in neurologic 
overactivity is 300 units as an intra-
vesical injection. Two Botulinum 
type A toxins are available. Botox 
is most widely used in current 
studies.  Botox is normally given 
as a 10 unit per m/L in 30 different 
sites of the bladder.  It can be 
given under general, regional 
or local anaesthetic.  No clear 
randomized study has been done 
to evaluate the specific treatment 
strengths.   Botulinum toxin can 
also be used into the sphincter to 
reduce the outflow resistance.  The 
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dose used in the sphincter is 50 – 
100 units.  It was clearly shown to 
reduce the post void residual. 
The side effect profile is extremely 
low and systemic complications 
almost unheard of. Other form of 
Botulinium A (Dysport) has been 
studied but not as widely and is 
also effective with other possible 
side effects, and different dosage 
regimens.
Drugs to enhance sphincter 
function
•	 Alpha -adrenergic agonists
•	 Estrogens
•	 Beta-adronergic agonists
•	 Tri-cyclic anti-depressants
Several drugs including Alpha-
Adronergic agonists, Estrogens, 
Beta-adrenergic agonists, as well 
as Tricyclic anti-depressants have 
been used to increase the bladder 
outlet resistance.  There is no 
clear recommendation whether 
these can be used for long-term 
treatment of sphincter deficiency.
A noradrenaline serotonin re-
uptake inhibitor (duloxitene) has 
been well studied and will increase 
urethral resistance.  The side effect 
of this is nausea and it is also used 
in the treatment of depression. 
Drugs to facilitate bladder 
emptying
•	 Alpha adrenergic blockers – 
lowers urethral resistance e.g. 
Tamsulosin, alfuzosin,  
•	 Cholinergic - increases detrusor 
contraction
Discussion
1. Alpha-Adrenergic blockers:  
Alpha-adreno receptors 
have been reported to be 
predominantly present in the 
bladder base and urethra.  
Alpha-blockers can therefore be 
used to lower the resistance of 
the bladder neck and urethra.  
They have been proven to lower 
the detrusor leak point pressure 
in children.
2. Cholinergic: In general Betanecol 
chloride seems to be of limited 
benefit of detrusor areflexia 
and for elevated residual urine.  
These drugs should not be used 
in the presence of detrusor 
sphincter dyssynergia.
Invasive treatment
Neuromodulation and electrical 
stimulation
Sacral nerve neuro modulation 
has been well proven to treat the 
refractory overactive bladder as 
well as the imbalance in pelvic 
floor stimulation.  It is essential 
that there be normal neural 
connections for this modality 
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to be effective.  The efficacy of 
the sacral neuromodulation also 
includes afferent stimulation and 
therefore intact neuropathways 
are necessary.  It does not work 
in the spinal cord injury or 
spina bifida patients.  The sacral 
neuromodulation is an electrode 
placed usually at S3 foramina and 
left in as a temporary stimulation 
for 2 to 3 weeks.  If there is a more 
that 50% improvement in their 
symptoms, a permanent generator 
is implanted on the lateral aspect 
of the buttock.  This can be set 
with an external programmer.  The 
placement of the electrode can 
be done in different positions, 
periurethrally or next to the 
pudendal nerve. Sacral root 
stimulation is currently the most 
extensively documented. 
 
Electrical Stimulation
Sacral anterior root stimulation.  
This is not a technique that 
will normally be done at the 
urogynaecology clinic but is more 
for specialized spinal units.  It is 
only performed on spinal patients 
where a posterior rhizotomy has 
been done.  This is an exciting 
development but not for discussion 
at this level.
Augmentation procedures
Detrusor Myectomy: (auto-
augmentation)
This will produce a diverticulum in 
the dome of the bladder if ±20% 
of detrussor muscle is removed. 
The urothelium is left intact.  It is 
mostly done as an extraperitoneal 
procedure.  Laparoscopic 
techniques are also described.
Enterocyctoplasty
It is the best reproducible 
operation to enlarge bladder 
capacity and increase storage 
function of the bladder especially 
in the small fibrotic bladders.   
Complications include infection, 
mucus production and incomplete 
bladder emptying.  Absorption 
through bowel might lead to 
metabolic acidosis.  Kidney 
function evaluation is very 
important before the procedure is 
considered. Ileum clam cystoplasty 
is done most often.  The 
urotheluim can be left intact and 
the bowel muscle used to cover 
it.  This will decrease the mucus 
production, and absorption.
Bladder replacement
New bladder can be preformed for 
patients with severely contracted 
and damaged bladders.  Small 
or large bowel can be used and 
a good storage pouch will be 
formed. The pouch is connected 
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to the sphincter.  The majority of 
these patients will have to self-
catheterize.
Procedures to enhance outflow 
resistance
Bulking agents can be used to 
increase passive urethral closing 
pressure.  The result of bulking 
agents is ± 60% in improving the 
incontinence.  
Mid-urethral slings
Mid- urethral slings are classically 
used for stress urinary incontinence 
(SUI). They are also very effective 
in the neurologic patient with SUI.
    
Mid urethral slings can also be 
used to obstruct the urethra in 
patients with a hypotonic urethra.  
It is better to use retropubic mid-
urethral slings for obstructive 
procedures than trans-obturator 
routes or mini slings.  The patient 
then has to self catheterized if 
the outflow is obstructed and the 
storage function of the bladder is 
normal.
 
Artificial sphincter  
The artificial sphincter (AMS800) 
can be used to close the bladder 
outlet. It is opened using a special 
valve system and the patient can 
void spontaneously if she has 
normal detrusor function.  Self-
catheterization can also be used 
with the sphincter if she has 
voiding dysfunction.
Diversions
Continent urinary diversions:  if 
the normal urinary tract cannot 
be used for storage and emptying 
function, a continence pouch can 
be formed, through which the 
patient will self-catheterize.  The 
technique is fairly difficult and the 
complication rate in the long term 
is relatively high.  These include 
infections, stone formation, 
mucus production, strictures of 
the stoma or ureter and metabolic 
disturbances. Small or large 
intestine can be used for the pouch 
and a number of valve mechanism 
can be formed
Conduit diversion: an incontinent 
diversion can be made with ileum 
and anastomosis of the ureter to 
a short piece of ileum.  The classic 
Bricker Ileostomy is still used for 
patients where no restoration of 
normal urinary tract can be done.
Bladder disconnection
In cases where there is a damaged 
bladder with a hypoactive or 
dilated urethra and incontinence, 
a bladder disconnection should 
be considered, especially if the 
patient’s mobility or hand function 
94
is not good.  The urethra can be 
closed and a permanent supra 
pubic catheter placed.  The 
urethral disconnection can be done 
as a vaginal procedure under local 
anaesthetic.
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Incidence
This is a rare condition occurring 
mainly in middle-aged women 
with a female to male ratio of 
10:1.
Etiology
There are many theories regarding 
the etiology of interstitial 
cystitis but a  deficiency of 
glycosaminoglycans (GAGS) in the 
urothelium is best documented. 
GAGs are the  polysaccharide 
macromolecules which cover the 
urothelium of bladder, preventing 
noxious substances in urine 
(such as potassium) penetrating 
urothelium and the bladder wall. 
GAG deficiency leads to urine 
penetrating the bladder wall, 
release of neuropeptides resulting 
in pain.
Clinical Features
Pain
•	 very debilitating
•	 suprapubic pain
•	 worse with a full bladder
•	 improved after voiding (doesn’t 
disappear)
•	 may also have perineal pain and 
dysuria
Irritative Voiding Symptoms
•	 severe frequency (day and night)
•	 severe cases may void half-
hourly
Urine
•	 may have a sterile pyuria
Diagnosis
Usually confirmed on cystoscopy 
(under general or regional 
anaesthesia):
Petechial bleeding is seen from 
the bladder wall (particularly after 
second filling of the bladder with 
Chapter 12
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irrigation fluid). There is usually 
a small bladder capacity and 
rarely an area of ulceration of the 
bladder wall (Hunner’s ulcer)
Differential Diagnosis
IC is a diagnosis of exclusion
1. Cystitis – urine dipstick and 
culture
2. TB – urine for AFBs and TB 
culture
3. Bladder carcinoma (particularly 
CIS) – urine cytology
4. Bladder stone – U/S and 
cystoscopy
5. Pelvic infection
6. Endometriosis
Intravesical Potassium Test
If instillation of a solution with 
high potassium concentration 
reproduces the patient’s pain this is 
diagnositic of IC.
Treatment
Medical Treatment
•	 Sodium Pentosan Polysulphate 
(Tavan SP): This is a synthetic 
form of GAG that replenishes 
the deficient GAG layer
•	 Amitryptiline: Useful for pain 
control
•	 Hydroxyzine (Aterax): 
(Antihistamine) Some cases 
of IC are associated with an 
allergic response and hence 
an antihistamine may prove 
beneficial. 
It is recommended that above 
three agents are used together to 
maximise effect.
•	 Anticholinergics: Usually 
ineffective in this condition
Intravesical Treatment
•	 Dimethylsulphoxide (DMSO)
•	 Heparin based solutions
Surgery
•	 Bladder hydrodistention: 
Bladder distention under 
anaesthesia often gives good 
temporary symptomatic relief 
and can be repeated.
•	 Surgery: Only in highly selected 
cases and includes cystoplasty 
to increase bladder capacity 
and occasionally cystectomy and 
urinary diversion.
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Introduction
Despite prolapse being a concept 
readily grasped by generations 
of medical students, a basic 
understanding of the concept has 
changed recently. This chapter 
will highlight some of the new 
developments in pelvic organ 
prolapse (POP), and examine 
modern surgical interventions with 
evidence supporting their use.
How Common Is 
Prolapse?
Pelvic organ prolapse (POP) is a 
distressingly common condition 
and 11% of women have a lifetime 
risk of surgery for this condition. 
Despite this, its aetiology is 
poorly understood, and the 
natural course of prolapse is 
grasped more in the anecdotal 
than scientific arena. With an 
Chapter 13
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aging population, reconstructive 
surgery for the management of 
pelvic organ prolapse (POP) will 
command increasing resources. 
Surgery is required to correct 
symptoms of POP, restore the 
anatomy, retain bowel, bladder 
and sexual competence, and be 
durable. We intuitively perceive 
that prolapse is the result of aging, 
vaginal parity, chronic elevation 
of intra – abdominal pressure and 
hysterectomy. Following novel 
anatomical insights occasioned by 
the cadaver dissections of Delancey 
and Richardson before him, a 
new description of prolapse and 
classification of the staging has 
emerged.
We have hitherto considered 
pelvic organ prolapse as consisting 
of a cystocoele (prolapse of the 
bladder), uterine or vault prolapse 
(depending on whether or not the 
uterus is present), or a rectocoele 
(prolapse of the rectum). Whilst 
98
we suppose that the cystocoele 
contains the bladder, a vault 
prolapse consists of the apex of the 
vagina and a rectocoele contains 
part of the rectum, this is not 
always the case.
New Definitions
Pelvic Organ Prolapse(POP) is the 
descent of one or more of anterior 
vaginal wall, posterior vaginal 
wall, and apex of the vagina 
(cervix / uterus) or vault (cuff) after 
hysterectomy.
Anterior vaginal wall prolapse 
(previously termed a “cystocoele”) 
is descent of the anterior vagina 
so the urethra – vesical junction (a 
point 3cm proximal to the external 
urinary meatus) or any anterior 
point proximal to this, is less than 
3cm above the plane of the hymen.
Prolapse of the apical segment 
of the vagina (previously termed 
“vault prolapse”) is any descent 
of the vaginal cuff scar (after 
hysterectomy) or cervix, below a 
point which is 2cm less than the 
total vaginal length above the 
plane of the hymen.
Posterior vaginal wall prolapse 
(previously known as a 
“rectocoele”) is any descent of 
the posterior vaginal wall so that 
a midline point on the posterior 
vaginal wall 3cm above the level of 
the hymen or any posterior point 
proximal to this is, less than 3cm 
above the plane of the hymen.
Is Prolapse “Normal”? 
Clearly some degree of prolapse 
is the norm, especially in a parous 
population. Women with prolapse 
beyond the hymenal ring have a 
significantly increased likelihood 
of having symptoms. In a general 
population of women between 
20 – 59, the prevalence of prolapse 
was 31%, whereas only 2% of all 
women had prolapse that reached 
the introitus. Some estimations 
suggest that a degree of prolapse 
is found in 50% of parous women, 
and up to 20% of these cases are 
symptomatic. An estimated 5% of 
all hysterectomies result in vaginal 
prolapse.
Apical prolapse is a delayed 
complication of hysterectomy, and 
follows vaginal and abdominal 
hysterectomy in equal numbers: 
it’s occurrence may be the result 
of damage to the upper vaginal 
supports occurring at the time of 
surgery.
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Urinary Incontinence 
And Prolapse
Urinary incontinence and POP 
are separate clinical entities 
that may or may not coexist. 
Significant protrusion of the 
vagina may obstruct voiding 
and defecation. Surgical repair 
of one pelvic support defect 
without repair of concurrent 
asymptomatic pelvic support 
defects appears to predispose 
to accentuation of unrepaired 
defects and new symptoms.
Women with POP may have to 
digitally reduce their prolapse 
in order to void or defecate. 
Although pelvic anatomy can now 
easily be measured accurately 
and reliably, the relationship of 
these anatomic findings with 
functional abnormalities is 
not well understood. Support 
abnormalities of the anterior 
vaginal wall are common in 
vaginally parous women; but stress 
incontinence is not consistently 
associated with this finding. Distal 
posterior vaginal wall support 
abnormalities may exist with or 
without defecation abnormalities. 
The relationship between anatomy 
and function is one of the most 
pressing research priorities in the 
domain of physical examination of 
women with POP.
When To Operate?
Prolapse is not always progressive, 
and will not necessarily worsen 
with the time. Thus it may be an 
over simplification to suggest 
surgery to avoid an operation “at a 
later stage”.
POP symptoms are vague and 
correlate poorly with the site and 
severity of prolapse. They include:
•	 Pelvic pressure
•	 Vaginal heaviness
•	 Irritative bladder symptoms
•	 Voiding difficulty
•	 Urinary incontinence
•	 Defecatory difficulty
•	 Back – ache
•	 Coital problems
Back – ache and pelvic pain 
may or may not be associated 
with POP. The level of evidence 
to support the notion that 
surgery consistently alleviates 
these symptoms is poor. When 
physiotherapy fails to alleviate 
symptoms of POP, or vaginal 
pessaries are unsuccessful or 
complicated by ulceration, 
then surgical POP repair may 
be indicated in symptomatic 
individuals. Up to 30% of 
operations for prolapse fail. 
It is probably unrealistic to 
100
use weakened native tissue to 
restore fascial defects. Ligaments 
and tissues are attenuated by 
age and childbirth, and further 
traumatised by the dissection and 
de – vascularisation of prolapse 
repair. Healing by fibrosis is 
unpredictable, and the further 
insults of age, obesity and estrogen 
deprivation makes the temptation 
to succumb to prosthetic repair 
seem attractive.
Route Of Surgery
There are hundreds of operations 
described for the correction of 
POP, with either an abdominal or a 
vaginal approach. Most textbooks 
suggest that prolapse surgeons 
be adept at both abdominal and 
vaginal procedures, but in reality 
the majority of POP surgery is 
performed via the vaginal route. 
However there are no good data 
on which to base the decision as 
to route of surgery. Reviewing 
prolapse literature is difficult 
because of the heterogeneous 
nature of the condition, variability 
in inclusion and exclusion criteria, 
the variety of procedures, non 
– standardized definitions of 
outcomes, lack of independent 
reviews and short term follow – 
up.
In general terms, there is 
good level 1 evidence that the 
abdominal approach is more 
robust, effective and durable 
for correcting the anatomy and 
preserving vaginal and lower 
urinary tract function. The 
vaginal route has fewer serious 
perioperative complications. 
Maher demonstrated that vaginal 
sacrospinous colpopexy was 
faster and cheaper with quicker 
return to normal activities, but 
has a significantly higher risk 
of recurrent anterior or apical 
prolapse than abdominal surgery 
using a mesh or sacral colpopexy 
technique. The vaginal approach 
is commonly preferred for the 
obese, chronic strainer who smokes 
and suffers obstructive pulmonary 
disease.
Prolapse And 
Concomitant 
Hysterectomy
Although hysterectomy is 
frequently a bedfellow of POP 
repair, there is no evidence that 
it improves prolapse surgery 
outcomes. In three studies it 
appeared that uterine preservation 
or removal did not affect the 
risk of POP recurrence. Some 
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to conserve the uterus, options are 
restricted and evidence to support 
specific procedures is very limited. 
Recently a number of novel 
techniques have been described 
involving Type 1 Prolene mesh 
placement vaginally, with fixation 
through the obturator foramen 
and sacrospinous ligament. 
(ProliftR: Johnson & Johnson 
Womens Health Urology, PerigeeR, 
ApogeeR, American Medical 
Systems). There is no specific 
need for vaginal hysterectomy 
when these mesh kits are used. 
Lateral prolene straps pass 
through ligamentous structures to 
provide support for central mesh 
hammocks placed without tension 
vaginally. The mesh systems are 
safe and minimally invasive but 
at present long term data are not 
available. Efficacy in the short 
term appears to be promising 
with few side – effects being 
encountered, but review of larger 
studies is desirable. Although these 
procedures using propriety kits 
are easily mastered by proficient 
prolapse surgeons, proper 
training and expert instruction is 
mandatory.
If the surgeon does not wish to use 
a propriety mesh kit, there are a 
few reports of uterine preservation 
authorities feel that hysterectomy 
is a major contributor to the 
occurrence of POP, and is part 
of the problem rather than the 
solution. Theoretically at least, 
cervical conservation at abdominal 
hysterectomy should maintain 
apical support and prevent vault 
prolapse. Randomized trials will be 
needed to asses whether cervical 
conservation prevents vault 
prolapse in the long term.
Procedures For 
Prolapse
Apical (Vault) Prolapse 
Procedures
A well supported vaginal apex is 
the cornerstone of pelvic organ 
support, and recognition of apical 
defects is critical prior to prolapse 
correction. 
Apical Support Procedures With 
The Uterus Present
Establishment of vaginal support at 
the time of vaginal hysterectomy 
is recommended and may be 
achieved by a “prophylactic” 
attachment of the vaginal cuff to 
the uterosacral or sacrospinous 
ligaments (level 4 evidence).
When women with a uterus have 
apical vaginal prolapse and wish 
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with apical support procedures, 
being small retrospective case 
series involving fewer than 50 
cases with short follow – up and 
poorly defined outcomes. (Level 3 
evidence)
Vaginal obliterative procedures 
(colpocleisis) have a role to play in 
stage III – IV POP in cases where 
women no longer wish to preserve 
coital function, and surgery is 
balanced by a positive impact 
on daily activities. The vagina is 
obliterated, the enterocoele is not 
addressed and the uterus is left 
in – situ unless there is separate 
pathology. The procedures are 
gentle with a speedy return to 
normal activity, with good success 
rates described (level 3 evidence). 
The distal anterior vaginal wall 
should be spared and not drawn 
into the operation, to reduce the 
risk of stress urinary incontinence.
Apical Support 
Procedures Post 
Hysterectomy
Transabdominal procedures
Sacrocolpopexy is durable with 
level 1 evidence supporting its use, 
and several workers have reported 
that concomitant hysterectomy 
is safe without any increase in 
surgical risks. Mesh erosions 
range from 3% to 40%. There is 
at present no data to clarify the 
use of routine culdoplasty with 
the procedure, and there are no 
standardized outcome measures to 
assess sacrocolpopexy success.
Level 1 evidence suggests an apical 
prolapse cure in 85% - 90% of 
cases, but quality of life data in 
these cases is very limited. Surgery 
may result in a dysfunctional 
vagina with dyspareunia, and 
so anatomical support does not 
necessarily equate to patient 
satisfaction. The risk of prolapse 
at other sites subsequently has not 
been sufficiently studied.
Abdominal sacrocolpopexy may 
also be approached by means 
of the laparoscopic route, but 
vast experience and patience is 
required to achieve good results 
within reasonable time frames. 
At present little published data 
evaluates laparoscopic vault 
support procedures.
In this country, Cronje 
has performed perineo – 
colposacrosuspension (PCSS) in 
many hundreds of cases, when 
women have stage 3 or stage 4 
prolapse, or stage 2 symptomatic 
103
prolapse - particularly with 
obstructive defecation (sometimes 
combined with a STARR 
procedure). This comprehensive 
repair represents major surgery, 
and is beyond the scope of the 
“generalist” gynaecologist. The 
recurrent prolapse rate is 10%, 
with a 5% occurrence of de – novo 
dyspareunia.
Vaginal Suspensory 
Procedures
The sacrospinous ligament 
suspension
Sacrospinous ligament suspension 
(SSLS) or fixation is popular, 
allowing simultaneous repair of 
anterior or posterior vaginal wall 
defects with less postoperative 
bowel dysfunction. Infrequent 
complications include buttock pain 
or a sacral / pudendal nerve injury. 
The recurrence of a high cystocoele 
is around 22% and may be a 
problem. Randomized trials favour 
the robust abdominal approach 
of the sacrocolpopexy, with the 
reservations mentioned previously.
High uterosacral ligament 
suspension (HUSLS) was first 
reported in 1997, and suspends 
the vaginal apex to the remnants 
of the uterosacral ligaments at 
the level of the ischial spines, and 
maintains the vaginal apex in the 
midline. However ureteric injury 
occurs in up to 11% of cases, with 
post – op bowel dysfunction due 
to recto - sigmoid narrowing. But 
it optimizes vaginal length and 
provides good vaginal support. 
This procedure has the same 
principle of action as the Mayo or 
McCall culdoplasty, although no 
comparative data exist.
Anterior Prolapse 
Procedures
The surgical management of 
anterior vaginal prolapse is 
controversial with limited and 
often conflicting data available. 
The traditional vaginal repair for 
cystocoeles was first described by 
Kelly in 1913, and in controlled 
trials has a 57% chance of curing 
cystocoeles. An abdominal 
approach is also feasible with the 
abdominal paravaginal repair 
having a success rate of up to 97%. 
But the abdominal approach may 
carry significant complications 
– including ureteric obstruction, 
bleeding, haematomas and abscess 
formation.
No randomized control studies 
have evaluated and compared 
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the abdominal, laparoscopic 
or vaginal route of repair in 
isolation. Goldberg and co – 
workers demonstrated in a case 
control study in women with 
anterior prolapse and stress 
incontinence, that the addition 
of a pubovaginal sling to the 
anterior colporrhaphy significantly 
reduced the recurrence of a 
anterior prolapse from 42% in 
the control group to 19% in the 
anterior repair and sling group. 
Which begs the question – does 
the addition of type 1 soft mesh 
to a vaginal repair make the 
procedure more robust, with an 
acceptable complication rate? It 
has already been established that 
the type 1 large pore prolene mesh 
is extra – ordinarily well tolerated 
in the vagina with very few long 
term complications. Workers have 
proposed that a tension – free 
mesh buttress may serve as a 
scaffold for collagen ingrowth and 
so reduce the incidence of repair 
failure.
The ProliftR and PerigeeR systems 
have been developed for this 
purpose and allow minimally 
invasive vaginal techniques 
anchoring a mesh hammock in 
situ by means of mesh extensions 
emerging through the obturator 
foramen. These novel procedures 
have no long – term follow up 
data in the published literature at 
present, and the results of studies 
are awaited with interest. The 
use of mesh would be particularly 
useful where conventional 
techniques have already failed, in 
large defects or in individuals with 
obstructive pulmonary disease 
or other predisposing causes of 
prolapse.
     
The surgeon should bear in 
mind that a certain percentage 
of women develop stress 
incontinence following anterior 
repair procedures. About 15% - 
20% may need urinary continence 
procedures, and all patients having 
anterior repairs must be councelled 
to this effect.
Posterior Prolapse 
Procedures
 
Nowdays several approaches are 
feasible for the repair of posterior 
wall prolapse. 
The Abdominal Route
The abdominal approach is well 
described, and involves placement 
of a mesh buttress anterior to 
the rectum behind the posterior 
vaginal wall fascia, commonly 
as part of a sacrocolpopexy 
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procedure. However a significant 
number of failures are still 
reported, with 10% of women 
needing surgery for complications 
specific to the surgery. The 
laparoscopic approach to the 
posterior prolapse requires further 
evaluation.
The Vaginal Route
Variations abound in transvaginal 
techniques. The traditional Jeffcoat 
levator ani plication produced 
an acceptable anatomical result, 
but 50% of patients described 
significant dyspareunia. 
Continuous midline plication of the 
rectovaginal fascia recognized the 
problems of the levator plication 
and was an advance on this 
earlier technique. More recently 
Richardson attributed rectocoeles 
to breaks in the rectovaginal 
fascia, and advocated the isolated 
repair of the focal defects. 
Discrete fascial repair offers 
good anatomical outcome with 
acceptable sexual function, but 
midline fascial plication is superior 
in correcting obstructed defecation 
in 80% of cases. Site - specific 
repair is less robust and durable 
than midline fascial plication, 
with less entrapment of faeces 
on straining (grade A evidence). 
The recent introduction of mesh 
kits for prolapse of the posterior 
vaginal wall has been alluded to, 
and these prolene mesh hammocks 
with supporting straps which pass 
through the sacrospinous ligament 
are being evaluated.
The Transanal Route
A number of papers have 
appeared describing a novel 
procedure to deal with posterior 
compartment prolapse and 
obstructed defecation. The 
STARR procedure, or “stapled 
transanal rectal resection for outlet 
obstruction”, employs a double – 
stapled circumferential resection 
of the lower rectum together 
with any associated rectocoele, 
intusseception or mucosal 
prolapse. The procedure is popular 
in continental Europe, and uses 
two ProximateR PPH – 01 stapling 
guns (Ethicon Endosurgery, Ohio, 
USA). However evidence to support 
its widespread implementation 
is tenuous at this stage. On the 
basis of two randomized trials,8 
with 3 series of transanal stapled 
resections published to date, it 
seems that this novel procedure 
is of potential benefit but 
needs careful evidence – based 
evaluation. Level 1 evidence 
demonstrates that the vaginal 
approach to rectocoele repair is 
superior to the transanal method.
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Prosthetic Materials 
And Surgery
There are insufficient data at 
present to draw any evidence - 
based conclusions with regard to 
the role of prosthetic materials 
in prolapse surgery. Part of the 
problem arises from the paucity 
of baseline data regarding the 
efficacy of “traditional” anterior 
and posterior vaginal repairs. As a 
result of this the efficacy of adding 
prosthetic material for primary 
or recurrent prolapse affecting 
these compartments is difficult 
to assess. While adding synthetic 
type 1 mesh grafts suggests a 
theoretical advantage, this must 
be balanced against increased cost 
and potential morbidity.
There is also a need for further 
long – term prospective studies, 
ideally in the form of randomized 
controlled trials as well as from 
structured personal series audits, 
in order to determine the long 
– term efficacy and potential 
morbidity associated with the use 
of prosthetic materials in primary 
or recurrent prolapse repair. 
Standardized criteria for staging 
POP, adequate follow – up and 
assessment of effects of surgery on 
bladder, bowel and sexual function 
are required to determine whether 
or not the use of these grafts 
confers advantage over standard 
prolapse repair, and in which 
category of patient they should be 
employed.
This will allow appropriate 
selection of both the type of 
prosthesis and the optimal surgical 
approach in women requiring 
reconstructive pelvic floor surgery. 
However, synthetic prostheses will 
not compensate for poor surgical 
techniques or a poorly conceived 
procedure. A host of “copy – cat” 
prostheses are available on the 
market, riding the wave of more 
established mainstream product 
usage. A prudent surgeon will 
evaluate published data on specific 
products before using “me – too” 
operations.
Conclusions
New insights classification systems 
have modified previously held 
beliefs in the field of pelvic 
organ prolapse. POP is a vast 
and amorphous field of surgery. 
Different causes of prolapse and 
a host of confounding variables 
makes one approach and any one 
standard procedure unscientific. 
The “one – operation fits all” 
methods of the past must be 
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eschewed, and a more thoughtful 
and evidence – based approach 
cultivated. If necessary, specialist 
knowledge and expertise may 
need to be consulted in an 
approach to difficult cases of POP.
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Prolapse and Incontinence 
are the result of physiological 
and anatomical failure. The 
mechanisms involved are complex 
with multiple factors playing a 
role.  Because this is such a diverse 
field, these aspects are addressed 
by two authors in this chapter.  
Part 1 - Paul Swart
The Aetiology of Prolapse
The aetiology of pelvic organ 
prolapse (POP) and stress urinary 
incontinence (SUI) are inseparable. 
These two conditions are different 
sides of the same coin and share 
common aetiological variables. 
Detrusor overactivity and urinary 
urgency, dry or wet, may co-exist in 
women with SUI and POP,  but is a 
separate condition with different 
aetiological factors  beyond the 
scope of this discussion.
Pelvic organ prolapse (POP) is 
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not caused by a single event or 
deficiency, but is the culmination 
of an interplay between complex 
multifactorial aetiologies which 
vary between women.  It  would 
not be wise to reduce the end 
result to a specific event and the 
best science can offer us, until we 
have greater understanding of 
these complex interactions, is to 
analyze different risk factors in 
a population and assign relative 
risks or odds ratios. It is difficult 
to counsel women regarding the 
ideal mode of delivery using the 
currently available evidence. 
Risk factors for POP can be 
classified into predisposing, 
inciting, promoting or 
decompensating. Predisposing 
factors include congenital 
anomalies, race, gender and 
hereditary defects such as Marfan’s 
syndrome. Inciting factors include 
pregnancy and vaginal delivery, 
surgical procedures and certain 
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myopathies and neuropathies. 
Factors outside the pelvis that 
could elicit POP, include obesity, 
smoking, pulmonary disease 
that leads to chronic coughing 
and lifestyle variables including 
repetitive heavy lifting during 
occupational duties or during 
recreational activities. These would 
be considered to be promoting 
causes. Decompensatory 
mechanisms include aging, 
menopause, neuropathy, 
myopathy, debilitating diseases 
and medication such as cortisone. 
A combination of factors each 
influence the development of 
this disease to a greater or lesser 
degree.  Overall, the risk factors 
most strongly associated with 
prolapse include advanced age, 
high gravidity and parity, number 
of vaginal deliveries and previous 
hysterectomy.
Pregnancy
Although increasing parity is a 
risk factor for prolapse, nulliparity 
does not provide absolute 
protection. In the Women’s Health 
Initiative (WHI) study nearly 20% 
of nulliparous women had some 
degree of POP. There is, however, 
no doubt that both pregnancy 
and the delivery of a baby play 
a role in the aetiology of POP 
and SUI. Francis et al found that 
40% of primigravid women had 
some SUI before falling pregnant, 
which always worsened during 
the pregnancy, improved after the 
pregnancy and recurred with later 
pregnancies. This would eventually 
become a problem even when they 
were not pregnant. The hormonal 
changes associated with pregnancy 
have an effect on the elasticity and 
distension of the pelvic contents 
by their effect on the muscle 
and collagen content as well as 
the changes in circulation of the 
pelvic floor. In addition there 
is the added stress of increased 
intra-abdominal pressures and 
distension by the fetal presenting 
part.
There are three mechanisms 
whereby labour influences the 
integrity of the pelvic floor and 
the continence mechanisms. Firstly, 
mechanical distension and tearing 
of muscle and connective tissue 
invariably occur. Secondly, vascular 
compression with the potential 
for hypoxic damage to the same 
structures as well as the urinary 
tract, and subsequent replacement 
of active tissue by scar formation, 
has also been shown to occur. The 
third mechanism is compression, 
stretching or hypoxic damage to 
nerve structures including both 
motor and sensory. EMG studies 
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and pudendal nerve terminal 
motor latency (PNTML) studies 
have demonstrated defects 
after vaginal deliveries which 
are not apparent following 
elective caesarean section. Strong 
associations are described for 
long labours, macrosomic babies, 
forceps deliveries, 3rd degree 
tears and multiparity. There are  
numerous studies that confirm 
these findings.
Among premenopausal women, 
those who have delivered at least 
one baby, have a higher prevalence 
of both SUI and urgency than 
nulliparous women.  In contrast, 
among postmenopausal women, 
pregnancy and childbirth seem 
to have a smaller impact on SUI. 
Older nulliparous females have 
been shown in some studies to 
have the same prevalence of SUI 
as parous women.  Co-morbidities, 
particularly aging, outweigh the 
effect of previous pregnancies 
in these women. Goldberg and 
Abramov report interesting 
findings after looking at pelvic 
floor dysfunction in a group of 
identical twin sisters, with a mean 
age of 47 years (range 18 and 
85 years). The sibling who had 
at least two vaginal births was 
three times more likely to report 
faecal incontinence and four 
times more likely to report urinary 
incontinence than her nulliparous 
twin sister.  In the WHI  study, 
it was concluded that a woman 
having a history of at least one 
delivery had double the risk of POP 
when compared to nulliparous 
controls. 
(i) Myogenic damage:
We  have histological confirmation 
and radiological evidence, 
using ultrasound and MRI, 
demonstrating that the mechanical 
trauma of delivery leads to rupture 
of the pelvic muscles. Imaging 
studies have also shown an inverse 
correlation between prolapse and 
the total volume of levator muscle 
and muscle strength.
(ii) Neuromuscular damage:
The  mechanism of neurological 
damage during labour is unknown, 
but pudendal nerve compression 
certainly plays a significant role. 
Snooks et al have shown that after 
vaginal delivery there is prolonged 
PNTML and this correlates with 
greater perineal descent during 
straining.  Forceps deliveries 
appear to make the greatest 
impact on PNTML whereas subjects 
having an elective caesarean 
section were no different from 
nulliparous controls. Most women 
will recover as innervation is re-
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established but in some women 
it never returns to normal. 
Viktrup et al, in a study on the 
risk of incontinence after delivery, 
report that most patients who 
are incontinent after the birth 
of their babies improve but are 
at a greater risk of developing 
incontinence a few years later.  Of 
the women who had SUI three 
months after the delivery, the 
majority of whom were dry 1 year 
later, 92% became incontinent 5 
years later. Sultan et al have also 
shown that a caesarean section 
performed after the onset of 
labour is less protective than an 
elective section. In the Term Breech 
trial, 4.5% of patients who had a 
caesarean section were incontinent 
after 3 months compared to 7.3% 
of the women that delivered 
vaginally with a relative risk (RR) of 
0.62 and a confidence interval of 
0.41 to 0.93.
Data from the EPINCONT study, 
suggest that after one baby, the 
RR for SUI becomes 2.4 in women 
aged 20-34 years but only 1.8 
when they are between 35 and 64 
years of age. In both age groups, 
however, the associations are 
statistically significant. Once the 
patients were over 65 years of age, 
there was no significant association 
between delivery and the risk of 
SUI. There was, however, the same 
trend with a larger RR for a parity 
of two or more. 
(iii) Damage to the endopelvic 
fascia:
During labour, tears develop in 
the connective tissue. This might 
not be immediately apparent 
but with continuous trauma and 
aging it plays an important role 
in the development of prolapse. 
It would appear that some 
women have a more vulnerable 
collagen. Studies have shown 
that there is a decreased collagen 
content in nulliparous women 
with SUI. There is also an increase 
in the concentration of weak 
cross-linked collagen in women 
with prolapse compared to the 
strong cross-linked collagen in 
women without prolapse. These 
differences are quantitative as well 
as qualitative on histo-chemical 
level. Furthermore, there is an 
increase in the metalloprotease 
enzyme activity in patients with 
prolapse suggesting an increase 
in the breakdown of collagen of 
these patients.
There is thus no question that 
pregnancy and the mode of 
delivery influences subsequent 
prolapse and SUI. However, most 
women have pregnancies and 
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deliveries without residual long-
term POP or SUI. The scientific 
challenge is therefore to identify 
a subgroup of women who are 
vulnerable to the consequences 
of pregnancy and to offer 
appropriate  counselling and 
possible intervention. Currently 
the only available intervention is 
caesarean section but the influence 
of this on subsequent pregnancies 
has to be accepted.
Epidural analgesia is possibly 
associated with subsequent POP or 
SUI. It may indeed increase the use 
of forceps in some institutions and 
this in turn might have deleterious 
effects on the pelvic floor but it 
seems unlikely that the epidural 
block per se has any deleterious 
role.
The use of episiotomy to prevent 
pelvic floor damage has no 
support in the  literature. There 
is no evidence that first or second 
degree tears are associated with 
later POP. Third degree tears do 
appear to be associated with 
subsequent POP and SUI. In some 
studies, episiotomies contributed 
to third and fourth degree tears. 
Aging
Virtually all studies that address 
the relationship between aging 
and POP find a positive association. 
There is however controversy as to 
the role of the menopause. 
Constipation
There certainly appears to be 
an association between POP 
and constipation. Posterior 
compartment prolapse can lead 
to difficult rectal emptying, due 
to herniation of the rectocele 
into the vagina. It has been 
shown that chronic constipation 
with repetitive straining leads 
not only to pelvic floor muscular 
damage, but also to neuropathy. 
Constipation appears to be 
significantly more common in 
women developing POP.
Occupational Stresses
There are studies from Italy and 
the USA reporting a correlation 
between a patient’s income 
and the prevalence of POP. The 
lower the income, the higher the 
prevalence of POP. The authors 
postulated that this was probably 
due to harder manual labour.  
Nursing has also been shown to 
be a risk factor.  A study looking 
at 28,000 Danish nurses found an 
odds ratio of 1.6 for developing 
POP or a herniated lumbar disc 
compared to  same-aged controls.
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Obesity
Obesity increases the intra-
abdominal pressure significantly 
and chronically. Most studies 
have found a positive correlation 
between obesity and POP as well 
as a greater risk for surgical failure 
in the obese.
Hysterectomy
According to the Oxford Family 
Planning Study, the incidence 
of POP is higher in women who 
undergo a hysterectomy for 
reasons other than prolapse. If 
a woman undergoes surgery for 
POP the subsequent risk appears 
to be even higher. It is uncertain 
whether a sub-total hysterectomy 
carries the same risk.
Previous Prolapse Surgery
There is little doubt that certain 
surgical procedures predispose 
patients to prolapse in other 
compartments. Two examples 
include an increase in posterior 
compartment prolapse after a 
Burch colposuspension and a 
greater number of cystocoeles 
after sacrospinous ligament 
fixation. There are also reports 
of prolapse of the vaginal vault 
after transection of the uterosacral 
ligaments for chronic pelvic pain.
Collagen Synthesis 
Abnormalities
As already stated above there 
are qualitative and quantitative 
differences in the connective 
tissue of women with and without 
POP. These would also include 
differences in the muscle actin, 
myosin and extra-cellular matrix 
proteins.
Variations In Skeletal Anatomy
Increases in thoracic kyphosis and 
decreases in lumbar lordosis both 
increase the risk for POP. The same 
is true for a wider transverse pelvic 
inlet.
Race
It would seem that POP is more 
common in women from European 
descent than African women but 
older publications show bigger 
differences than more recent 
publications. Access to health 
care facilities might play a role 
but quantitative and qualitative 
histochemical differences in 
collagen and muscle tissue are 
awaited.
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Part 2 - Etienne Henn
Pelvic floor damage due to 
childbirth
Pelvic floor disorders (PFD) 
include urinary incontinence 
(UI), anal incontinence (AI), and 
pelvic organ prolapse (POP). It 
has been shown on numerous 
occasions, that one of the main 
causes of female pelvic floor 
dysfunction is vaginal childbirth. 
The consequences can be short 
term or lifelong. The potential 
space in the female pelvis is limited 
and has been shown, in relative 
terms, to have decreased over 
time. Human evolution theory, 
postulates that the fetal head 
has enlarged significantly over 
time, and thus a larger fetal head 
has to pass through the female 
pelvis at childbirth. About 1.5 
million years ago, Homo erectus 
had a cranial capacity of 900 cm3 
while Homo sapiens now has a 
cranial capacity of approximately 
1800 cm3. It is therefore not 
surprising that the structures of 
the pelvic floor are damaged due 
to pregnancy as well as childbirth. 
Some studies have shown that one 
in two parous white women will 
suffer pelvic floor dysfunction, to 
varying degrees, due to vaginal 
childbirth. Of these women, up to 
60% of will undergo surgery. It is 
important to note that although 
vaginal birth is the most important 
etiological factor in pelvic 
floor dysfunction, other factors 
contribute including advancing 
age, vascular disease, spinal cord 
injury, primary bowel disease, 
molecular and genetic factors.  
This chapter shall focus on the 
impact of childbirth and delivery 
factors on the development of 
pelvic floor dysfunction. We shall 
divide the available evidence into 
different compartments to enable 
a thorough overview of this impact 
on the pelvic floor. 
Trauma to the nervous system
Neuromuscular function of the 
pelvic floor is dependent on the 
integrity of the nervous system. 
Pelvic floor peripheral nerves, 
such as the nerves to the levator 
ani, and the pudendal nerves are 
at greatest risk of injury during 
pregnancy and childbirth. The 
pudendal nerve is particularly 
prone to damage where it curves 
around the ischial spine and 
enters the pudendal canal. Ample 
evidence links neurologic injury 
with PFD. Prolonged pudendal 
nerve motor latency (PNML) has 
been reported after delivery 
in 42% of women delivering 
vaginally, but not in those women 
delivered by planned caesarean 
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section. PNTML returned to normal 
in 60% of these women at two 
months postpartum. Another 
study found evidence of pudendal 
nerve denervation in 80% of 
women after vaginal delivery. The 
mechanism of injury is most likely 
to be a combination of direct 
trauma and traction injury during 
delivery. Risk factors included a 
long second stage (> 56.7 minutes), 
a large baby (> 3.41 kg), and a 
forceps delivery. Weakness was 
shown in both the levator ani 
muscle and the external anal 
sphincter after vaginal delivery. 
This is the result of a combination 
of loss of total motor units as well 
as asynchronous activity in those 
that remained. Sensory nerve 
function is also likely to become 
impaired by nerve damage. This 
will be clinically most evident 
in the anal canal, with its many 
afferent nerve endings, resulting 
in anal incontinence or faecal 
urgency. Caesarean section has 
been shown to be protective, but 
only in women who delivered 
electively. 
Trauma to the pelvic floor 
muscles
Anatomical and functional changes 
to the pelvic floor can develop 
secondary to pelvic floor distension 
during descent of the fetal head 
and maternal expulsive efforts 
during the second stage of labor. 
The most important muscles of the 
pelvic floor are the puborectalis, 
pubococcygeus and anal sphincter 
muscles. The genital hiatus in 
nulliparous women measures 6-36 
cm2 during valsalva while the 
surface area of the fetal head is 70-
100 cm2. This clearly demonstrates 
the extent (± 300%) that the 
levator ani muscle is required to 
stretch during childbirth. Partial 
levator avulsion has been shown 
to occur in 15% of women during 
delivery (Figure 1). These women 
are at an increased risk for severe 
pelvic organ prolapse, urinary 
incontinence and even recurrent 
prolapse after surgical treatment. 
Studies on MRI of the pelvic floor 
did not identify any levator ani 
defects in nulliparous women, in 
contrast to the findings in 20% 
of primiparous women, who had 
a visible defect in the levator ani 
muscle. These defects were usually 
in the pubovisceral portion of the 
levator ani muscle. Reported risk 
factors include higher maternal 
age (>35 yrs), large babies, 
prolonged second stage, and 
forceps delivery. Pelvic floor muscle 
strength has been also been shown 
to decrease by 25-35% following 
vaginal delivery compared to 
caesarean section. Interestingly, 
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6-10 weeks postpartum there is 
however no significant difference 
from antenatal values, excepting 
for a lower intravaginal pressure in 
multiparous women.
 
Injury to the anal sphincter during 
childbirth occurs either as a result 
of direct disruption of the muscles 
or due to injury to the pudendal 
nerves. The incidence of anal 
sphincter damage varies between 
0.5 – 2.5% where mediolateral 
episiotomies are used, and 7% 
where midline episiotomies 
are used. The use of endoanal 
ultrasound has demonstrated a 
much higher incidence of anal 
sphincter injuries (Figure 2) in 
asymptomatic women, the so-
called occult injuries with as many 
as 35% of primiparous and up to 
44% of multiparous women having 
evidence of sphincter disruption. 
Risk factors for both the overt and 
occult sphincter injuries include 
forceps delivery, prolonged second 
stage, large birth weight, midline 
episiotomy, and occipitoposterior 
positions. 
Figure 1:  Levator avulsion injury 
on ultrasound, the vagina reaching 
the pelvic sidewall (arrow) with 
no intervening muscle, unlike the 
healthy contralateral side.
Figure 2:  Two-dimensional 
endoanal ultrasound image of anal 
sphincter disruption secondary to 
obstetric injury.
Connective tissue trauma
Pelvic organ support essentially 
consists of or relies on the 
endopelvic fascia and the 
condensations of this fascia that 
forms the ligaments (uterosacral, 
transverse sacral). Increased pelvic 
organ mobility (POM), manifesting 
as pelvic organ prolapse (POP), 
occurs as a consequence of 
weakness of these supports. It is far 
more common in parous women 
(50%), compared to nulliparous 
women (2%). During vaginal 
delivery, the mechanism is most 
likely due to mechanical trauma of 
these supporting structures with 
subsequent degrees of disruption. 
Spontaneous healing might also 
lead to weaker collagen and so 
predispose to incontinence and 
prolapse. 
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Effect of childbirth on 
specific pelvic floor 
disorders
Urinary incontinence
Urinary incontinence is a 
common symptom in pregnancy 
and has been reported in up 
to 85% of women. Women 
reporting antenatal stress urinary 
incontinence (SUI) are at an 
increased risk for future SUI. De 
novo SUI has been reported to 
develop in 7% of primigravid 
women immediately following 
vaginal delivery but this only 
persisted in 3% at one year. 
The most likely mechanism is a 
combination of nerve and tissue 
damage.  At five-year follow 
up, 19% of women without 
urinary symptoms after the first 
delivery reported SUI. In contrast 
92% of  women reporting stress 
incontinence three months after 
delivery, had SUI five years later. 
Antepartum incontinence has also 
been reported to strongly predict 
postpartum incontinence. It is 
remains unclear as to whether it 
is the pregnancy or specifically 
the vaginal delivery that is the 
risk factor for developing  urinary 
incontinence. It would appear that 
vaginal delivery roughly doubles a 
woman’s chance of developing UI. 
It is important to remember that 
after adjusting for other potential 
causes of pelvic floor damage, 
a woman’s risk for moderate to 
severe incontinence decreases 
from about 10% to 5% if all of her 
children are delivered by caesarean 
section. The protective effect of 
caesarean delivery and nulliparity  
dissipates around the sixth decade 
of life, such that the women 
have the  same incidence of UI 
regardless of their delivery status. 
Anal incontinence
AI is a distressing social handicap 
and vaginal delivery is a major 
etiological factor. AI occurs 
in as many as 29% of women 
nine months after delivery. The 
reported incidence of AI following 
anal sphincter rupture is in the 
region of 16-47%.  There is some 
evidence to suggest that elective 
caesarean section is protective 
against AI but the impact of 
delivery mode  appears to decline 
with age. The use of forceps is 
the single independent risk factor 
associated with anal sphincter 
damage and the development 
of AI. The first vaginal delivery 
has been suggested to be the 
most significant event leading 
to damage of the anal sphincter. 
Retrospective studies have 
reported that the prevalence of 
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AI 30 years after delivery was 
comparable, regardless of mode of 
delivery.
Pelvic organ prolapse 
Pelvic support defects appear to 
occur before delivery. Pregnant 
women have been shown to be 
more likely to have POP than 
their nulliparous counterparts. 
Parity increases the risk for POP 
and is the variable most strongly 
related to surgery for POP. We 
await prospective studies on the 
impact of vaginal delivery and 
intrapartum management, on the 
development and prevention of 
defects in the connective tissue 
and levator muscles that lead to 
pelvic organ prolapse.
Conclusion
There appears to be a strong 
association between the 
development of pelvic floor 
disorders including UI, AI and POP 
and pregnancy and childbirth. 
Mechanisms of injury include direct 
muscular trauma, disruption of 
connective tissues, and denervation 
injury. The first vaginal delivery 
is the most significant event 
impacting of the development 
on subsequent pelvic floor 
dysfunction. Other risk factors 
include advanced maternal age at 
first delivery, prolonged second 
stage of labour, delivery of a large 
baby, midline episiotomy, and the 
use of a forceps for delivery. Less 
pelvic floor damage may occur 
after elective caesarean section, 
but not necessarily with emergency 
caesarean section. The advantage 
of caesarean section appears, 
however, to dissipate in the long 
term in the majority of women and 
it is therefore not recommended 
in all women. It will not only be 
unnecessary in at least 50% of 
parturients, but many women 
desire the experience of vaginal 
delivery. Ideally, women should be 
offered strategies to reduce pelvic 
floor injury such as pelvic floor 
exercises.  Adequate management 
of labour is essential and elective 
caesarean section should only be 
offered to women at high risk for 
pelvic floor damage.
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Pelvic organ prolapse is common 
and is seen in 50% of parous 
women .One recent community 
survey by Slieker-ten et al found 
that 40% of the general female 
population aged 45 to 85 years had 
evidence of pelvic organ prolapse 
of at least stage two.
Pelvic organ prolapse is rarely 
life-threatening, but may have a 
significant impact on a woman’s 
quality of life.  Choice of treatment 
for prolapse depends on the 
severity of prolapse, its symptoms, 
and the woman’s general health 
and preference. Options available 
for treatment can be categorized 
as conservative, mechanical 
and surgical. Conservative or 
mechanical treatment is generally 
considered for women with a mild 
degree of prolapse, those who 
wish to have more children, the 
frail or those unwilling to undergo 
surgery.
The interventions which could 
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be considered in conservative 
management consist of the 
following:
•	 Lifestyle interventions
•	 Physiotherapy
•	 Pessaries
1. Life Style 
Interventions
Several studies have addressed 
the association of heavy lifting 
and strenuous physical activity 
in the causation of pelvic organ 
prolapse. Jorgensen and colleagues 
compared the incidence of surgery 
for prolapse in 28 619 Danish 
nursing assistance compared to 
a staggering 1652533 female 
population controls. The nursing 
assistants occupation constantly 
exposed them to repetitive heavy 
lifting. He found that these 
nursing assistants where 1.6 times 
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more likely to undergo surgery 
than their controls. This study 
did not however adjust for parity 
and other contributing factors. 
In another study by Spernol et al 
they found that 68% of women 
with prolapse reported heavy to 
medium work compared to 0% 
of controls. Again there was no 
adjustment for parity, mode of 
delivery, or other contributing 
factors.
Body weight was also considered 
a risk factor in the British Oxford 
Family Planning Association Study. 
All of these studies unfortunately 
were cross -sectional studies and 
do not control for parity, degree 
of prolapse or other confounding 
factors.
Constipation and a history of 
irritable bowel syndrome were 
strong and independent risk 
factors for symptomatic prolapse 
in an epidemiological trial done by 
Guri Rortveit et al. This association 
between constipation and 
prolapse has not been observed 
in other studies that included 
the condition as a potential risk 
factor for prolapse. Straining with 
chronic constipation may damage 
the pelvic floor; alternatively, 
constipation may be a symptom 
of posterior prolapse. This was 
however, a cross-sectional study 
and did not allow any inference 
about causal relationships.
There is no conclusive evidence 
that lifestyle changes are going to 
improve the degree of prolapse or 
the symptoms associated with the 
prolapse. 
2. Physiotherapy
Pelvic muscle training (Kegel 
exercises) is a simple, noninvasive 
intervention that may improve 
pelvic function. Whether Kegel 
exercises can resolve prolapse 
has not been adequately studied 
in good randomized controlled 
trials since Kegel’s original articles. 
While systematic reviews and 
randomized controlled trials (RCT) 
have shown a convincing effect 
of pelvic floor muscle training 
for stress and mixed urinary 
incontinence, there seems to 
be a paucity of data for other 
conditions associated with pelvic 
floor dysfunction.  It is commonly 
recommended as adjunct therapy 
for women with prolapse, often 
with symptom directed therapy. 
The POPPY Trial, a multi-centre 
randomized controlled trial of a 
pelvic floor muscle training for 
women with pelvic organ prolapse, 
which is currently being conducted 
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in Australia, may address this issue.
Prevention
Harvey et al in a systematic 
review on the role of pelvic floor 
exercises in preventing pelvic floor 
prolapse, failed to validate its use 
as a preventative measure.  Piya-
Anant et al performed a cross 
sectional study in 682 women 
and an intervention study of 
654 of the same cohort . Seventy 
percent of the subjects in the cross 
sectional study had POP. Thirty 
percent were classified as severe 
and 40% as mild prolapse. The 
women were randomly allocated 
to an intervention or a control 
group. Women in the intervention 
group were taught to contract 
the pelvic floor muscles 30 times 
after a meal every day. Women 
not able to contract were asked to 
return to the clinic once a month 
until they could perform corrected 
contractions. They were also 
advised to eat more vegetables 
and fruit and to drink at least two 
liters of water per day to prevent 
constipation. They were followed-
up every six months throughout 
the 2-year intervention period. 
The results indicated that the 
intervention was only effective in 
the group with severe prolapse. 
The rate of worsening of POP was 
72.2 and 27.8% in the control 
group and in the pelvic floor 
muscle training group, respectively.
The two main hypotheses on the 
mechanism of action of PFMT 
include morphological changes 
occurring after strength training 
and the use of a conscious 
contraction during an increase 
in abdominal pressure in daily 
activities. There is an urgent need 
for good quality RCT’s, preferably 
using the POP-Q system and using 
standardized exercise programmes.
3. Vaginal Pessaries
Pessaries have been manufactured 
from many materials including 
silicone, rubber, clear plastic, soft 
plastic and latex. Most pessaries 
today are made of silicone and 
as a result are non allergic ,do 
not absorb odours or secrete 
substances. Silicone is resistant 
to breakdown with repeated 
cleansing and autoclaving.
Pessaries are often used in 
pregnant patients, the elderly and 
in patients who do not want or 
are too frail to undergo surgery. 
Pessaries may also be used to 
facilitate preoperative healing 
of vaginal and cervical ulcers 
in patients who present with 
a procidentia. Another useful 
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advantage of these devices is that 
they can be used to elicit occult 
stress incontinence before surgical 
repair of genital prolapse. A 
pessary can also predict whether 
surgery will correct problems such 
as pelvic and back pain.
While pessary manufacturers 
provide suggestions for different 
pessary shapes to manage different 
types of prolapse, experience 
suggests that trial and error is 
really the only way to determine 
the best fit for each patient . This 
depends on factors such as the 
site, severity and the symptoms 
associated with the prolapse.  
Other factors, such as the patient’s 
physical capacity and willingness 
to participate in the care of the 
pessary, together with the size of 
the introitus, the patient’s weight 
and her physical activity also play a 
role when choosing a pessary.
Fritzinger et al stated that there 
is no scientific data outlining the 
standards of care for users of 
vaginal pessaries. However, most 
authors agree that routine follow 
up of women using pessaries is 
necessary to minimize the risk 
of complications associated with 
their use. At each visit the pessary 
should be removed and cleaned 
using mild antibacterial soap and 
warm water. It should be examined 
to ensure that the integrity of the 
silicone is intact .The vagina should 
also be examined for signs of 
constant pressure.
Patients should be advised that 
intercourse may be possible with a 
ring in situ. She  should be aware 
that it may cause some discomfort 
to both partners in the beginning 
but this often settles as the 
patient and her partner become 
comfortable with it. Women who 
are able to remove and reinsert 
the pessary should be encouraged 
to do so prior to intercourse.
Contraindications to Pessary 
Insertion
•	 Severe untreated vaginal 
atrophy
•	 Vaginal bleeding of unknown 
 
A simulated picture depicting the 
position and placement of the 
pessary
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origin
•	 Pelvic inflammatory disease
•	 Abnormal pap smear
•	 Dementia without possibility of 
dependable follow-up care
•	 Expected non-compliance with 
follow-up
Types of Pessaries
Often referred to as the 
“incontinence ring” since it has 
been designed for use in women 
with stress incontinence.
•	 Has a membrane to support 
prolapse.
•	 Has holes for drainage.
•	 Knob applies pressure to the 
urethra against the pubic bone.
Soft silicone, donut shaped. 
•	 Occludes upper vagina and 
supports a uterine prolapse
•	 Useful for cystocele or rectocele
•	 May be used for vault prolapse
•	 Adequate tone of the introitus 
is necessary for the pessary to 
remain in place
White silicon cube
Indications: Third-degree prolapse, 
cystocele or rectocele, with or 
without good vaginal tone.
•	 Often this is the only satisfactory 
support for women with a 
complete prolapse
•	 Excellent for vaginal wall 
prolapse in that it keeps the 
vaginal walls from collapsing at 
the six pressure points.
•	 May be used by an athlete and 
removed after exercise.
•	 Mucosa molds to the concavities 
creating a negative pressure 
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Incontinence Dish
•	 Dish-shaped pessary with holes 
to allow for drainage.  
•	 The flexible membrane of the 
dish supports and elevates a 
mild cystocele.
•	 Used in patients with stress 
urinary incontinence with 1st or 
2nd degree prolapse, or a mild 
cystocele.
Arch Heel Gehrung
•	 U-shaped device that provides 
support to the anterior vaginal 
wall.  The heel rests flat on the 
vaginal floor
•	 It avoids pressure on the rectum 
while supporting the anterior 
wall
•	 It is  malleable and can be 
shaped to suit the shape of the 
vagina 
•	 Creates a “bladder bridge”
Ring - with and without 
support
•	 Helps support the urethra and 
bladder neck.
•	 Membrane provides additional 
support for a cystocele.
•	 Useful for a first or mild 
second-degree uterine prolapse 
associated with a mild cystocele.
Complications of pessaries
All authors listed vaginal discharge 
and odor as the most common 
complication. Other complications 
which may occur are pelvic pain, 
bleeding and development of 
urinary incontinence. Failure to 
retain a pessary in the vagina, 
or failure of the pessary to 
hold the prolapse properly is 
an obvious disadvantage. Flood 
and Hanson described erosions 
of the vaginal wall as being a 
common problem. They state 
that early intervention using an 
estrogen-based cream or vaginal 
lubricant are essential to proper 
pessary care. Severe complications 
such as vesico-vaginal fistulae, 
hydronephrosis, sepsis, and even 
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small bowel incarceration were 
cited in the literature as the 
result of inadequate follow-up. 
Poma, reports in a review of 2,341 
vaginal cancers, that 10.1% were 
associated with a pessary .It is 
debatable if this is a risk factor for 
vaginal malignancy.
Conclusion
There is paucity of good 
randomized controlled trails that 
evaluate the use of conservative 
methods for the management of 
pelvic organ prolapse. Perhaps 
with the POP Q scoring system for 
prolapse and renewed interest in 
non surgical management, this will 
change in the future.
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Introduction
Urogenital prolapse is a common 
condition and though not life-
threatening, it has a significant 
impact on the quality of life of 
women.  Its treatment is one of the 
most common surgical indications 
in gynaecology, accounting for 
20% of elective major surgery with 
this figure increasing to 59% in 
the elderly population. Despite 
numerous modifications to the 
traditional surgical techniques and 
the recent introduction of novel 
procedures, the permanent cure of 
urogenital prolapse remains one of 
the biggest challenges in modern 
gynaecology. 
  
Surgical Management
The following factors need to 
be taken into account when 
considering surgical intervention 
for prolapse: 
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•	 Bothersomeness of symptoms 
and extent of prolapse
•	 Desire for future pregnancy
•	 Sexual function
•	 Age
•	 Fitness for surgery and 
anaesthesia
•	 Associated incontinence 
symptoms
•	 Patient’s wishes
Important point
There is as yet no surgical 
technique that can guarantee 
100% success in treating prolapse 
and some procedures such as 
anterior colporrhaphy carry failure 
rates of up to 30%. This important 
point needs to be emphasized 
whenever counselling patients 
regarding the management of 
prolapse. 
General principles
All women  should receive 
prophylactic antibiotics to 
cover gram-negative and gram 
positive organisms, as well as 
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thromboembolic prophylaxis in 
the form of low dose heparin and 
thromboembolic deterrent (TED) 
stockings.
Patients having pelvic surgery 
are positioned in lithotomy 
with their hips abducted and 
flexed. To minimise blood loss, 
local infiltration of the vaginal 
epithelium is performed using 
0.5% xylocaine and 1/200 000 
adrenaline although care should 
be taken in patients with co-
existent cardiac disease. 
1. Surgical options 
for Anterior 
Compartment 
prolapse
1.1. Vaginal Approach
Anterior Vaginal Repair 
(Anterior Colporrhaphy)
An incision is made in the vaginal 
epithelium below the urethral 
meatus to the cervix or vaginal 
vault. A diamond-shaped incision 
is sometimes made. The cystocele 
is dissected off the overlying 
vaginal skin using scissors and 
blunt dissection. The underlying 
pubocervical fascia is then reduced 
using vicryl 3/0 sutures, known as 
fascial plication. Many surgeons 
place an additional plication 
layer of support using a delayed 
absorbable suture such as PDS 
in the levator connective tissue 
medial to the iscniopubic rami.  
Skin edges are trimmed and closed 
using polyglycolic sutures (Vicryl, 
Ethicon). 
Mid-urethral tapes such as the TVT 
or TOT should be placed through 
a separate incision to prevent the 
tape from migrating up towards 
the bladder neck.  
Vaginal Paravaginal Repair
Some surgeons perform an 
extensive dissection stretching 
from the pubis anteriorly to the 
ischial spine posteriorly. Up to 
four sutures are placed along the 
white line.  This is the vaginal 
paravaginal repair. 
1.2 Abdominal  Approach
Abdominal Paravaginal Repair 
This is the abdominal approach to 
anterior compartment prolapse. 
It is employed when another 
intra-abdominal procedure eg. 
sacrocolpopexy or hysterectomy is 
being performed. 
Through a Pfannenstiel incision, 
the retropubic space is opened 
and the bladder swept medially, 
128
exposing the pelvic sidewall, very 
similar to a burch colposuspension 
procedure. Two fingers are placed 
in the vagina and it is elevated 
digitally.  The pubocervical fascia 
is reattached to the pelvic sidewall 
using interrupted polydioxanone 
(PDS, Ethicon) sutures from the 
pubis to just anterior to the ischial 
spine. 
2. Surgical Options 
For Posterior 
Compartment 
Prolapse
Traditionally this compartment 
is approached vaginally when 
operated on by the gynaecologist. 
It is important to remember 
that the colo-rectal surgeons 
also operate on the posterior 
compartment using a transanal 
approach. The patient should be 
referred to a colorectal surgeon 
for assessment if the following are 
present: concurrent anal or rectal 
pathology such as hemorrhoids, 
rectal wall prolapse or rectal 
mucosal redundancy.   
Posterior Colpoperineorrhaphy
Procedure
Two allis or littlewood forceps 
are placed on the perineum 
at the level of the hymenal 
remnants, allowing the calibre 
of the introitus to be estimated. 
Following infiltration, the 
perineal scarring is excised and 
the posterior vaginal wall opened 
using a longitudinal or triangular 
incision. The rectocele is mobilized 
from the vaginal skin by blunt and 
sharp dissection.  The rectovaginal 
fascia is then plicated using either 
an interrupted or continuous 
absorbable suture (Vicryl 3/0), to 
repair the defect. This is often 
called the site-specific repair. Care 
should be taken not to create a 
constriction ring in the vagina 
which will result in dyspareunia.  
The redundant skin edges are 
then trimmed taking care not to 
remove too much tissue and thus 
narrow the vagina. The posterior 
vaginal wall is closed with a 
continuous Vicryl 2/0 suture. Many 
surgeons, in addition to the site-
specific plication, place a number 
of interrupted lateral sutures 
that incorporate the Levator Ani 
muscles. This Levator plication has 
been shown to be associated with 
significant dyspareunia and is no 
longer recommended.   Finally a 
perineorrhaphy is performed by 
placing deeper absorbable sutures 
into the perineal muscles and 
fascia thus building up the perineal 
body to provide additional support 
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to the posterior vaginal wall and 
lengthening the vagina. Injury to 
the rectum is unusual but should 
be identified at the time of the 
procedure so that the defect 
can be closed in layers using an 
absorbable suture and the patient 
managed with prophylactic 
antibiotics, low residue diet and 
faecal softening agents to avoid 
constipation.
3. Middle 
Compartment
3.1 Uterovaginal prolapse
3.1.1 Vaginal hysterectomy
The cervix is circumscribed and the 
utero-vesical fold and pouch of 
Douglas opened. The uterosacral 
and cardinal ligaments are divided 
and ligated first, followed by the 
uterine pedicles and finally the 
tubo-ovarian and round ligament 
pedicles. In cases of procidentia, 
care should be taken to avoid 
kinking of the ureters which 
are often dragged into a lower 
position than normal. The most 
important part of the procedure 
is support of the vault since these 
women are at high risk for post-
hysterectomy vault prolapse.  The 
uterosacral ligament sutures are 
therefore tied in the midline and 
brought through the posterior 
part of the vault and tied after 
the vault has been closed. For 
additional support, a high 
uterosacral ligament suspension 
can be performed by placing 
additional PDS sutures through  
the lateral aspects of the vaginal 
vault on each side and securing 
these to the ipsilateral uterosacral 
ligament. This procedure places 
the ureters at risk and therefore 
ureteric patency should be 
confirmed post-operatively by 
cystoscopy. These sutures are 
also tied after the vault has been 
closed. An alternative to the high 
uterosacral ligament suspension 
is a McCall suture. This is a purse-
string suture that goes through 
both corners of the vaginal vault, 
through the uterosacral ligaments 
and also through the posterior 
peritoneum to obliterate the 
pouch of Douglas to prevent 
enterocele formation.
3.1.2 Uterine preservation 
procedures 
Sacrohysteropexy 
(See a separate chapter on 
Sacrocolpopexy)
This technique involves 
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attaching the uterus to the 
sacral promontory using a 
broad piece of prolene mesh. 
Through a Pfannenstiel incision 
the peritoneum over the sacral 
promontory is opened. The 
prolene mesh is attached to the 
posterior aspect of the uterus with 
the sutures secured at the level 
of insertion of the uterosacral 
ligaments. The mesh is then 
attached to the anterior aspect 
of the sacral promontory using 
either an Ethibond suture or screw 
tacks. The perioneum is then 
partially closed over the mesh. This 
operation can be combined with 
an abdominal paravaginal repair 
in a women with a cystocele and a 
colposuspension in a patient with 
stress incontinence.   
Manchester repair (Fothergill 
repair)
This procedure is only rarely 
performed nowadays. Cervical 
amputation is followed by 
approximating and shortening 
the cardinal ligaments anterior to 
the cervical stump and elevating 
the uterus. This is combined 
with an anterior and posterior 
colporrhaphy. The operation 
has fallen from favour as long 
term problems include infertility, 
miscarriage and dystocia in 
addition to recurrent uterovaginal 
prolapse and enterocele formation.
3.2 Enterocele repair
An enterocele repair is normally 
performed using a vaginal 
approach. The vaginal epithelium 
is dissected off the enterocele sac 
which is then reduced using two or 
more polyglycolic (Vicryl, Ethicon) 
or polydioxanone (PDS, Ethicon) 
purse string sutures. It is not 
essential to open the enterocele 
sac although care should be taken 
not to damage any loops of small 
bowel which it may contain. The 
vaginal skin is then closed.  
An abdominal approach may also 
be used although this is much 
less common. The Moschowitz 
procedure is performed by 
inserting concentric purse string 
sutures around the peritoneum 
in the pouch of Douglas thus 
preventing enterocele formation, 
although care must be taken not 
to ‘kink’ or occlude the ureters.
3.3 Vaginal vault procedures
Risk of post-hysterectomy apical 
prolapse is about 0.36% per year; 
or 1% (at 3yrs) and 5% (at 17yrs). 
The vaginal vault can be supported 
vaginally or abdominally.
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Vaginal procedures that suspend the 
apex
Sacrospinous ligament fixation (Sacrospinous 
colpopexy)
Modified McCall cul-de-plasty (Endopelvic 
fascia repair)
Iliococcygeus fascia fixation
High uterosacral ligament suspension with 
fascial reconstruction
Vaginal obliterative procedures
Colpectomy & colpocleisis
Abdominal procedures that suspend the 
apex
Sacralcolpopexy
New techniques
Transobturator- procedures including Prolift, 
Apogee and Avaulta
3.3.1 Vaginal Procedures
Sacrospinous Ligament Fixation 
(SSF)
A longitudinal posterior or anterior 
vaginal wall incision is performed 
to expose the ischial spine using 
sharp and blunt dissection. The 
sacrospinous ligament may then 
be palpated running from the 
ischial spine to the lower aspect of 
the sacrum. A delayed absorbable 
suture (PDS) is passed through the 
ligament. A number of techniques 
are available to do this. A standard 
long needle holder or a specially 
designed Miya hook ligature 
carrier can be used. Most recently, 
the Capio® ligature carrier (see 
picture) has been launched 
which makes the procedure 
significantly easier.  Both right and 
left Sacrospinous ligaments can 
be used to support the vagina. 
Some surgeons employ only one 
ligament but there is no evidence 
to suggest that a uni-or bilateral is 
better. 
Care must be taken to avoid 
the sacral plexus and sciatic 
nerve which are superior to the 
ligament, and the pudendal 
vessels and nerve which are 
lateral to the ischial spine. The 
sacrospinous sutures are then 
tied to support the vaginal vault 
from the sacrospinous ligament. 
Since the vaginal axis is changed 
by the procedure there is a risk 
of post-operative dyspareunia 
and development of stress 
incontinence. Success rates for this 
procedure are in the region of 80-
95%.
Complications of SSF:
•	 Haemorrhage
•	 Buttock pain
•	 Nerve injury
•	 Rectal injury
•	 Stress incontinence
•	 Vaginal stenosis
•	 Anterior vaginal wall prolapse
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3.3.2 Illiococcygeus Fixation
In this procedure, the vaginal vault 
is fixed to the illiococcygeus muscle 
fascia on both sides, just anterior 
to the ischial spines. The procedure 
can be performed through either 
an anterior or posterior vaginal 
incision. A delayed absorbable 
suture is used and secured to the 
vaginal vault and is associated 
with a good anatomical result 
with an adequate vaginal 
length with no deviation. A trial 
comparing illiococcygeus fixation 
and sacrospinous fixation found 
similar outcomes and comparable 
complication rates. 
3.3.3 Abdominal Procedures
Abdominal Sacrocolpopexy
See separate chapter
3.4 Obliterative Procedures
Colpocleisis 
Colpocleisis is an excellent option 
in patients who are certain 
that they will not want to be 
sexually active in the future. This 
is often a last resort in many 
women who have had recurrent 
procedures for vaginal prolapse.  
In partial colpocleisis (so-called 
Le Fort colpocleisis), the vagina is 
obliterated by excising rectangles 
of vaginal epithelium from the 
anterior and posterior aspects of 
the prolapse. These raw areas are 
then sutured together, thereby 
burying the cervix and obliterating 
the vagina. In total colpocleisis all 
the vaginal skin is removed and 
the anterior and posterior vaginal 
walls approximated. In both 
these procedures, an aggressive  
perineorrhaphy is performed. 
There is a high incidence of 
stress incontinence (up to 42%) 
following these procedures and 
therefore a concomitant mid-
urethral tape is mandatory.  
These procedures are performed 
on an outpatient basis with an 
immediate return to normal 
activities, and success rates as high 
as 100% have been described.
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Definition
Sacrocolpopexy (SCP) is the 
suspension of the vaginal vault to 
the sacrum.  A synthetic mesh is 
usually used which is fixed  to the 
vaginal vault and to the anterior 
longitudinal ligament of the 
sacrum opposite S1 – S2.  The mesh 
is usually placed retroperitoneally 
and the procedure is done 
abdominally by laparotomy or 
laparoscopy.
Variations
There are numerous variations:
1. Tension
The tension of the mesh can vary 
from tension-free to a moderate 
tension. Due to fibrosis the mesh 
shrinks and therefore, excessive 
tension should be avoided.
2. Length
The length of mesh along the 
vagina can vary:
From:
Introïtus or mid-vagina or Vault 
Vagina to Sacrum or Perineal body 
or mid-vagina or Vault
The longer the mesh extends 
along the vagina, the lower the 
recurrence rate for prolapse.  
However, complications such as 
overactive bladder symptoms and 
mesh erosion increase with longer 
mesh.
3. Material
Type 1 macroporous monofilament 
synthetic mesh is recommended.
4. Rectum
Rectum mobilization with 
elevation and fixation of it to the 
mesh (rectopexy) is recommended 
but not proven to be beneficial.
Indications
Any type of prolapse, stage 3 
or 4  (POPQ).   It is particularly 
useful for vault prolapse and large 
enterocoeles.  It is also performed 
for anterior compartment 
prolapse, but the larger the 
cystocoele, the greater the extent 
Chapter 17
Sacrocolpopexy
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from above (between bladder and 
vagina).
Insert a strip of mesh (about 15 x 3 
cm) into the abdomen.
Fix the bottom of the mesh to 
the arcuate ligament below the 
symphysis pubis and surrounding 
vaginal wall.
Close the anterior vagina.
Open the posterior vaginal wall.
Open the rectovaginal space and 
join it with the abdominal cavity.
Insert a second strip of mesh.
If necessary, perform a perineal 
body repair.
Fix the mesh to the perineal body 
and surrounding vaginal wall.
Close the vagina.
*Hydrodissection is recommended 
before incision. Use 200ml 
saline with 2 ampules Por-8 
(omnipressin).  It is injected 
between the vagina and bladder 
or rectum.
(iii) Abdominally
The two strips of mesh are fixed to 
the vaginal vault and then to the 
sacrum at level S1-2.  Moderate 
tension should be applied.  
Thereafter the rectum is pulled 
upwards and along its medial 
side fixed to the mesh.  Finally, 
the peritoneum is pulled over the 
mesh (it is often trimmed) and 
sutured to the rectum.  A markedly 
of bladder mobilisation.
Contraindications
Patients too young (<40 yr)
Patients too old (> 70 yr)
Marked obesity
Medical problems that may create 
post-operative problems such as 
deep vein thrombosis.
Patients on anticoagulants, 
including Disprin.
Age group
The ideal age group is 45 – 65 
years.
Recommended technique
The operation consists of a 
laparotomy and can be divided in 
three parts:
(i) Abdominally
Separate the bladder from the 
vagina to the level of the bladder 
neck.
Open the peritoneum medially 
to the rectum from the sacral 
promontory to the vagina.
Open the rectovaginal space for a 
short distance.
Open the presacral space and 
aggressively mobilize the rectum 
down to the pelvic floor.
(ii) Vaginally*
Open the bladder neck area.
Open the space already made 
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elevated pouch of Douglas is 
characteristic of this operation.
A suprapubic catheter is usually 
inserted for determining the 
residual volume on day 3-4 
postoperatively.  It should be 
less than 70ml.  A vaginal plug 
is inserted after the operation 
and removed 36-48 hours 
postoperatively.  The skin 
stitches are kept in for 2 weeks.  
Anticoagulant therapy is applied 
from the first day after the 
operation.
Bowel action is important 
postoperatively and when she 
is discharged.  Initially, laxatives 
should be given. Antibiotics are 
also given for the first few days.
Results:
The main results of SCP as 
described above are the following:
Recurrent prolapse about 10% 
(depending on the surgeons’ 
experience and the type of 
prolapse).
Mesh erosion about 10-15% of 
which 95 – 98% can be treated in 
the consulting room by excision 
of the exposed mesh followed by 
vaginal estrogen cream 1 – 2x/
week.
Overactive detrusor 40-60%, but 
the incidence decreases over time.
Stress urinary incontinence in  
about 10% of cases. Physiotherapy 
or a mid-urethral tape should be 
considered.
Abdominal pains during the first 6 
months.
Vaginal bleeding during the first 
month.
Dyspareunia 5 – 6% (the same 
figure as preoperatively).
Although the bowel action 
improves markedly in most 
patients, a minority of women 
have persistent  constipation.
If obstructive defaecation 
persists after the operation, a 
defaecogram should be done (very 
similar to a barium enema).  If a 
rectocoele (particularly with rectal 
intussusception) is demonstrated, 
a STARR procedure could be 
considered (consult a colorectal 
surgeon).
Outcomes
1. Cronjé HS. Colposacrosuspension 
for severe genital prolapse. Int J 
Gynecol Obstet 2004; 85: 30-35.
Recurrent prolapse:    8%
Repeat surgery:    4%
TVT /Ob-tape postoperatively: 12%
136
2. Cronjé HS, De Beer JAA.  
Abdominal hysterectomy and 
Burch colposuspension for 
uterovaginal prolapse. Int 
Urogynecol J 2004; 24: 408-413.
Recurrent prolapse:  10%
Repeat surgery:    9%
TVT/Ob-tape:     3%
3. Cronjé HS, De Beer JAA. 
Vault prolapse treated by 
sacrocolpopexy. S Afr J Obstet 
Gynaecol 2007; 13: 80-83.
Recurrent prolapse:  14%
Repeat surgery:  8%
TVT/Ob-tape:   8%
4. Cronjé HS, De Beer JAA. 
Combined abdominal 
sacrocolpopexy and Burch 
colposuspension for the treatment 
of stage 3 and 4 anterior 
compartment prolapse. S Afr J 
Obstet Gynaecol 2007; 13: 84-90.
Recurrent prolapse:  16%
Repeat surgery:  6%
TVT/Ob-tape:   8%
5. Cronjé HS, De Beer JAA.  
Culdocele repair in female pelvic 
organ prolapse. Int J Gynecol 
Obstet 2008; 100: 262-266.
Recurrent prolapse:  10
Repeat surgery:  5
TVT/Ob-tape:   13
6. Cronjé HS, De Beer JAA, Nel 
M,  Picton AJ.  The length of 
mesh used in sacrocolpopexy and 
subsequent recurrence of prolapse. 
(In press).
Mesh from vaginal vault to sacrum: 
24% recurrent prolapse.
Mesh from mid-vagina to sacrum:
9% recurrent prolapse.
Mesh from vaginal introitus to 
sacrum:        8% recurrent prolapse.
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Introduction 
Interest and expertise in pelvic 
floor function and rehabilitation 
has expanded markedly over 
recent years. While the field of 
Women’s Health physiotherapy 
is not yet deemed mainstream, 
it is a growing specialty and is 
increasingly included as a first line 
of investigation and management 
in conditions ranging from non-
resolving lower back pain (LBP) 
to urinary urgency/frequency. 
It is now accepted as standard 
treatment for female urinary 
incontinence and pelvic floor re-
education is included as routine 
care in many obstetric services. 
This popularization within 
physiotherapy can be partially 
attributed to an improved 
understanding of the pressures in 
the pelvis and lumbar spine, and 
how these relate to pelvic floor 
Chapter 18
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rehabilitation
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loading and the associations with 
movement and visceral function. 
Work on muscle rehabilitation was 
profoundly impacted by Andre 
Vleeming’s description of forces 
around the sacroiliac joint (SIJ). 
The concept of form closure and 
force closure as they apply to 
the body (skeletal vs. muscular 
and fascial systems) resulted in 
a rethink of the transmission of 
pressure between the central 
core of the lower spine and 
the abdomen (intra-abdominal 
pressure (IAP)), the thorax 
(breathing) and limbs (activity).  
Evidence based research describes 
the types of muscle function under 
varying degrees of load, looking 
at the different muscles that 
stabilize and mobilize the body. 
Muscle function is further divided 
into local and global systems, each 
having partner muscles working 
within functional slings. Control 
and quality of movement are 
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•	 Sexual dysfunction: 
•	 pain on penetration, 
•	 dyspareunia, 
•	 post-coital pain, 
•	 orgasmic disorder, 
•	 vaginismus
•	 Bowel dysfunction: 
•	 faecal incontinence (FI), 
•	 flatus, urgency, 
•	 incomplete evacuation, 
•	 constipation, 
•	 disordered ano-rectal 
function, 
•	 anismus
•	 Pelvic organ prolapse (POP)
The scope of physiotherapeutic 
management extends from 
conservative measures, 
including behavioural 
modification, pelvic floor 
muscle rehabilitation to 
electrotherapy.
Recent additions to the pelvic 
floor rehab repertoire include 
myofascial techniques, trigger 
points and low load vs. high load 
muscle activation.
now central treatment objectives, 
whereas the older benchmarks 
of strength and range of motion 
(ROM) are simple progressions. 
This chapter aims to examine the 
diverse roles and functions of the 
pelvic floor. We will address the 
need for specificity in assessment 
and rehab selection and outline 
treatment options and techniques 
used to quantify and qualify PF 
function. 
The scope of 
physiotherapy and 
aims of pelvic floor 
rehabilitation
A broad range of complaints 
and conditions occur as a result 
of pelvic floor dysfunction 
and may therefore respond to 
pelvic floor rehabilitation.
•	 Bladder dysfunction: 
•	 stress incontinence (SI), 
•	 overactive bladder (OAB), 
•	 frequency/urgency, nocturia, 
•	 post void residuals (PVR) and 
other voiding dysfunction, 
•	 hesitancy, interstitial cystitis, 
•	 leaking with intercourse, 
recurrent urinary tract 
infections (RUTIs) 
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The physiology of micturition 
as it relates to the pelvic floor 
•	 The pelvic floor co-ordinates 
cortically stimulated activities 
(when and where to void). 
Other functions are mediated 
at the spinal level.
•	 There are a number of reflexes 
acting between the pelvic floor 
and the bladder:
•	 The Perineodetrusor inhibitory 
reflex inhibits detrusor activity 
in response to increasing tone in 
the pelvic floor muscles. (Storage 
phase - early)
•	 The Perineobulbar detrusor 
inhibitory reflex inhibits 
contraction of the detrusor 
in response to contraction of 
the perineal and pelvic floor 
muscles. (Storage phase - late)
•	 The Urethrosphincteric 
guarding reflex stimulates a 
powerful contraction of the 
external striated urethral 
sphincter in response to urine 
in the proximal urethra and/
or increasing tension in the 
trigone. (Storage phase - under 
stress)
Abdominopelvic synergy
The pelvic floor has been shown 
to have ‘partner muscles’ that co-
activate to form functional slings. 
Pelvic floor function and dysfunction
Characteristic Function Dysfunction
Base element of core Control changes in IAP Poor generation of IAP with 
function e.g. weak cough
Lumbar and pelvic load Lumbopelvic stability Low back pain and chronic 
pelvic pain/pelvic girdle pain
Fast twitch muscle activity
High load
With activity and physical 
stress
SI, POP
Slow twitch muscle activity
Low load
For antigravity support, 
bladder inhibition, anorectal 
angle 
POP, OAB, FI
Eccentric muscle activity Release pelvic sling whilst 
supporting ano-rectum during 
defaecation 
Obstructed defaecation, POP
Tone and elasticity Supportive sling POP
Sexual participation Sexual awareness/enjoyment Dysparuenia, decreased sexual 
enjoyment
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Some of the notable partners are: 
Abdominal Muscle Pelvic Floor
Transversus Abdomi-
nis (TA)
Pubococcygeus (PC) 
& anterior PF 
Obliques Levator ani 
Rectus Abdominis 
(RA)
Puborectalis 
NB: Whilst the PF is defined along 
anatomical lines, its function 
should be considered as part of a 
greater unit. Indeed, the associated 
abdominal co-contraction may be 
more important than contracting 
the PF in its entirety. 
The pelvic floor as a pressure 
mediator
The normal pelvic floor, with 
intact fascia, needs little more 
than its inherent elasticity 
and reflex activity to function 
adequately. When the normal 
fascial attachments, however, 
are compromised by pregnancy 
and other factors increasing IAP, 
forces are exerted unequally 
through the pelvis, hence loading 
different compartments selectively 
and repeatedly. The pelvic 
floor therefore usually requires 
selective rehabilitation to ensure 
appropriate activation for either SI, 
OAB or POP.
The pelvic floor as a 
pressure mediator for Stress 
Incontinence Rehabilitation 
aims to enhance the mechanical 
functioning of the pelvic floor, 
particularly speed and strength. 
The woman needs to learn to 
recruit the guarding reflex, 
which consists of a concomitant 
PF contraction with increasing 
IAP, when coughing or any other 
similar events. This is a focal 
contraction.
The pelvic floor as a pressure 
mediator for OAB rehabilitation 
aims to normalize detrusor 
activity via tonal changes in 
the PF (see reflexes above). 
Functional use of the PF to 
mediate detrusor activity is 
usually focal. Postmenopausal 
women invariably have decreased 
pelvic floor tone secondary to 
atrophic changes, and therefore 
in this group particularly, 
prophylactic PF focused advice and 
education will be of benefit. If the 
inhibitory reflexes are insufficient, 
harnessing S2-4 dermatomes and 
myotomes may also improve the 
PF contraction. It is important that 
these are not used in place of, but 
in conjunction with an appropriate 
PF contraction
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Dermatomes for 
S2-4
Myotomes for S2-4
Saddle area (sitting 
on e.g. arm of chair)
Gluteus Muscles 
(buttocks gripped)
Back of legs (rub-
bing back of legs)
Adductors (knees 
together)
Clitoris (manual 
perineal pressure)
Plantar flexors (up 
on toes)
Intrinsic foot muscles 
(up on toes)
III S2-4 Dermatomes and Myotomes
The pelvic floor as a pressure 
mediator for frequency/
urgency Rehabilitation aims to 
differentiate urgency secondary 
to decreased detrusor 
inhibition as opposed to  
urgency secondary to abnormal 
pelvic floor firing (autonomic 
up-regulation, disturbing 
normal detrusor activity) as a 
result of pelvic floor trigger 
points. 
The pelvic floor as a pressure 
mediator for hesitancy 
and incomplete emptying 
rehabilitation aims to normalize 
inappropriate PF activity 
with voiding (dyssynergia). 
Voluntary relaxation is essential 
and this usually co-exists with 
a functional inability to de-
activate abdominal bracing.
Objective Assessment
An objective assessment with 
clearly defined parameters is 
essential, to formulate a patient 
specific rehab programme. 
Posture changes over time. 
Repeated incorrect posture 
over time becomes habitual  
progressing into a movement 
pattern. Poor spinal posture 
inhibits appropriate use of the 
core.
Breathing habits as with 
posture, become habitual. The 
normal muscle ratio of breathing 
is mostly diaphragmatic with a 
smaller lateral thoracic component 
and the least from the thoracic 
apex.  This becomes disordered and 
the normal bellows-action of the 
lungs, filling from the oxygenated 
bases rather than the apices, is 
compromised. The decrease in 
diaphragmatic work (often due to 
splinting) results in less efficient 
breathing. Furthermore, the core 
is loaded from the top leading to 
greater dysfunction. 
Abdominal wall 
The abdominal wall is assessed 
for skin changes, muscle tone and 
integrity, and myofascial trigger 
points (TPs). Many abdominal TPs 
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will refer to the abdominopelvic 
area. Symptoms of pain and 
discomfort include vulvodynia, 
coccydynia, levator ani syndrome, 
vulvar vestibulitis, dyspareunia, 
vaginismus and pelvic floor tension 
myalgia.
Visceral effects include 
frequency-urgency syndrome, 
interstitial cystitis and irritable 
bowel syndrome (IBS). TPs can 
exacerbate, and in extreme cases, 
cause pudendal neuralgia/nerve 
entrapment.
Neurological testing of 
dermatomes is mandatory and 
if any abnormality is detected, 
warrants further testing of S2-
4.
External perineal examination
Observations of skin, mucosa and 
scarring are noted. The movement 
relationship between the perineal 
body and PF is observed. 
Internal digital examination
A digital vaginal exam is indicated 
in all patients except those who 
cannot give consent, and those 
who are not yet sexually active.  
The international guidelines are 
continually being updated to 
include qualitative measures. As 
with all assessments, quantitative 
outcomes are recorded.
Palpation – anterior, lateral and 
posterior walls are assessed 
for laxity and movement in 
response to changes in IAP. 
Physiotherapists do not grade 
according to POPQ although 
should be familiar with the 
scale. Any areas of focal 
tenderness are explored as 
trigger points. 
Perfect Score
The subject performs a maximal 
contraction against the therapist’s 
index finger.
P records power according to a 
Modified Oxford Scale 
With a brief consistent rest 
between contractions, the 
following are assessed:
E records endurance to a max of 
10seconds at said power
R records repetitions to a max of 
10 repetitions at said power and 
endurance.
After 1 minute rest:
F records fast contractions to a max 
of 10 before fatigue
ECT reminds us that every 
contraction is timed to formulate a 
patient specific formula
Therefore: 4/8/4//7 records a good 
contraction, held for 8 seconds, 
repeated 4 times before fatigue; 
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and after a minutes rest, 7 quick 
contractions before fatigue.
Initiation and stability
The speed and control of initiation 
and the stability of the contraction 
are noted, along with any coupled 
movement and breathing patterns.
Voluntary contraction – absent/
present 
Is the subject able to perform a 
satisfactory PFC?
Involuntary contraction - 
absent/present
Does the PF automatically kick-in 
with increased IAP?
Voluntary relaxation - absent/
present
Is the subject able to relax 
appropriately?
Involuntary relaxation - absent/
present
Does the PF relax with 
defaecation?
 
Technique 
An overall assessment of the ease 
of activation and appropriate co-
activation of the abdominopelvic 
unit is recorded. A strong PF 
contraction with breath-holding 
is non-functional and therefore 
needs rehab. 
QOL question
A quality of life questionnaire 
allows the subject to self-grade.
If you were to spend the rest of 
your life with your symptoms as 
they are now how would you feel? 
If indicated – spine, hip/pelvic 
girdle, myotomes, reflexes, 
sensation, biofeedback
Behaviour
Two consecutive days (48 hour) 
of behaviour are charted, be it 
fluid intaket/output or food diary. 
Symptoms (notably leakage) are 
noted. 
Score Response on fingers
0 = nil Muscle bulk present/absent
1 – flicker/very weak (min) Very weak/fluctuating 
2 – weak (poor) Increase in tension
3 – moderate (reasonable) Lift
4 – some strength (good) Lift + resistance
5 – strong (max) Lift + strong resistance
IV. Muscle Testing – the Modified Oxford Scale
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Treatment
Behavioural modifications
1. Fluid/diet management; diaries 
are of great use as behaviour 
sensitisers. 
2. Education and counselling 
are of particular importance 
in identifying triggers and 
breaking psychological 
sensitisers. 
3. Bladder training using the 
PF as an inhibitor of detrusor 
activity helps to decrease urge 
incontinence, control urgency, 
delay voiding, increase bladder 
capacity and decrease nocturia. 
Often, in that order!
4. Defaecatory technique teaching 
correct positioning and pressure 
transmission can alleviate 
the signs and symptoms of 
obstructed defaecation.
5. Disability management; 
although the aim is a clean 
dry subject, there will be times 
when management of disability 
is the best short-term solution; 
this includes the use of pads 
and occlusive devices in sports 
women.
PF Muscle Rehab 
Physiotherapists specialise in 
muscle function and rehabilitation. 
PF rehab follows very similar 
guidelines to general muscle 
rehab, relying on the same 
physiological responses of exercise 
and overload (without fatigue) 
to cause muscle hypertrophy. 
All aspects of muscle function 
need to addressed. Furthermore, 
the specific function of that 
particular component needs to be 
considered e.g. fast twitch work 
of the compressae urethrae. The 
PF, working as it does as a low 
load support (bladder inhibition, 
support of pelvic viscera, support 
of rectum during defaecation) 
and a high load resistor (fast 
twitch activity with rapid changes 
in pressure/speed), needs to be 
rehabilitated through a variety 
of diverse functions. A balance 
needs to be found between 
power and endurance training. 
Pure technique needs to be offset 
against functional outcome 
and skill acquisition. The PF 
muscles, like the fascial muscles, 
QOL Delight-
ed
Pleased Satis-
fied
Fence 
sitting
Dissatis-
fied
Un-
happy
Terrible
Score 0 1 2 3 4 5 6
V. QOL scale
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control a number of openings, 
through a range of activites, for 
a variety of functional outcomes. 
The challenge with the PF lies 
in sensory motor integration. 
Virtually all other muscle rehab 
can be mediated by some form of 
feedback, usually visual. The PF 
and its actions cannot be seen or 
mediated. Biofeedback remains an 
invaluable tool for the PF specialist 
physio. 
Re-ed breathing
All rehab should begin with basic 
body awareness and breathing. 
Some form of automatic speech 
e.g. counting is often beneficial 
as it mediates the breath whilst 
giving auditory feedback. 
Re-ed PF 
In the 1940s Kegel described 
a basic contraction of the PF 
musculature. To date, aspects such 
as stablility and ease of activation 
are as important as strength and 
endurance. Despite enjoying a 
certain popularity (notoriety?) in 
the media (women’s magazines), 
many medical staff remain dubious 
about the benefits of specific 
rehab for the PF. Whilst there is 
increasing emphasis on ante and 
post natal care and education, 
many women are not being 
advised that there is something 
that they can do before medication 
or surgery need to be explored. 
A basic rehab program would 
progress as follows:
Rehab Outcome
Assessment Baseline
Active exercise Muscle conditioning
Skill training Functional 
Recruitment of 
muscle and reflexes
Patterning for auto-
matic function
Sensory awareness Improved efficiency
Biofeedback, prefer-
ably EMG Enhanced awareness
Neuromuscular 
stimulation
Enhanced awareness 
and function
Rehabilitation of Muscles
Not all subjects will require the full 
scope of rehab. 
Re-ed abdopelvic synergy
Research in the field of 
orthopaedic manual therapy (OMT) 
is increasingly showing coupled 
relationships between the PF and 
abdominal muscles. This research is 
ongoing. At a glance:
Abdominal Muscle Pelvic Floor
Transversus Abdomi-
nis (TA)
Pubococcygeus (PC) 
& anterior PF 
Obliques Levator ani 
Rectus Abdominis 
(RA) Puborectalis 
Abdominopelvic Partners
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These muscle pairings allow for 
different types of spinal load (low 
load, rotation, high load) to be 
distributed evenly through the 
pelvis. 
Rehab any objective deficits 
Biofeedback, a useful tool in any 
rehab setting, is invaluable in 
rehabilitation of the PF due to 
the lack of other forms of sensory 
feedback. 
If the deficit includes a marked 
motor component (<Gr3 Modified 
Oxford Scale) then some form 
of artificial stimulation may be 
indicated. 
Rehab whole body A strong PF 
that cannot contract at precisely 
the right time is insufficient for 
daily life. The stresses, strains and 
pressures of individual subjects 
need to be assessed. Gyrokinesis, 
Pilates, Yoga and Tai Chi (amongst 
others) offer exercise within 
functional limits. In particular, an 
excellent PF may still be insufficient 
for the rigours of long distance 
road running, and certain jumping 
activities.
Home Exercise Programme 
(HEP)
A combination of PFEs, core 
work and sports specific training 
will achieve a certain level of 
skill acquisition. A maintenance 
programme is invaluable. Many 
women choose to include PF work 
to improve their current sporting 
function or to enhance another 
form of exercise
Biofeedback 
In cases of poor sensation and 
proprioception, biofeedback serves 
as an external mediator of internal 
function, allowing the subject to 
create ‘movement memories’. 
The age old ‘jade egg’ has 
morphed into today’s weighted 
vaginal cone. Of major significance 
is the conical end, which stretches 
the introitus as it descends with 
increased IAP, hence cueing a PF 
contraction.
Pressure biofeedback and some of 
the simple EMG options offer real 
time imaging. Many EMG options 
allow for viewing on a workout 
session via recorded imaging
Electrotherapy
As with all evidence based 
practices, the strength of 
the research methodology is 
paramount when selecting a 
treatment modality. Differing 
patient populations, protocols 
and outcome measures make clear 
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guidelines difficult. Electrotherapy 
should not be considered as a 
single treatment option, but 
the next level of conservative 
management. Different settings 
on the equipment can select for 
slow or fast twitch neuromuscular 
activation. EMG in combination 
with NMS allows accurate feedback 
of response to stimulation.
EMG biofeedback 
Electromyography (EMG) is the 
undisputed gold standard of 
biofeedback. Ideally, it shows a 
range of work over a period of 
time, allowing assessment of:
•	 Maximum/minimum contraction
•	 Maximum/minimum relaxation
•	 Stability contraction/relaxation
•	 Speed of initiation/release
•	 Endurance and fatigue 
resistance
•	 Concentric and eccentric control
EMG is best performed with a 
shaped vaginal (or anal) electrode.
It may used across a range of PF 
tonal abnormalities from the up-
scaling of a PF contraction to the 
down-regulating of high resting 
tone.
Neuromuscular Stimulation
Where the PF has a strength of 
less than Grade 3, or has very 
poor sensory awareness (pudendal 
nerve latencies), neuromuscular 
electrical stimulation is indicated. 
Electrical impulses set up an 
action potential in the pudendal 
nerve, causing it to fire and 
contract the PF. This improves 
nerve conduction, activates the 
neuromuscular junction and 
stimulates a muscle contraction. It 
also promotes synapse formation, 
protein production and muscle 
hypertrophy.
Depending upon the symptoms 
and aims of treatment, the 
settings are selected according 
to wavelength and frequency. A 
classic ‘fast twitch’ training would 
include active assisted contractions 
with the machine (NMS) for speed 
and strength.
A classic ‘slow twitch’ treatment 
would be passive and would 
improve sensory conduction, 
resting tone and normalize bladder 
reflexes. 
Conclusion
The pelvic floor physiotherapist 
 
A neuromuscular stimulation 
unit – The Myomed 932
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has the necessary skills to assess 
muscle function and dysfunction 
and rehab according to sound 
evidence based principles. Highly 
developed palpation is needed 
to differentiate between subtle 
differences in tone and strength. 
We are, essentially, working 
blind! Special insight into the 
psychological implications and 
management of behaviour make 
the Pelvic Floor Physio an excellent 
conservative one-stop-shop. 
A clear assessment, with a patient 
specific programme and regular 
monitoring of compliance and 
motivation can yield excellent 
results; better than standing in the 
corner doing 100 squeezes per day, 
but not contracting with a cough!
Physiotherapy for pelvic floor 
disorders does not compete with 
medication or surgery. It finds its 
niche somewhere between patient 
responsibility and doing the best 
you can with what you’ve got.
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same person, if he has a fractured 
femur and cannot move to the 
bathroom quickly enough, will, 
by definition, experience urge 
incontinence, despite having 
completely normal anal sphincter 
function. Also, a patient with 
damaged sphincter muscles may 
be able to cope for many years 
until the injury is unmasked by 
new onset diarrhoea or weakening 
of the pelvic muscles with age.  
The table below summarises 
the common causes for faecal 
incontinence. 
History taking
The severity of incontinence, as 
well as its impact on the patient’s 
lifestyle should be assessed. 
Numerous scoring systems for 
incontinence exist, but a simple 
and useful classification is simply 
to determine if the patient is 
incontinent to flatus (least severe), 
liquid stool (more severe), or solid 
stool (most severe). One should 
Faecal incontinence is a common 
condition, affecting up to 10% 
of adults, with about 0.5 to 1% 
having regular symptoms that 
significantly affect their quality 
of life. Unsurprisingly, in view of 
the social stigma attached to this 
problem, it may be underreported, 
and patients often present late.
It is important to understand 
that faecal incontinence is a 
symptom, not a diagnosis in itself, 
and that incontinence is usually 
multifactorial in origin. Adequate 
continence requires higher mental 
function, intact sensory and motor 
nerve pathways, an adequate 
rectal reservoir and an intact anal 
sphincter complex. In addition, 
the consistency of the stool and 
the patient’s general mobility play 
an important part in maintaining 
continence.  For example, any 
person who has sufficiently severe 
diarrhoea will experience urgency 
(having to ‘run to the toilet’). The 
Chapter 19
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also ascertain whether the problem 
is urgency or passive incontinence 
(in which the patient is unaware of 
the passage of stool). 
The patient should be asked about 
any general medical conditions, 
as well as their mobility. Diabetes 
and many neurological and spinal 
diseases can affect pudendal nerve 
and therefore sphincter function.  
Obstetric history is especially 
important, particularly any 
history of instrumental deliveries, 
episiotomies or perineal tears.
One should ask about the patient’s 
bowel habits and stool consistency 
with particular attention to any 
recent change in bowel habits, 
as well as any other symptoms 
suggesting bowel cancer or 
inflammatory bowel disease (such 
as blood or mucus per rectum or 
weight loss).
Examination
Apart from a general clinical 
examination, one should examine 
the perineum for signs of rectal 
or vaginal prolapse and perineal 
descent. Examination of the 
perineum and anus may reveal a 
palpable anal sphincter defect. 
A digital anal examination is 
important not only subjectively to 
assess sphincter tone (both resting 
and ‘squeeze’), but also to exclude 
anorectal neoplasms, and to detect 
faecal loading. Where appropriate, 
Common causes for facial incontinence
Anatomical site Disorders
Anus/ perineum Anal sphincter injury, pudendal neuropathy, 
rectal prolapse.
Colon and rectum Inadequate rectal reservoir due to e.g. Radia-
tion or inflammatory bowel disease.
Stool quality Diarrhoea or mucus production from any 
cause. This includes inflammatory bowel 
disease and faecal impaction or colorectal 
neoplasms with overflow diarrhoea.
Numerous medications.
Sensorimotor pathways Diabetes, neurological disorders 
Brain Dementia, psychological disturbances
General Impaired mobility 
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a full neurological or cognitive 
assessment should be performed. 
Investigation
All patients with new onset faecal 
incontinence who are over 50 years 
old, or who have experienced 
changes in bowel habits should be 
referred for a colonoscopy in order 
to exclude colorectal neoplasms or 
inflammatory bowel disease.
Endo- anal ultrasound is a non- 
invasive procedure which allows 
visualisation of the anal sphincters, 
and is indicated in all patients 
in whom anal sphincter damage 
is suspected. It will identify the 
group of patients with isolated 
sphincter injuries (almost all of 
which are due to obstetric injuries) 
who may suitable for surgical 
sphincter repair. The illustration 
below is a typical example of an 
obstetric sphincter injury involving 
the anterior part of the external 
and internal sphincters.
Anorectal manometry is commonly 
performed to document anal 
sphincter function. Measuring 
resting sphincter pressures 
provides information about 
the function of the internal 
sphincter, while the quality of the 
(consciously controlled) ‘squeeze’ 
pressure is dependant on external 
anal sphincter function. One may 
also gain information about the 
compliance of the rectum, and 
the anorectal inhibitory reflex 
(which causes the anus to relax 
during defecation). It is unusual, 
however, for this to change the 
management of an incontinent 
patient, and its usefulness is mainly 
in research and in documentation 
for medico legal purposes.
Sacral nerve latency testing aims 
to detect sacral neuropathy (which 
is common in incontinent women, 
and usually due to obstetric injury). 
The test has poor inter- observer 
reproducibility in most operators’ 
hands, and seldom gives results 
that change management.
MRI scanning provides detailed 
imaging of the anal sphincters. 
It can not only detect sphincter 
injury, but also gives information 
about sphincter muscle atrophy. 
At present it is not widely used in 
the assessment of anal sphincter 
injuries, but may become more so 
in the future.
Management
Treatable specific conditions
Patients with sphincter injuries 
should be referred for possible 
repair. Although the long- term 
results of anal sphincter repairs 
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are disappointing (about 25% 
of patients will be continent for 
liquid stool after 10 years), this 
offers the best hope of cure in this 
group of patients.
Faecal impaction is common, 
especially in the elderly, and should 
be treated with enemas and oral 
laxatives (and manual disimpaction 
under general anaesthesia if 
necessary) until the rectum is 
empty.
Rectal prolapse may require 
surgical correction.
Bowel diseases such as colorectal 
neoplasms or inflammatory bowel 
disease should be treated as usual.
Conservative management
Unfortunately, most patients 
with faecal incontinence do 
not have curable diseases. They 
should initially be treated with 
conservative measures aimed 
at reducing the impact of the 
incontinence on the patient’s 
lifestyle.
Bowel habits may be improved by 
modifying fibre intake (some will 
improve by increasing the fibre 
in their diet, others by decreasing 
it). Reducing caffeine intake may 
decrease bowel frequency. If 
the patient is receiving chronic 
medication, one should try to 
stop any with side effects on 
gastrointestinal motility.
If the patient has loose stools in 
the absence of an identifiable 
colorectal pathology (on 
colonoscopy), loperamide is the 
drug of first choice to firm the 
stool and decrease stool frequency. 
Tricyclic antidepressants may 
also have a role in reducing stool 
frequency.
Rectal washouts may be helpful 
to motivated patients. They can 
empty their rectum at a convenient 
time, and hopefully not soil 
themselves during the intervening 
time.
Other surgical options
Patients with incontinence due 
to pudendal nerve dysfunction 
or surgically non- repairable anal 
sphincter injuries may benefit from 
sacral nerve stimulation. Short 
term data for this intervention 
are encouraging, but long- term 
outcomes are not well known.
Neosphincter construction, 
whether with a prosthetic 
sphincter or gracilis muscle 
transposition, are complex 
operations with significant 
complications. These should only 
be performed in highly specialised 
centres.
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In summary, the management of 
these patients remains difficult. It 
is important for the patient and 
the clinician to realise that the 
prognosis for cure is poor, and 
that treatment must be aimed at 
improving long- term quality of 
life.
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Failure of surgery for pelvic 
organ prolapse is a reality facing 
every vaginal surgeon, despite 
the numerous modifications and 
innovations to surgical technique 
over the past century.  As many 
as 29% of women will require an 
additional operation following 
primary prolapse surgery. With 
second and subsequent procedures 
these figures increase. 
Surgical failure may be the 
attributed to a number of factors. 
Surgical technique is rudimentary 
and inattention to important 
aspects such as tissue handling, 
correct choice of suture material 
and strict asepsis will have an 
important impact on the outcome 
of the prolapse repair. Thorough 
pre-operative assessment is also 
crucial in ensuring the appropriate 
procedure is performed and 
support in all three vaginal 
compartments is addressed.  In 
addition there is now evidence to 
suggest that factors distinctive to a 
specific patient will predispose to 
a recurrence of the prolapse. This 
includes inherent deficiencies in 
tissue quality or healing, persistent 
increases in intra-abdominal 
pressure and exogenous factors, 
like steroid use. 
Despite thorough pre-operative 
assessment and meticulous surgical 
technique, pelvic organ prolapse 
will recur. In an attempt to 
improve outcomes, gynaecologists 
involved in reconstructive pelvic 
floor surgery have looked to 
the general surgeons, who have 
employed various graft materials 
for the correction of abdominal 
wall hernias. A wide variety of 
synthetic and biological grafts are 
currently available. The synthetic 
grafts have shown some promise 
Chapter 20
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in the prevention of recurrent 
prolapse but unfortunately have 
a tendency to erode, extrude or 
become infected. The biological 
grafts have been developed to 
avoid these complications. The 
autografts, derived from the 
patient’s own tissue, unfortunately 
have the disadvantages associated 
with harvesting from the thigh, 
vagina or abdominal wall, while 
the allografts which are harvested 
from cadavers, bring with them 
the risk of cross-infection. The 
newest development has been 
the introduction of xenograft 
materials, derived from animal 
sources, into prolapse surgery. 
These products carry a low 
infection risk and, in addition, 
have low erosion rates and do not 
need to be harvested. There are 
however reservations regarding 
the longevity of these grafts. 
The introduction of new prostheses 
into practice has regrettably been 
marketing rather than evidence 
driven. It is vital that practitioners 
involved in reconstructive pelvic 
floor surgery are aware of the 
efficacy, limitations and potential 
morbidity of these products. In this 
chapter we will briefly review the 
failure rates following anterior, 
apical and posterior compartment 
surgery. In addition, we will classify 
and assess the properties of both 
synthetic and biological prostheses 
employed in reconstructive pelvic 
floor surgery and evaluate surgical 
outcomes and peri-operative 
morbidity following the use of 
these materials.
Failure Of Primary 
And Secondary 
Prolapse Procedures 
Anterior Compartment 
(See table 1)
Ahlfelt in 1909 stated that the only 
problem in plastic gynaecology 
left unresolved was the permanent 
cure of the cystocele. In 1913 
Kelly described the anterior 
colporrhaphy, which involved 
plication of the urethral muscle.  
A number of other procedures 
advocated for the repair of the 
cystocele have subsequently 
evolved and these include: 
vaginal para-vaginal repair, 
colposuspension and abdominal 
paravaginal repair. The success 
rates of anterior colporrhaphy in 
the management of cystoceles 
range from 70-100% in 
retrospective series.  Much higher 
recurrence rates have, however 
been reported. In two randomized 
control trials, Weber et al and 
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Sand et al reported the anterior 
colporraphy to be successful in 
only 42% and 57% respectively. 
Success rates of the vaginal 
paravaginal repair for cystoceles 
in various case series range from 
1-33%.  In addition, this procedure 
has significant morbidity including 
ureteric ligation, retropubic 
haemorrhage and abscess 
formation. Colposuspension has 
a failure rate of up to 33% and 
abdominal paravaginal repair fails 
in up to 24%. 
In addition to the traditional risk 
factors, recurrence of anterior 
compartment prolapse may be 
related to failure of the initial 
procedure to identify and repair all 
support defects. Adequate support 
of the vaginal apex is essential 
in ensuring the longevity of an 
anterior compartment procedure.
Posterior Compartment 
(See table 2)
Reports of recurrence after 
rectocele repair range from 7% 
to 67%, depending on the type of 
operation. Rectocele repair can be 
approached vaginally, transanally 
or abdominally. The vaginal 
procedures include: site –specific 
repair, fascial plication and levator 
plication repair.  For the vaginal 
Table 1: Failure rates of anterior compartment prolapse repair
 Procedure Follow-up Failure
(variably defined)
Midline fascial placation 1 – 20 yrs 3-58 %
Site-specific fascial repair 6 mths – 2 yrs 10-32 %
Vaginal-paravaginal repair 6 mths – 6 yrs 30-67 %
Abdominal paravaginal repair 6 mths – 6 yrs 20 %
Concomitant sling support 17 mths – 4 yrs 2-57 %
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approach, failure rates are quoted 
at between 7-32%.  
Midline fascial plication during 
the vaginal approach seems to be 
more successful than site specific 
repair. The transanal repair, the 
colorectal surgeon’s route of 
choice, has reported failure rates 
of up to 67%.
Apical Prolapse
The vaginal apex, be it uterus or 
post –hysterectomy vaginal cuff, 
is the keystone of pelvic organ 
support. Appropriate attention 
to apical support is crucial in 
the prevention of posterior and 
particularly anterior vaginal wall 
prolapse.  
A number of procedures; including 
the vaginal, abdominal and 
laparoscopic approaches are 
employed for apical prolapse. 
Objective failure rates vary from 
24% to 47% in various studies 
on sacrocolpopexy, bilateral 
iliococcygeus fixation and 
sacrospinous fixation. 
Table 2: Failure rates of posterior compartment prolapse repair
Procedure
 
 
Failure Persistent POP 
symptoms
Dyspareunia
Levator plication 10-20 % <20 % 27-50 %
Midline fascial 
plication
7-13 % 7-20 % 4.2 %
Site-specific fascial 
repair
10-32 %   
Trans-anal repair 30-67 % 17-30 %  
Laparoscopic 
rectocoele repair
20 % 20 %  
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Classification And 
Properties Of Graft 
Materials
Prostheses may be derived from 
synthetic materials, biological 
tissues or mixed synthetic and 
biological grafts.  The biological 
grafts include autologous grafts, 
which are derived from the 
individual’s own tissues, allografts 
from human donor tissue and 
xenografts from an animal origin.  
Recently, a mixed synthetic 
and biological graft has been 
produced. The pelvic reconstructive 
surgeon needs a working 
understanding of these grafts. 
Important aspects that should be 
considered when selecting a graft 
include the inherent strength, 
surgical handling, its reaction 
within human tissues and potential 
morbidity. The properties of the 
ideal graft for pelvic reconstructive 
surgery are listed in table 3.
Table 3: Properties of the ideal 
graft
Biocompatible
Inert
Hypoallergenic
Hypoinflammatory
Resistant to mechanical stress
Sterile
Non-carcinogenic
Affordable
Accessible
Easy to handle
Flexible
Synthetic Grafts
Synthetic grafts are durable, easy 
to handle and readily available. 
They do not require harvesting as 
with the autografts and they do 
not carry the infection risks of the 
allografts. 
Over the past few years, there 
has been extensive research and 
development in an attempt to 
identify the properties of an 
ideal synthetic prosthesis. A 
number of different grafts have 
been manufactured, each with 
its own properties and in-vivo 
responses. Mesh prostheses have 
been used to reinforce abdominal 
hernia repair by general surgeons 
for a few decades now. When 
placing mesh through a vaginal 
incision, additional factors need 
to be considered in prosthesis 
selection.   The risk of infection 
is four times higher if placed 
vaginally rather than abdominally. 
The sexual function of the vagina 
also needs to be retained and 
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the mesh should therefore be 
soft with smooth edges. Erosion 
is the greatest risk of synthetic 
mesh and infection of the graft 
is the most common cause of this 
complication, however it may also 
result from inadequate vaginal 
closure, superficial placement 
of the graft or vaginal atrophy.  
Injection of local infiltration, 
which increases tissue volume, may 
also increase the risk of extrusion 
by placement of the graft at an 
insufficient tissue depth. The pelvic 
reconstructive surgeon therefore 
has an important responsibility - 
since the incorrect choice of mesh 
and inappropriate technique 
will doom a woman to possible 
dyspareunia, erosion, chronic pain 
or recurrence of the prolapse.
Classification of Synthetc Mesh 
(See table 4) 
Synthetic mesh prostheses were 
classified by Parvis Amid into 4 
Types, based on filament type 
and pore size.  Based on data 
drawn from a number of animal 
and clinically based studies, the 
following factors need to be 
considered when selecting a 
synthetic prosthesis.
Material Type
Absorbable and non-absorbable 
materials have been used 
with varying success rates. 
The absorbable mesh used is 
almost exclusively Polyglactin 
910 (Vicryl). Recently, concerns 
have been expressed regarding 
the longevity of the absorbable 
prostheses and the trend is now 
towards the use of non-absorbable 
products. The most common 
non-absorbable materials used 
include polypropylene, polyester, 
polytetrafluoroethylene, and 
polyamide.  (Table 5)  The in-vivo 
tissue response to polypropylene 
appears to be the most favourable. 
Comparative studies have shown 
the inflammatory response 
elicited by this product to be 
significantly lower than with 
the other materials and it also 
appears to have a higher resistance 
to infection. It is the general 
surgeon’s mesh of choice and 
it is now used in more than 1 
million hernia repairs annually. 
It therefore appears to be the 
ideal selection when choosing a 
synthetic material for pelvic floor 
repair.
Weave and Porosity
Synthetic mesh can be woven, 
knitted or non-woven and non-
knitted. Microscopically, a woven 
mesh would resemble a wicker 
basket whereas a knitted mesh 
would look like a fishing net. 
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Non-woven and non knitted 
mesh resembles a piece of plastic 
sheeting. The structure determines 
the pore size of the mesh. Pore size 
is an extremely important property 
of any prosthesis since it influences 
its susceptibility to infection, the 
flexibility of the graft and the 
ability of the graft to become 
incorporated into the surrounding 
tissue. 
The mean diameter of leukocytes 
and macrophages is 9–15 microns 
and 16–20 microns respectively 
while the average bacterium is 
<1um in size. Selection of a graft 
with a pore size that allows access 
to the leukocytes is therefore 
crucial in preventing sepsis and its 
sequelae. 
Table 4: Classification Synthetic Grafts  
Type Component Pore 
Size
Trade Name Fibre Type
Type I
Totally 
Macroporous
Pore size>75um
Polypropylene Macro Prolene
(Ethicon,Summerville.NJ)
Monofilament
Polypropylene Macro Marlex   (Bard,Cranston,RI) Monofilament
Polypropylene Macro Atrium 
(Atrium,Hudson,NH)
Monofilament
Polypropylene Macro Apogee, Perigree (AMS) Monofilament
Polypropylene Macro Prolift ( Gynecare) Monofilament
Polypropylene Macro Posterior IVS (Tyco) Monofilament
Type II
Totally 
Microporous
Pore size <10
Expanded 
PTFE
Micro Gore-Tex (Gore, Flagstaff, 
AZ)
Multifilament
Type III
Macroporous 
with 
multifilaments 
or microporous 
component
Polyethylene Micro/
macro
Mersilene (Ethicon, 
Summerville, NJ)
Multifilament
Polypropylene/ 
Polyglactin 
910
Macro Vypro 
(Ethicon,Summerville,NJ)
Mono/Multi
Polyglactin 
910
Macro Vicryl 
(Ethicon,Summerville,NJ)
Multifilament
Type IV
Submicronic 
pore size
Pore <1um
Polypropylene 
sheet
submicro Cellgard (not used in 
gynae surgery)
Monofilament
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Pore size also determines 
angiogenesis and in-growth of 
collagen, which allow adequate 
incorporation of the graft into 
the native tissue. When these 
processes are suboptimal, the 
mesh will become encapsulated 
rather than incorporated into the 
tissues.   A  pore size of more than 
75um is considered to be ideal 
for integration of the graft into 
the pelvic tissues. Therefore, a 
knitted mesh with pores measuring 
>75um, as in the Amid Type I, 
is considered to be the optimal 
configuration to prevent infection, 
promote integration and allow 
flexibility and softness. Table 
6 summarises the percentage 
relative porosity of a number of 
the commonly available mesh 
prostheses.
  
Filament type
Mesh materials are either 
mono- or multi- filamentous. 
Multifilament grafts are made of 
multiple braided strands whereas 
in monfilament prostheses the 
individual strands of the mesh 
are solid. As with pore size, the 
interstices between the strands 
play an important role in a graft’s 
predisposition to infection.  A 
distance of less than 10 microns 
between the strands will allow 
the passage of small bacteria (< 
1 micron) but not leukocytes and 
hence predispose to infection.  
[40] Monofilamentous grafts, 
e.g.  Amid Types I and III, are 
monofilamentous and therefore 
considered to be a better choice. 
Weight and flexibilty
The risk of erosion or vaginal 
Table 5
Material Type Example
Polyglactin 910 VICRYL
Polypropylene PROLENE
GYNECARE GYNEMESH* PS
GYNECARE TVT
MARLEX,
URETEX 
SURGIPRO, IVS
SPARC
Polyester MERSILENE
Polytetrafluoroethylene GORETEX
Polyamide NYLON
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irritation is also likely to be 
influenced by the stiffness or 
flexibility of the graft.   The latter 
is influenced by both the fibre and 
pore size. More recently, emphasis 
has been placed on the weight, 
expressed in milligrams per square 
centimeter, of synthetic mesh 
prosthesis. A graft with a lower 
weight will be softer and more 
flexible, both desirable qualities 
for a vaginal prosthesis.  Again 
Type I mesh appears to have the 
greatest flexilbity with the newer 
Type Ib lightweight mesh having 
the greatest softness and flexibility
Shrinkage
Another clinically relevant property 
of the synthetic grafts is shrinkage. 
Excessive contraction of a mesh 
leads to erosion and extrusion. 
Most grafts will shrink by about 
20% and enough excess should 
therefore be left when using these 
materials. 
Biological Grafts 
(see table 7)
Erosion rates of up to 25% have 
been reported for the synthetic 
grafts. Biological grafts have 
therefore been used and industry 
continues to develop newer grafts 
derived from biological tissues, to 
overcome this problem. 
Autologous grafts 
Autologous grafts may be 
harvested from the patient’s 
vagina, fascia lata or rectus fascia.  
The latter options, however, are 
associated with increased peri-
operative morbidity. Walter et 
al   reported an incidence of 
4% haematoma or seroma and 
5% cellulitis following fascia 
lata harvesting in 71 women. In 
addition, 13% of the patients 
reported dissatisfaction with the 
technique as a result of pain, 
cosmesis or both.In addition, 
in women with prolapse, these 
tissues may be inherently weaker 
than normal, predisposing to 
fragmentation and surgical failure. 
Allografts 
Allografts include cadaveric 
derived fascia lata, dura mater 
and acellular dermal matrix 
(AlloDerm®). These materials 
have the advantage of avoiding 
the morbidity of harvesting 
autologous tissue and a 
significantly reduced  risk of graft 
erosion.  Fascia lata and dura 
mater allografts are harvested 
using an aseptic technique and are 
then soaked in antibiotics.  The 
grafts are cultured and screened 
for HIV, Hepatitis B and C and 
T-Lymphocyte virus type 1.  The 
graft is then freeze-dried and 
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sterilized using gamma irradiation 
in keeping with FDA guidelines. 
The freeze-drying process leaves 
a significant amount of cellular 
material on the prostheses and 
there is still a small risk of prion 
or HIV transmission. A newer 
processing technique, the solvent-
drying Tutoplast process, involves 
soaking the graft in sodium 
hydroxide followed by peroxide. 
This reduces the risk of viral and 
prion transmission significantly 
and provides an acellular collagen 
matrix graft.  In the older –type 
allografts, where there is residual 
antigenic expression, a ‘host versus 
graft’ type immunological reaction 
may occur resulting in autolysis 
of the graft and surgical failure.  
Surgical failure may also arise 
due to intrinsic deficiencies in the 
strength of the graft. 
The newer acellular dermal matrix 
(AlloDerm®) is derived from 
human skin tissue.  In the USA, 
the tissue is supplied by tissue 
banks approved by the American 
Association of Tissue Banks (AATB) 
and FDA guidelines. The FDA has 
classified it as banked human 
tissue. The graft is prepared 
by a process that removes the 
epidermis and the cells that lead to 
tissue rejection and graft failure, 
without damaging the matrix. This 
matrix provides a template for 
revascularization, cell repopulation 
and normal tissue regeneration, a 
similar principle to the xenograft 
collagen matrices. 
Xenografts 
The most widely used xenografts 
are porcine and bovine in origin. 
They include porcine dermal 
grafts (Pelvicol), small intestinal 
submucosa (SIS) and bovine 
pericardium (Veritas). They lack 
the ethical implications associated 
with cadaveric grafts and are 
more readily available. The idea 
behind the use of these prostheses 
is to provide a stable three-
dimensional structure that ideally 
attracts host cells and acts as an 
interactive scaffold for host cell 
migration, neovascularization, and 
tissue remodelling. Various animal 
studies have however shown that 
this does not always occur and the 
implanted graft materials may also 
undergo either  encapsulation with 
graft fibrosis or breakdown with 
loss of support. The manufacturing 
processes of the graft prior 
to implantation may alter its 
structural integrity and the host 
cell may identify the implant as a 
foreign body rather than a matrix 
for remodelling. 
There are also the religious 
implications of using porcine and 
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bovine products. This is, however, 
open to individual interpretation 
and the women should obtain 
counsel from her local religious 
leader.   
The two most commonly employed 
xenografts include SIS® and 
Pelvicol®. Pelvicol® is a porcine 
dermal collagen. It comprises 
fibrous acellular collagen and 
its elastin fibers that are cross-
linked by hexamethylene – di-
isocyanate to resist degradation 
by the collagenases. It is durable 
and easy to work with and readily 
available. Recently the product 
has been modified (Pelvisoft) 
after a number of reports have 
suggested that this graft may 
predispose to encapsulation rather 
than integration. This has involved 
changing the structure to a netting 
–type configuration rather than 
a solid sheet. Another porcine 
dermal collagen product (InteXen) 
claims to have up to 25% more 
Table 6: Relative porosity of various synthetic meshes
GYNEMESH PS 65,6
MERSILENE 62,7
PROLENE 53,1
GYNECARE TVT 52,1
MARLEX 49,3
IVS 37,7
SURGIPRO 37,7
strength than pelvicol.
 
Bovine pericardium (Veritas) is 
another acellular product used in 
prolapse surgery. Recently fetal 
bovine pericardium (Cytrix) has 
been marketed and is reported 
to have no risk of transmission of 
prion disease. 
Table 9 and10 summarises some 
of the differences between the 
various grafts.
Evidence For The Use 
Of Graft Materials In 
Prolapse Surgery 
There is regrettably very little 
robust evidence to either support 
or refute the use of these grafts 
in vaginal prolapse surgery. It is 
principally based on observational 
case series and case-control 
studies with limited long-term 
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included women with both 
primary and recurrent prolapse 
in the same cohort. Some reports 
compare a mixture of women who 
had procedures in addition to graft 
insertion, e.g. vaginal hysterectomy 
and repair of prolapse in other 
compartments.  This would have 
impacted on outcomes including 
recurrence and erosion rates. For 
outcome data. Many of these are 
retrospective studies and report 
on relatively small numbers 
of patients.  Only a few small, 
randomized control trials have 
been performed.  In addition, in 
many of the studies the patient 
cohort was heterogenous with  
significant confounding variables. 
For example, many of the studies 
Table 7: Classification of Biological Mesh
Xenograft Porcine
Small Intestinal
Submucosa
SymphaSIS (8-ply)
SurgiSIS (4-ply)
StrataSIS
(Cook, Letchworth, UK)
Porcine dermal 
collagen
Pelvicol  
Pelvisoft
(Bard, Cranston, RI)
InteXen (AMS)
Bovine pericardium Veritas
Braille biomedical Industria
Commercio E representacoes S/A
Cytrix (TEI Biosciences)
Allograft Dura Mater
Fascia Lata Suspend (Tutoplast) Mentor Corp Santa 
Barbara California
Acellular Dermal 
Matrix 
AlloDerm
Lifecell, Branchberg , NJ
Axis
Mentor Corp Santa Barbara California
Duraderm (Boston Scientific)
Replform (Boston Scientific)
Autologous Rectus  Sheath
Fascia Lata
Vaginal Mucosa
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example, it has been shown that 
performing a vaginal hysterectomy 
at the same time as anterior 
insertion of a graft will increase 
the risk of erosion. 
Criteria used to define recurrence 
also vary greatly between 
studies, with some authors using 
validated objective data and 
others, unvalidated subjective 
observations.
There is therefore an urgent need 
for large, multicentre, randomised 
control trials with strict inclusion 
criteria and results based on 
objective observations and 
validated questionnaires. 
Anterior 
Compartment
Synthetic Materials
(See tables 11 to 13)
Prosthetic reinforcement has been 
employed in women undergoing 
anterior colporrhaphy for both 
primary and recurrent cystocoele. 
Most of the studies on grafts and 
cystocele repair have investigated 
the type 1 polypropylene mesh. 
Julian [45] was the first to 
publish a clinical study evaluating 
cystocele repair with prosthetic 
re-enforcement in 1996.  In this, 
the only randomised controlled 
trial on Type I monofilament 
polypropylene mesh (Marlex),  24 
women with recurrent cystocoeles 
(Grade 1) were allocated to 
anterior colporrhaphy alone or 
reinforcement with the graft.  
At 24 month follow-up, the 
success rate was 100% in those 
who underwent prosthetic 
reinforcement, compared 
to only 66% in those who 
underwent anterior colporrhaphy 
alone. Despite this significant 
improvement in outcomes in the 
group having the mesh it was 
coupled with a very high erosion 
rate of 25%. 
There have only been  an 
additional three randomised 
control trials looking at the use of 
synthetic mesh in anterior repair 
and these have all been done on 
absorbable mesh Polyglactin 910 
(Vicryl)  with conflicting results.  
Sand performed a study on 161 
women with cystocoeles more than 
grade 1. At 12 months of follow-
up, those undergoing fascial 
plication alone had a recurrence 
rate of 43%, compared to  (p = 
0.2) 25% in those women whose 
repairs were re-inforced with vicryl 
mesh. Koduri et al also found 
that the addition of a Polyglactin 
graft improved outcomes with a 
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recurrence rate of 1% in those 
with the prosthesis compared with 
13% in those without. However, 
in a prospective RCT by Weber 
[14], 140 women were assigned 
randomly to three different 
techniques of anterior repair: 
standard anterior repair, standard 
plus polyglactin and ultralateral 
anterior colporrhaphy.  After 
follow-up of 83 women (76%) 
at a median of 23.3 months, 
the author concluded that the 
three techniques for anterior 
colporrhaphy provide similar 
symptomatic and anatomic cure 
rates and that the addition of 
polyglactin 910 did not confer 
any advantage over standard 
anterior repair. It should also be 
mentioned that in the Weber and 
Sand studies, recurrence rates were 
particularly high in all the groups.
Table 8
MIXED 
BIOLOGICAL and 
SYNTHETIC
Monofilament 
polypropolene 
mesh coated 
with hydrophilic 
porcine collagen
Pelvitex (Bard) 
Avaulta Plus
Monofilament Macro
Monofilament 
polypropolene 
coated with 
atelocollagen, 
polyethelene 
glycol and 
glycerol 
Ugytex 
(Sofradim 
France)
Monofilament Macro
There have been a large number 
of non-randomised studies of 
polypropylene mesh in anterior 
compartment prolapse reporting 
recurrence rates ranging from 
0-8.4% and erosion rates up to 9%. 
There are, however difficulties in 
interpreting and comparing these 
data. The techniques differed 
significantly between the studies, 
ranging from surgeons who 
sutured the graft firmly in placed 
to a tension –free approach. In 
addition, different criteria were 
used to define recurrence and 
duration of follow-up also varied 
significantly.
 
Combined absorbable and non-
absorbable prostheses (eg Vypro: 
Polyglactin 910 / Polypropylene) 
were introduced in an attempt to 
further reduce mesh complications. 
The results using this graft have 
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however been disappointing. 
It is hypothesized that the 
polyglactin component provokes 
an inflammatory reaction leading 
to erosion and poor healing 
with resultant recurrence of the 
prolapse. Denis et al used Vypro 
to treat prolapse in 106 women. 
50 % of the women  experienced 
a recurrence after a mean follow-
up of only 7.9 months. Moreover, 
there was a very high erosion rate 
of 40%. 
Biological materials 
(Tables 14 and 15)
Again there is very little robust 
evidence for the use of biological 
grafts in anterior compartment 
prolapse. 
Gandhi et al have recently 
completed a randomised control 
trial investigating the use of 
solvent dehydrated fascia lata 
(Tutoplast) in recurrent cystocele in 
153 women.  Failure was defined 
as prolapse of Stage 2 or more 
(Aa or Ba more than or equal to 
-1).  At 12 month follow-up there 
was no difference in recurrence 
between the women who had the 
patch (21%) compared with those 
that did not have a patch (29%). 
As with many of these studies, 
most of women had concomitant 
prolapse procedures and this may 
have confounded the results. 
Other observational studies 
looking at fascia lata have 
reported good outcomes but this 
was dependant on the criteria used 
to define recurrence.  Kobashi used 
the outcome measure of prolapse 
more than Grade 1 and reports 
a failure rate of 1.5% after 12 
months.  Powell however found 
objective recurrence (>Grade 1) 
of 19% versus only 2% subjective 
Table 9: Biological responses to the different graft materials
Prolene SIS (4 ply) Pelvicol
Structural integrity Fully intact at 1 year Not recognisable at 
60 days
Partially recognisable 
at 1 year
Collagen Deposition
At one year
Dense, fibrous  
organised
Thin layer fibrous 
collagen
Thin layer fibrous 
collagen
Neovascularisation Numerous and wide 
calibre
Smaller and fewer Smaller and fewer
Inflammatory resonse Mononuclear 
High level response to 
1 year
Mononuclear and 
polymorponuclear 
with low level 
response at 1 year
Mononuclear and 
polymorponuclear 
with low level 
response at 1 year
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recurrence (ie no symptoms of 
bulge).  There was no reported 
erosion with these grafts which 
was very encouraging. 
More recently, attention has 
turned to the use of xenograft 
materials in the anterior 
compartment. From the 
observational studies, they appear 
to have low reported erosion 
rates but variable recurrence 
rates. Recurrence rates for porcine 
dermis grafts (Pelvicol ®, Bard ) are 
between 4 and 19%. The human 
dermal collagen grafts appear 
to have poorer outcomes than 
their porcine counterparts. It is 
also noteworthy that of none of 
the 21 women that were sexually 
active in Clemons’ study reported 
any adverse outcomes. There is 
Table 10: Properties of Biological vs Synthetic Graft Materials
Biological Synthetic
Tensile strength + +++
Antigenicity +++ +
Tissue remodelling +++ +
Erosion + +++
Cost ++++ ++
Consistency of graft strength + +++
Availability - +++
Infection + +++
Stretch + +++
one preliminary report of a RCT 
evaluating the efficacy of Pelvicol® 
in primary cystocele repair. No 
significant difference has been 
detected but follow- up is still only 
6 months. The long term results 
of this and other current studies 
on the xenografts in the anterior 
compartment are eagerly awaited. 
Mixed evidence to support the use 
of grafts in women with primary 
cystocele.
Grafts should not be used to 
compensate for poor surgical 
technique.
Prosthetic reinforcement appears 
to improve  short term outcomes in 
recurrent cystocele.
Expert opinion would support the 
use of grafts in recurrent cystocele 
and in primary cystocele  at high 
risk for recurrence.
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Summary
Posterior Compartment
Synthetic materials (Table 17)
There has been a justified 
reluctance to employ prosthetic 
material in the posterior 
compartment because of the risk 
of erosion and concerns regarding 
dyspareunia. A disturbing increase 
in dyspareunia in 64% of women 
after posterior repair using prolene 
mesh was recently reported by 
Milani et al. Despite very good 
anatomical outcomes, the authors 
feel that the prolene prosthesis 
should be abandoned. 
In another study, de Tayrac et 
al performed a sacrospinous 
suspension with insertion of 
polypropylene mesh in 26 women 
with rectoceles. Cure was 92% 
after 22 months of follow up but 
again this was coupled with a high 
erosion rate of 12%. One of the 
13 sexually active women reported 
increased dysparunia.  
Adhoute et al [52] reported on the 
outcome of 52 non-consecutive 
women undergoing trans-vaginal 
rectocele and or cystocele repair 
using polypropylene mesh 
(Gynemesh®).  Depending on 
the circumstances, the operation 
comprised anterior or posterior 
mesh implantation, hysterectomy 
and TVT insertion.   After a mean 
Table 11:
Anterior compartment grafts
Synthetic materials
Randomised control Trials Polyglactin 910
Study Prosthesis 
Type
N Study Type Follow-
Up
Recurrence Erosion
Koduri
2000 
Polyglactin 
910
125 Prospective 
randomised
12 months 13% no mesh
1% mesh
Weber [
(2001)
Polyglactin 
910 
(Vicryl)
140 RCT Mean 23.3 
months
70% (no mesh)
58% 
ultralateral
54% mesh 
(non significant)
0%
Sand 
(2001)
Polyglactin 
910
(Vicryl)
161 RCT
Recurrent 
21
Primary 140
12 months 25% (with 
mesh)
43%
(no mesh)
p=0.02
0%
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follow-up of 27 months, the 
anatomical success was 100% in 
those who had rectocele repair 
and there was no reported erosion.
Other studies of synthetic mesh 
in the posterior compartment are 
small [69,70] and one revealed a 
very high erosion rate.  
Recurrence rates following 
posterior repair using synthetic 
mesh do appear to be low, 
however erosion and dysparunia 
are common and the pelvic 
surgeon should take this into 
consideration when choosing 
to insert a graft in the posterior 
vaginal compartment.
Biological Materials 
(See table 18)
The newer xenografts have a 
much lower tendency to erode and 
fibrose. There have been a number 
of recent promising reports on 
their use in rectocele repair. 
Kohli and Miklos in 2003, described 
rectocele repair in 43 women using 
a dermal allograft to augment site-
specific fascial repair. [72] No major 
complications were reported.  
Thirty-three women were available 
for follow-up (mean 12.9 months) 
with a 93% surgical cure rate 
defined by POP-Q evaluation.  
Moore also reports favorable 
cure and low erosion rates in a 
study looking at 195 women who 
received either a porcine or human 
dermis graft during a posterior 
repair. [73] A further case series 
of 188 women, by Chaudhry et al 
[74], employed a human dermal 
allograft (AlloDerm®) for posterior 
repair. They showed some very 
promising results after 18 months 
of follow up. There was a 5% 
recurrence and a 0.5% erosion 
rate.
Most recently Altman et al 
assessed quality of life and 
anatomical outcomes following 
posterior repair using a collagen 
allograft. There were significant 
Table 12:
Anterior compartment grafts
Synthetic materials
Randomised control Trial Polypropylene
Study Prosthesis Type N Study Type Follow-Up Recurrence Erosion
Julian 
(1996)
Marlex 
(Type1 Monofiliament 
polypropolene)
24 Prospective 
(recurrent)
24 months 0% (mesh)
34%
(no mesh)
25%
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improvements in several variables 
associated with quality of life and 
no change in sexual function or 
dypareunia rates. The anatomical 
outcomes were however 
unsatisfactory.
The biological grafts appear to 
have significantly lower rates 
of erosion and dysparunia than 
polypropylene mesh when used 
in the posterior compartment. 
However anatomical efficacy 
remains to be validated.
Apical Prolapse
Abdominal or laparoscopic 
sacrocolpopexy appears to be 
the procedure of choice for vault 
prolapse. It restores the normal 
vaginal axis whilst maintaining 
vaginal capacity and coital 
function. It  has the lowest 
recurrence rate. A number of 
prosthetic materials have been 
used for this technique.  Success 
rates range from 73-100% at a 
follow-up interval of 1-136 months 
(Table5) [31-33]. Because the mesh 
is being inserted abdominally, the 
risk of infection is significantly 
lower compared to the vaginal 
route. The majority of the studies 
reported in the literature involve 
the use of synthetic prostheses, 
with mesh or suture complications 
occurring in 0-12%. Erosion rates 
vary depending on the type of 
synthetic material used with the 
lowest seen with Polypropylenes 
and the highest with Goretex.  
In a review of 592 operations, 
Iglesia reports an overall revision 
and removal rate of 2.7%.  Sacral 
osteomyelitis and bladder erosion 
were rare complications. The 
procedure involves the placement 
of numerous sutures around 
the vaginal vault and this may 
predispose to tissue ischemia and 
resultant prosthetic erosion. 
There have been several small 
observational studies on 
laparoscopic sacrocolpopexy 
showing short-term outcomes 
and mesh complication rates  
comparable to the abdominal 
approach.    
Due to the low erosion rates 
and extensive experience with 
the synthetic materials, the 
biological grafts have not been 
widely employed in abdominal 
sacrocolpopexy. In addition 
there are concerns regarding 
the longevity of the biological 
grafts.   Fitzgerald in 1999 
reported on a series of 67 women 
who underwent sacrocolpopexy 
using donor cadaveric fascia 
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Table13:
Anterior compartment grafts
Synthetic materials
Non Randomised Trials Polypropylene
Study Prosthesis 
Type
N Study Type Follow-
Up
Recurrence Erosion
Adhoute 
2004
Gynemesh 52
+ hyste 
(28%)
entero 
(9.5%)
recto 
(28%)
Case series 27 5% cysto
0% recto
3.8% 
cysto
Flood 
(1998)
Marlex 
(Type1 
Monofiliament 
polypropylene)
Tension free
142 Retrospective
(primary)
36 
months
0% 2.1%
Natale 
(2000)
Polypropylene
(Tension free)
138 recurrent 18 
months
2.2% -
Bader
(2004)
Tension-free 
monofilament 
polypropylene 
mesh
40 Observational 16.4 - 7.5%
Yan 
(2004)
Synthetic 
mesh secured 
through 
obturator 
foramina
30 Observational 6.7
(2-12)
3% 7%
Korushnov  
(2004)
Polypropylene 45 RCT <12 
months
Not 
significant 
(trend 
towards 
better cure 
with mesh
14%
Dwyer 
2004
Polypropylene
(Atrium)
64 Retrospective 
review
6-52
mean 29
6% Not 
stated 
but 9% 
for total 
cohort
de Tayrac 
2005
Polypropylene 87
84 
follow-up
Case Series 9-43
mean 24
8.4% 8.3%
Eglin 
2003
Polypropylene 
Transobturator 
subvesical mesh
103 Case series 18 3% 5%
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lata. Recurrent vault prolapse 
was recognised in 8% of women 
at a follow-up interval of 6-11 
months. Absence or attenuation 
of the prosthesis was observed 
in the 7 patients requiring re-
operation. This clearly questions 
the use of this allograft for use 
in sacrocolpopexy.  Culligan et al,  
used an acellular human dermal 
graft for ASC in 32 patients with 
follow-up of 1 year.  In contrast 
they report no post-operative 
complications and acceptable 
outcomes with this newer 
generation allograft.
Overview on complications 
when using mesh in POP 
surgery
There remains very little Grade 1 
evidence for the use of mesh and 
grafts in POP surgery and more 
data is emerging regarding the 
complications. Sexual function is 
often not reported in the literature 
and those studies that do look at 
this aspect of vaginal function, 
usually confine it to a number 
of short sentences with very 
little questionnaire-based data.  
There are, however, concerning 
reports on a rise in dyspareunia 
following repair with synthetic 
mesh.  Milani et al report a 63% 
increase in the number of women 
reporting dyspareunia following 
posterior repair and 20% increase 
following anterior repair. In a 
further study reporting on the 
use of polypropylene, Salvatore 
et al describe an increase in 
dyspareunia from 18 to 78%.  
Zhongguo et al also report a 64% 
incidence of dyspareunia following 
transobturator polypropyle mesh 
insertion.  
Role of the Mesh Kits
Pelvic organ prolapse is often 
associated with a global weakness 
of support structures and in 
order to replace this tissue, 
the new mesh kits have been 
developed. Three companies have 
launched these devices and they 
are all available in South Africa. 
They consist of an anterior and 
posterior system. The anterior 
system consists of a central mesh 
portion and two lateral arms on 
each side that are placed through 
the obturator foramina. The 
posterior kit has a central mesh 
portion with bilateral arms that 
go through the buttock, traverse 
the ischiorectal fossa and enter the 
pelvis via the illiococcygeus muscle 
or sacrospinous ligament.  The first 
of these devices to be launched 
was the Prolift System, marketed 
by Johnson and Johnson. American 
Medical Systems, AMS, have 
developed an anterior mesh system 
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called Perigee and a Posterior 
Apogee system. Bard have also 
developed a system called the 
Avaulta. The Posterior Avaulta 
has two arms on either side. The 
superior arm is inserted in a similar 
fashion to the Posterior prolift and 
Apogee but in addition, it also 
has two inferior perineal arms. 
The Avaulta Solo is polypropylene, 
similar to the J&J and AMS 
product but the Avaulta Plus is a 
polypropylene coated with porcine 
Table 14:
Anterior compartment grafts
Biological grafts
Fascia lata grafts
Study Prosthesis 
Type
N Study Type Follow-
Up
Recurrence Erosion
Kobashi 
(2000)
Cadavaric 
Fascia lata
132 Observational 
study
12.4
(6-28)
1.5% 
(cystocelee)
9.8% (apical)
0%
Groutz Solvent- 
dehydrated 
cadaveric 
fascia  
21 Observational 20.1 0% 0%
Powell
2004 
Fascia lata 58 Case Series 24.7
12-57
Objective 
19% 
subjective 
2% 
Cystocele
4% 
enteroceles
12% 
symptomatic 
rectoceles
Not 
mentioned
Gandhi
2005
Solvent 
dehydrated 
fascia lata
162
76 
patch
78 no 
patch
RCT 12 21% patch
29% no 
patch
NS
0%
collagen.   
These products would appear to be 
a revolutionary step to improving 
outcomes in POP surgery. They 
have, however, been implemented 
with very little data to support 
their use.  At the time of writing, 
there were six studies on the 
Gynecare Prolift system. (See table) 
The maximum follow up time in 
these studies was seven months. 
Failure rates ranged from 4-12%. 
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The AMS product features in two 
publications with varying failure 
rates from 7-13%. 
These devices are associated with 
major complications including 
bladder and bowel injury. There 
is no data on sexual function 
pre or post surgery and this fact 
should deter any wise and prudent 
surgeon from using these products 
Table 15:
Anterior compartment grafts
Biological grafts
Human and porcine dermal grafts
Study Erosion N Study Type Follow-
Up
Recurrence Erosion
Salomon Porcine 
skin 
collagen 
implant
27 Observational 14
(8-24)
19%
Gomelsky
2004 
Porcine 
dermis 
grafts
70
65 sling
50 BIF
Retrospective 
chart review
24 Grade 2 – 
8.6%
Grade 3 
–4.3%
1 Superficial 
vaginal 
wound 
separation 
conservative 
Mx 
Clemons Acellular 
dermal 
matrix
(Alloderm)
33 Observational 
study
6 recurrent II
24 prim + 
Recur III
3 Grade IV
18 41 % 
objective
3% 
subjective
64% 
sexually 
active  - 
no problems 
no erosion
Oestergard 
2004 
Pelvicol 
(Porcine 
Dermis)
31 Observational
Cystocele 
>Gr 2 
6 13% 
(Grade 2)
Not 
mentioned
Arya 
2004
Porcine 
dermal vs 
cadaveric 
dermal 
graft
Porcine 72
Cadaveric 
45
Retrospective 
repeated 
measures 
study
Cadaveric  
22
(19-28)
porcine
18 (7-22)
Cadaveric 
69%
Porcine
4%
None
Meschia
 2004
Pelvicol RCT primary 
cystocele 
6.5 
months
Optimal Ba 
73% vs 65% 
P0.86
5 % 
defective 
healing
in a sexually active patient. These 
devices should only be inserted by 
a skilled pelvic floor surgeon who 
has selected the case appropriately.
177
Table 16:
Anterior compartment grafts
Synthetic materials
Randomised control Trial Polypropylene vs Acellular dermal collagen
Study Prosthe-
sis Type
N Study 
Type
Follow-
Up
Ana-
tomical 
Failure
Sym-
tomatic 
Failure
Erosion
Cervigni Pelvicol® 
vs
Prolene 
soft®
72 RCT 8.8 (Pel-
vicol)
8.1 
(Prolene 
soft)
68% 
Pelvicol
58% 
Prolene 
soft
2.8% 
Pelvicol 
8% 
Prolene 
soft
2.7% 
Pelvicol 
8.3% 
Prolene 
soft
Table 17:
Posterior Prolapse 
Synthetics
Study Prosthesis 
Type
N Study 
Type
Follow-
Up
Recur-
rence
Erosion
Adhoute Gynemesh 52 Observa-
tional
Mean 27 
months
Cystocele  
5%
Rectocele 
0%
3.8% (cys-
tocele)
Stanton Mersilene 29 Observa-
tional
14 0% of 
stage II 
and III
3%
De Tay-
rac**
Gynemesh 26 Observa-
tioinal
22.7 8% 12%
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Table 18:
Posterior prolapse 
Biological Materials
Study Prosthesis 
Type
N Study 
Type
Follow-
Up
Recur-
rence
Erosion
Kohli and 
Miklos  
(2003)
Dermal 
allograft
43 Prospective 
descriptive
12.9 
months
7% 
follow-up 
in 33
(on POP-Q)
Moore 
2004
Porcine 
dermal 
graft vs
Human 
dermal 
graft
195
porcine 
100
human
95
Retrospec-
tive chart 
review
Porcine 
14.2
Human
20.9
Porcine 
1%
Human 
9.6%
no
Chaudhry
2004
Alloderm 188 Case series 18
3-32
5% 0.5% 
erosion
0.5 % 
abcess
Altman
2005
Collagen 
allograft
33 Prospective 
case series
12 39% 
objective
Significant 
improve-
ment in 
QOL scores
none
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Table 19: Abdominal sacrocolpopexy – operative outcome and peri-
operative morbidity. 
Author N Prosthesis Follow up
(months)
Success Complications
Rust [1975]   12 Mersilene 9-42 100% Nil
Symonds[1981]   17 Teflon 60-360 88% Nil
Addison[1985]   56 Mersilene 6-126 89% Nil
Timmons 163 Mersilene 9m – 18 
years
99% Nil
Drutz[1987]   15 Marlex 3-93 93% 1 sepsis mesh 
removal
Baker[1990]   59 Prolene 1-45 86% Nil
Snyder[1991] 147 78 Gore -Tex
65 Dacron
60 73% 4 mesh erosions
Creighton[1991]   23 Mersilene 3-91 91% 2  sinuses removal 
mesh
Van Lindert[1993]   61 Gore-Tex 15-48 ? 1 erosion and 
fistula
Valaitis[1994]   43 Teflon 3-91 91% 1 sepsis removal  
mesh 
Khohli[1998]   57 47 Marlex
10 Mersilene
2-50 100% 5 mesh erosions
2 suture erosions
Fitzgerald[1999]   67 Fascia lata 12 91% 6 fascial breakdown
Fox[2000]   29 Teflon 6-32 100% 1 sepsis removal  
mesh 
Winters[2000]   20 Marlex 6-27 100% Nil
Visco[2001] 273 269 Mersilene
4 Gore-Tex
1-87 ? 15 erosions
Culligan 2001 32 Acellular hu-
man dermal 
graft 
12 satisfac-
tory
nil
Rocha 
2003
32 Abdominal 
Fascia
12 97% 3 % Dysparunia
Lindeque
2002
262 Dura mater 
(18)
Goretex (244)
16 98.9% 3.8%
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Table 20: Results of Prolift
Study N Follow-Up Recurrence Ero-
sion
Other Complications
Fatton 110 3 months 4.7% 4.7% Bladder injury  1
Haematomas 2
Dalenz 41 7 months Vault 5%
Cystocele 2%
2% Perirectal haematoma  1
Erosion 1
Altman 123 2 months Anterior 13%
Posterior 9%
Total 12%
 Pelvic organ perforation    
3.2%
Bladder injury 1
Rectal injury 1
Neumann 100 Not stated 1% 3% Bladder injury 1
Lucioni 12 7 months 8% Enterocele  0
Abdel-fatteh 289 Not Stated 5%   
Table 21: Results of Apogee/perigee
Study N Follow-
Up
Recurrence Erosion Other 
Complications
Garuder-Burmester 110
I6 vault
I3 m 7% of anterior 
No vault
3% None
Shek 46 13%
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or at follow up. These so-called 
occult sphincter injuries have been 
shown to occur in up to 35% of 
primiparous women. 
Importance
Anal spincter tears are associated 
with significant morbidity. Failure 
to recognise and repair an anal 
sphincter injury is one of the top 
four reasons for complaint and 
litigation arising in labour ward 
practice in the UK.  The sequelae 
of OASI affect women not only 
physically but psychologically as 
well. Johanson et al report that 
only one third of women suffering 
with faecal incontinence sought 
help. 
Risk factors
A large amount of work has been 
done in an attempt to more clearly 
define risk factors for developing 
an OASI. Hudelist et al looked at 
5044 women delivering vaginally. 
They report that 4.2% of these 
Obstetric anal sphincter injuries 
(OASI) are unfortunately a 
common event associated with 
vaginal delivery. If these third 
and fourth degree tears are 
not recognised and managed 
appropriately, these women are 
at high risk for developing a 
number of significant long-term 
complications including faecal 
incontinence, perineal pain and 
dyspareunia. 
Incidence
The incidence of OASI varies. 40 
000 women in the UK develop 
faecal incontinence related to 
sphincter injuries in the first year 
after birth. The RCOG guideline 
reports an incidence ranging 
from 0.6-9%, depending not only 
on obstetric practice but also on 
the vigilance exercised in their 
detection. A large number of OASI 
are not clinically apparent  but 
are demonstrated at ultrasound 
either immediately post-partum 
Chapter 21
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patients developed a sphincter 
defect. Risk factors emerging 
included low parity, prolonged 
first and second stage, high birth 
weight, episiotomy and  forceps 
delivery. They analysed the same 
data, applying multivariate logistic 
progression analysis and only high 
birth weight and forceps delivery 
emerged as risk factors. Dandolu 
et al later defined this risk using 
odds ratios, reporting the risk 
associated with forceps to be 
OR 3.84 and for vacuum delivery 
2.58. Occiptoposterior postion 
also appears to be associated 
with sphincter injury, with Wu et 
al reporting a fourfold increase 
compared to occipitoanterior 
positions. The relationship 
between episiotomy and sphincter 
injury remains unclear. Overall, 
50% of third degree tears are 
associated with episiotomy and 
midline episiotomy is 50 times 
more likely to result in third 
degree tear. The greater the angle 
the episiotomy makes with the 
vertical, the smaller the risk of 
sphincter injury.  
Recognition and diagnosis 
All women following vaginal 
delivery must be thoroughly 
examined with a systematic 
inspection of the vulva, vagina 
and perineum. If any injuries are 
detected a rectal examination 
must always be performed. If the 
patient has had a instrumental 
delivery or  if a large episiotomy 
was performed, she should be 
examined by an someone who 
is experienced  in the diagnosis 
of sphincter injury. If in doubt, 
it is useful to ask the women to 
contract her anal sphincter while 
performing gentle PR examination 
and any loss of tone will suggest 
and underlying sphincter defect. 
Another useful manoeuvre is to 
“pill-roll” the sphincter with the 
forefinger in the rectum and the 
thumb in the vagina. This will 
enable the clinician to detect 
any loss of sphincter bulk – again 
suggesting an underlying third or 
fourth degree tear. If there is still a 
significant amount of uncertainty, 
it would be prudent to perform 
the repair under anaesthesia.
Classification of injuries 
The nomenclature of OASI has 
been dogged with inconsistency 
for many years. Sultan and Thakar 
looked at every Obstetric Text 
in the RCOG library and17%  of 
the books made no mention of 
a classification for OASI and of 
those that did, 22% classified a 
sphincter injury as a second degree 
tear. Recently consensus has been 
achieved and internationally OASI 
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are now classified into four grades. 
The standardization of sphincteric 
injury has made it easier to 
compare data on outcomes and 
repair techniques. 
The anal sphincter comprises:
External Anal Sphincter Sphincter 
(EAS)
•	 Subcutaneous 
•	 Superficial 
•	 Deep
Internal Anal Sphincter  (IAS)
•	 Thickened continuation of 
circular smooth muscle of bowel
The classification of tears is as 
follows:
First degree: laceration of the 
vaginal epithelium or perineal skin 
only.
Second degree: involvement of 
the vaginal epithelium, perineal 
skin, perineal muscles and fascia 
but not the anal sphincter.
Third degree: disruption of the 
vaginal epithelium, perineal skin, 
perineal body and anal sphincter 
muscles. This should be further 
subdivided into:
3a: partial tear of the external 
sphincter involving less than 50% 
thickness.
3b: complete tear of the external 
sphincter.
3c: internal sphincter torn as well.
Fourth degree: a third degree 
tear with disruption of the anal 
epithelium.
Rectal mucosal tear (buttonhole) 
without involvement of the anal 
sphincter is rare and not included 
in the above classification.
Repair of Third and 
Fourth degree tears
General Principles
All third and fourth degree 
tear repairs should be done 
in an operating theatre. This 
recommendation is made for 
a number of reasons. Firstly, in 
theatre one has access to proper 
anaesthesia. A general or spinal 
anaesthetic makes it much easier 
to inspect the tissues and to 
adequately visualise the tear. The 
sphincter is usually more relaxed 
which makes it easier to retrieve 
if the ends are retracted.  In 
theatre it is possible to position 
the patient in a more appropriate 
way. The surgeon also has access 
to better lighting and proper 
instrumentation and often it is 
easier to get an assistant if the 
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procedure is being performed in 
theatre.  
Inexperience of the operator 
significantly increases morbidity 
and may also predispose to 
litigation. 
Overlap or end to – end repair 
of the Sphincter.
Repair of the sphincter following 
an acute obstetric injury has 
undergone a significant change 
over the past decade. Traditionally, 
the repair was done by an end-
to-end approximation of the torn 
sphincter. The outcomes following 
acute repair of sphincter injuries 
are poor with some studies 
reporting faecal incontinence 
rates of up to 37%. (range 15-
59%). Many women later require 
secondary repair of the sphincter. 
This is usually done by a colo-
rectal surgeon and an overlapping 
technique is employed in the 
majority of cases. The reported 
success rates with an overlapping 
technique are better, with 
continence outcomes between 
74 and 100%. For this reason, 
Monga and Sultan performed the 
first pilot study on an overlapping 
technique for acute OASI. In this 
trial, using matched controls, they 
report significantly improved 
outcomes with incontinence rates 
being reduced from 41% to 8%. 
In addition to recommending 
an overlap technique, Monga 
and Sultan also performed a 
separate repair of the internal 
anal sphincter and this may also 
profoundly impact on outcomes. 
A number of RCT’s comparing 
end-to-end and overlap repair 
have been performed.  In a trial by 
Fernando et al 24% of women who 
had an end-to-end repair reported 
faecal incontinence compared 
to no cases of incontinence 
in the overlap group. A vastly 
underreported complication of 
OASI is long term perineal pain. 
In the Fernando trial, 20% of the 
women who had an end-to-end 
repair reported this troublesome 
symptom compared to none in the 
overlap group. A recent cochrane 
systematic review addressed the 
issue of overlap versus end-to-end 
repair of OASI in 279 women. They 
report a statistically significant 
lower incidence in faecal urgency 
and lower anal incontinence score  
in the overlap group. The overlap 
technique was also associated 
with a statistically significant 
lower risk of deterioration of anal 
incontinence symptoms over one 
year. 
      
Specifics of repair
The anal mucosa is repaired with 
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interrupted vicryl 3-0 sutures 
with the knots tied in the lumen. 
The torn muscle, including  the 
internal and external sphincter, 
should always be repaired with 
a monofilamentous delayed 
absorbable suture such as PDS 
or Maxon 3/0. The internal 
anal sphincter should first be 
identified and then repaired using 
an interrupted suture. It is not 
possible or necessary to overlap 
the IAS and it is adequate to suture 
this muscle using an end-to-end 
technique. It is often difficult to 
identify the IAS, but usually it is 
paler in colour than the external 
sphincter.
If it is a Grade 3A tear, ie less than 
50% of the EAS is torn, the muscle 
is repaired using and end-to end 
technique. If it is a 3B, an overlap 
technique is probably better and 
this is done as follows: The ends 
of the torn muscle are identified 
and clamped using Allis forceps. 
A double breasted technique is 
used to approximate these ends. 
It is important to identify the 
full length of the sphincter and 
this can stretch for up to 4-5cm. 
Whether an end-to-end or overlap 
technique is used, between three 
and four sutures are inserted and 
these are tied following insertion 
of all the sutures.  
After the sphincter has been 
repaired, the vaginal skin is closed 
much like one would close an 
episiotomy, making every effort to 
reconstruct the perineal body. 
Every woman should be given 
antibiotics and stool softeners 
following the repair. 
Women sustaining third and fourth 
degree tears should always be 
offered a follow up appointment 
to assess them for faecal 
incontinence, perineal pain and 
dyspareunia. 
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Urogenital fistulae typically 
involve a communication between 
the genital tract (vagina, cervix, 
uterus) and the urinary tract 
(ureter, bladder, urethra).  They 
are described by their anatomical 
location (Table: I) and can be 
classified according to organ 
involvement, i.e simple fistulae 
(which involves 2 organs) or 
complex fistulae (involving 3 
or more organs) (Table: II).  The 
majority of urogenital fistulae 
occur between the vagina and 
the bladder (vesicovaginal) with 
urethrovaginal and ureterovaginal 
occurring less frequently. 
Communication between the 
lower urinary tract and the uterus 
or cervix are rare (Figure: 1)
The aetiologies of urogenital 
fistulae are shown in Table III.
Aetiology And 
Pathophysiology
In well resourced settings, 
urogenital fistulae occur as a 
consequence of surgery, most 
commonly following abdominal 
hysterectomy and more recently 
after laparoscopic hysterectomy.  
In most series, gynaecological 
surgery is responsible for 70-80% 
of urogenital fistulae with the 
remainder following urological, 
vascular and colorectal procedures.  
In a study of 303 women with 
urogenital fistulae from the Mayo 
Clinic, 82% of cases were caused by 
gynaecological surgery, followed 
by obstetric related fistulae in 8%,  
6% related to pelvic radiation and 
4% following trauma.
Most vesicovaginal fistulae (VVF) 
follow abdominal hysterectomy 
for benign conditions such as 
uterine fibroids, endometriosis 
Chapter 22 
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or pelvic adhesions, with only 
a few occurring after vaginal 
hysterectomy.  High risk intra-
operative scenarios for fistula 
formation include excessive 
bleeding at the angles of the 
vault, pelvic adhesions, a previous 
caesarean section leading to 
difficulty in separating the bladder 
peritoneum from the uterus, and 
surgery for pelvic malignancies. 
Fistula formation is postulated 
to result from unrecognized 
direct injury to the bladder or 
ureter, devascularization of 
tissue leading to ischaemia and 
avascular necrosis, and inadvertent 
suture placement between the 
bladder and vaginal cuff leading 
to erosions. Uncommon causes 
for urogenital fistulae include 
vaginal foreign bodies,  trauma 
or a bladder calculus.   Radiation 
induced fistulae , especially 
radiotherapy for cancer of the 
cervix, may develop as a result of 
progressive endarteritis obliterans 
leading to tissue fibrosis and 
necrosis.  Most radiation associated 
VVF develop 6 months after 
completion of therapy. There are 
reports of cases presenting many 
as five years after therapy.   It is 
imperative to investigate these 
women for a possible recurrence 
of the malignancy.  Closure of 
the fistulae in these cases is 
particularly technically difficult and 
urinary diversion is the procedure 
for these patients, despite the 
guarded results of this operation.  
Fortunately, recent advances in 
radiation therapy have significantly 
decreased the occurrence of  
fistulae. 
Ureterovaginal fistulae occur most 
commonly with laparoscopic or 
abdominal hysterectomy, usually 
when removing the adnexae.  
The pelvic portion of the ureter 
is most susceptible to injury at 
a number of places including 
the infundibulo-pelvic ligament 
when the ovarian blood supply is 
ligated, at the cardinal ligament, 
as the ureter passes beneath 
the uterine vessels and at upper 
vagina as the ureter crosses to 
enter the bladder base.  The 
mechanism for ureterovaginal 
fistula formation is similar to that 
of VVF - unrecognized surgical 
TABLE I: Urogenital Genital 
fistulae classified by anatomical 
location
Vesicovaginal
Vesicouterine
Ureterovaginal
Ureterourerine
Urethrovaginal
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injury or ligation and tissue 
necrosis following ischaemia or 
inflammation.
Urethrovaginal fistulae may 
occur following surgery for 
urethral diverticulae, anterior 
vaginal prolapse, stress urinary 
incontinence and more rarely, 
radiation therapy.
In under-resourced countries, 
obstetrics is the leading cause of 
genitourinary fistulae usually as 
a result of prolonged obstructed 
labour causing ischaemic necrosis.  
The exact prevalence is unknown 
but they are particularly common 
in Africa and South Asia. The 
level at which the fetal head 
becomes impacted during labour 
determines the site of injury and 
type of fistula.  For example, if 
the impaction occurs at the level 
of the pelvic inlet, the VVF may 
be intracervical, if the impaction 
occurs at a lower level, the urethra 
will most likely be involved.  The 
urethra is involved in 28% of cases 
of obstetric related fistula with 
total urethral destruction in 5% 
of patients. Vesico-uterine fistulae 
contributed to 10.5% (4/42) of 
cases in a review of 42 patients 
with obstetric fistulae in Durban.
Symptoms 
Symptoms of fistulae vary 
depending on the aetiology.  A 
women who presents with fluid 
leaking from her vagina following 
pelvic surgery, should be suspected 
to have a fistula unless proven 
otherwise. Classically, patients 
complain of a continuous or 
intermittent watery vaginal 
TABLE II: Classification 
according to organ involvement
Simple Fistulae
Vesicovaginal
Vesicouterine
Ureterovaginal
Ureterourerine
Urethrovaginal
Complex Fistulae
Uretero-vesico-vaginal
Uretero-vesico-uterine
Vesico-vagino-rectal
TABLE III: The Aetiology of 
Urogenital Fistulae
Surgery
Obstetrical
Trauma
Malignancy
Radiation
Infection
Foreign body
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discharge that smells like urine. 
Vesicovaginal and ureterovaginal 
fistulae may present in the 
first few days postoperatively.  
Fistulae that occur as a result 
of tissue ischaemia, infection, 
devascularization and necrosis 
typically present later between 
day 5 and 21. In these women, a 
foul smelling or persistent vaginal 
discharge often precedes the urine 
leakage. Febrile episodes are not 
common with uncomplicated VVF.
Ureterovaginal fistulae are also 
not infrequently associated 
with febrile episodes. If there is 
extravasation of urine into the 
abdominal cavity, patients may 
present with anorexia, nausea, 
vomiting, increasing abdominal 
pain, abdominal distension and 
postoperative ileus.  Flank pain 
should alert the physician not only 
to a possible ureterovaginal fistula, 
but also to ascending infection 
complicating the urinary tract 
injury.
As a general rule, women who 
later develop an uncomplicated 
VVF, recover uneventfully from the 
initial surgery, the only complaint 
being a clear watery discharge that 
smells like urine.  The amount of 
urine leakage varies depending on 
the size and location of the VVF, 
but most have continuous leakage 
independent of the body posture.  
On the other hand, patients 
with ureterovaginal fistula have 
intermittent but more profuse 
episodes of urinary leakage.
Women who develop obstetric 
fistulae, usually present with 
urinary leakage approximately one 
week following delivery (range day 
5-21).  There is usually a history of 
a prolonged and difficult labour 
resulting in a stillbirth. Unlike 
iatrogenic surgical fistulae which 
are characterised by a discrete 
injury, the pathophysiological 
effects of obstructed labour 
are wider and can result in a 
broad range of injuries including 
neurapraxia, lower bowel 
dysfunction, muscle injury and 
even rectovaginal fistula.  The term 
“field injuries” has been coined to 
refer to this range of damage.
Examination
Patients with urogenital fistulae 
may be relatively well but often 
they will present with signs and 
symptoms of acute illness.  Fever, 
anorexia, nausea, and vomiting 
are suggestive of acute sepsis and 
peritonitis, and require prompt 
admission and investigation.  If 
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the patient is not ill, evaluation 
and diagnostic investigation 
as an outpatient is acceptable.  
Other important findings include 
costovertebral angle tenderness, 
associated with ureteric injuries 
or infection of the upper urinary 
tract; and abdominal tenderness 
which is suggestive of an 
intraperitoneal urine collection or 
sepsis.
The pathognomonic finding is 
the observation of urine leaking 
into the vagina on speculum 
examination.  The use of a Sims 
speculum with downward pressure 
on the posterior wall facilitates 
examination of the anterior 
vagina and apex.  The majority 
of fistulae following abdominal 
hysterectomy are located near the 
vaginal apex and it is therefore 
difficult to determine clinically 
whether the origin of the leakage 
is the bladder or ureter. Following 
pelvic examination, the bladder 
should be always catheterized and 
a urine sample sent for microscopy 
and culture. The bladder is then 
filled with methylene blue and the 
diagnosis confirmed by observing 
the leakage of dye-stained urine 
into the vagina. If a ureteric fistula 
is suspected, the patient should 
ingest 200mg oral phenazopyridine 
( pyridium) 3 hours before 
examination.  A tampon is then 
placed in the vagina and again 
methylene blue is instilled into 
the bladder via the catheter.  If 
the tampon turns orange, a 
vesicouretric fistula is diagnosed. 
If the tampon turns both blue and 
orange, then a combined VVF and 
vesicouterine fistula should be  
suspected.
Investigations
The aims of the investigations 
are as follows:-
1. To confirm the discharge is urine
2. To establish that the leakage 
is extraurethral rather than 
urethral
3. To locate the site of leakage
4. To diagnose multiple fistulae
Biochemistry and 
microbiology
Initial laboratory investigations 
for urogenital fistula include:-
1. Urine for culture and microscopy 
to rule out infection
2. FBC – to assess the haemoglobin 
and white cell count (infection)
3. Urea and electrolyte – assess 
urea and creatinine level which 
may be elevated with ureteric 
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4. If the vaginal discharge is 
suspicious of urine, then it 
can be analysed for its urea 
and creatinine content.  If the 
urea and creatinine level of 
the discharge is greater than 
the serum values, it is highly 
suggestive that the discharge is 
urine
Imaging
Cystography is not very helpful 
if a clinical diagnosis of a 
VVF has been made. It will, 
however, confirm a suspected 
vesicouavaginal, vesicouterine 
or complex fistula.  It is good 
practice to image the upper 
urinary tract in all patients with 
VVF.  An intravenous urography 
(IVU) is usually done to exclude 
a ureterovaginal fistula and 
ureteric obstruction.  When the 
ureter is involved at the margins 
of a VVF, an IVU will demonstrate 
a standing coloumn of contrast 
within the ureter, extravasation of 
contrast around the distal ureter 
or gross hydronephrosis.  With 
suspected ureterovaginal fistula, 
the diagnosis is confirmed by a 
dilatated ureter with extravasation 
of dye at the distal end and a 
normal cystogram.  If the IVU 
findings are equivocal, contrast 
enhanced CT of the pelvis will aid 
in the diagnosis of vesicouterine 
fistula.
Retrograde pyelography is a 
reliable way to identify the exact 
site of a ureterovaginal fistula. 
Positive pressure urethrography 
may be needed to diagnose 
urethrovaginal fistulae, especially 
those following the insertion of 
midurethral tapes. 
Examination Under 
Anaesthesia And 
Cystoscopy
Careful examination under 
anaesthesia and cystoscopy 
is required to determine the 
following:-
1. The site of the fistula and the 
proximity of the fistula to the 
ureteric orifii and bladder neck
2. To exclude intravesical sutures or 
other foreign bodies (stones)
3. To assess the bladder mucosa. 
In under-resourced countries 
schistosomiasis and tuberculosis 
should be excluded
4. To assess the mobility of the 
vaginal  tissue and confirm 
surgical access if planning 
vaginal repair
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5. To inspect the fistula margins 
and consider biopsy if one 
suspects a malignancy or 
infection (schistosomiasis, 
tuberculosis)
6. To assess whether graft tissue 
will be required for definitive 
surgery. With bladder neck 
and proximal urethral fistulae, 
there may be circumferential 
loss of the urethral sphincter 
mechanism. Usage of a Martius 
graft at definitive surgery will 
have beneficial effects with 
regard to assisting in urethral 
continence.
At cystoscopy, it may be necessary 
to digitally occlude the fistula 
to achieve distension.  If the 
tissues are necrotic or there is 
substantial slough or induration, 
then definitive surgery should be 
delayed.
Preoperative 
Management
Patients should always be well 
informed, especially during 
the waiting period from fistula 
diagnosis to repair. The carers 
should always be sympathetic 
to these women’s needs which 
should always include offering 
them incontinence pads, to 
prevent soiling of their clothes 
and to enable them to function 
socially. Silicone barrier creams 
should be applied to their vulval 
skin and perineum to protect 
them from urinary dermatitis.  The 
preoperative use of oestrogen 
vaginal cream is recommended in 
postmenopausal women.  These 
creams change the vaginal flora 
to aerobic bacteria thus improving 
the integrity of the vaginal wall 
and promoting vaginal healing. 
Counselling is pivitol in the 
management of these patients. 
It is important to remember that 
many of these women are healthy 
individuals who entered hospital 
for a routine procedure and by 
developing a fistula have ended up 
with worse symptoms than their 
original complaints. 
Surgical Management
Timing Of Repair
The timing of the fistula repair is a 
controversial issue. Surgical success 
should not be compromised by 
operating too early. Advances in 
antibiotic therapy, suture material 
and surgical techniques have 
encouraged many surgeons to 
attempt early surgical repair which 
if successful avoids the prolonged 
morbidity and discomfort of 
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delayed repair. Several published 
series support early attempts 
at repair.   If surgical injury is 
recognized within the first 24 
hours postoperatively, immediate 
repair can be attempted, 
provided the injury site is not too 
oedematous and extravasation of 
urine into the tissues has not been 
too extensive.
Small VVF discovered within 7 days 
of surgical injury can be treated 
with continuous bladder drainage 
to facilitate spontaneous closure.  
Although the optimal duration of 
drainage has not been established, 
it is reasonable to allow drainage 
for at least 4 weeks.  If closure is 
not achieved, then a concomitant 
ureterovaginal fistula should be 
excluded and surgery planned 12 
weeks later. 
With larger fistulae, definitive 
repair should be planned at 3 
months.  This period will allow for 
the oedema and inflammation to 
resolve and improve the likelihood 
of a successful repair.
With obstetric related fistulae, 
most surgeons suggest waiting 
a minimum of 3 to 4 months to 
allow the slough to separate and 
the induration to settle, before 
embarking on definitive surgery. 
During this period, any evidence 
of cellulitis should be vigorously 
treated and the patient should 
maintain optimal nutrition and 
fluid intake to encourage healing. 
Recently, Waaldijk has advocated 
surgery as soon as the slough 
separates, but more studies are 
needed to justify this approach.12 
With previous surgical failures, it is 
prudent to wait at least 12 weeks 
before re-attempting to repair 
the fistula. Surgery for urogenital 
fistula should only be undertaken 
by surgeons with appropriate 
training and skills since the first 
attempt will give you the best 
results.
Route Of Repair
Surgeons involved in fistula 
management should be skilled in 
both the abdominal and vaginal 
approach and should have the 
surgical expertise and versatility 
to modify their technique based 
on the individual case. When 
access is good and the vaginal 
tissue sufficiently mobile, the 
vaginal route is the preferred 
option (less invasive, less morbidity 
than abdominal approach).  The 
abdominal route is favoured if the 
vaginal access is poor, the fistula 
is close to the apex , and the 
ureter is in close proximity to the 
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fistula edge (anticipate ureteric 
reimplantation.)  As a general 
rule, most surgical fistula arising 
from abdominal surgery require an 
abdominal approach, perhaps with 
the help of a skilled urologist.
Instruments And Sutures:-
Instruments that make your 
surgery easier include:
1. Fine scalpel blade on a number 
7 holder
2. Potts-De Martel  scissors and a 
Chasser Moir 30 degree  angle-
on-flat scissors
3. Lone star ring retractor for 
vaginal approach
4. Skin hooks to put the tissue on 
torsion during dissection
5. Turner – Warwick double curved 
needle holder
Absorbable sutures, including  
polyglactin (vicryl) 2-0 sutures on a 
25 mm heavy taper cut needle are 
preferred for the vagina and a 2-0  
vicryl suture on a round body  for 
the bladder. For ureteric implants, 
a 4-0 polydiaxonone (PDS) on a 13 
mm round bodied needle is the 
suture of choice.
Dissection
Great care must be taken over 
the initial dissection.  The fistula 
should be circumscribed in the 
most convenient orientation.  A 
longitudinal incision should be 
made around the urethral or 
midvaginal fistula while vault 
fistulas are better managed by 
a transverse elliptical incision.  
Because of the scarring, dissection 
close to the fistula is usually 
undertaken with a scalpel or 
Potts-De Matel scissors.  It must be 
appreciated that the actual defect 
in the bladder may be larger 
than the visible defect because of 
the scarring and fibrosis.  Wide 
mobilization of the bladder should 
be performed so that the repair 
is tension free.  Caution should 
be exercised to avoid excessive 
bleeding and this is achieved by 
dissecting in the correct plane.
Principles Of Fistula Repair
1. Excision of all scar tissue around 
the fistula tract
2. Wide mobilization of the 
bladder
3. Tension free layered closure
4. Interposing tissue between the 
2 organs
5. Obtaining a water tight tension 
free closure
6. Good haemostasis
7. Complete bladder drainage 
postoperatively
8. Prophylactic antibiotics
Vaginal Repair
1. Circumferential incision is 
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made around fistula using a 
size 12 blade. Initial incision 
can be aided by inserting a 
foleys catheter through the 
fistula, inflating the bulb and 
by exerting traction on the 
catheter.  It allows for access to 
the fistula.
2. Sharp dissection around the 
fistula edges.
3. The bladder is separated 
from the vaginal wall and 
fully mobilised. Potts-De 
Matel scissors are used for the 
dissection. 
4. The fistula edges are trimmed. 
5. The bladder is sutured 
transversely. The first 2 sutures 
are inserted at the angles 
using vicryl 2-0.  Additional 
sutures are inserted towards 
the centre from both angles 
with interrupted closure. The 
sutures are usually placed 3 mm 
apart (less interference with  
vascular supply as compared to 
continuous suturing).
6. Avoid penetration of the 
bladder mucosa during suture 
insertion and ensure that the 
knots are secure and cut short.
7. The second layer of sutures 
should invert the first layer. This 
is also done with interrupted 
suturing.
8. Confirm a water tight seal by 
instilling methylene blue dye 
into the foley catheter.
9. Close the vaginal epithelium 
with interrupted suturing 
along the vertical plane to 
avoid overlapping of the suture 
repair between the bladder and 
vagina.
Abdominal Approach
This can either be transvesical or 
transperitoneal.
Transvesical
This approach is extraperitoneal.  
The cave of Retzius is entered and 
a vertical incision on the dome of 
the bladder is made. The fistula 
is identified and the ureters are 
stented. A vaginal probe is inserted 
into the vagina and the fistula 
site is elevated. The fistula tract 
is circumscribed and the bladder 
is mobilised with the Potts De-
Matel scissors.  The vagina (VVF) 
or uterus (vesicouterine) is sutured 
with interrupted vicryl through 
the bladder and the bladder 
is then sutured at 90 degrees 
(interrupted vicryl) so that the 
repair sites do not overlap.  The 
initial bladder cystotomy is then 
repaired with continuous vicryl. A 
disadvantage of this route is that 
no interposition graft can be used.
Transperitoneal 
With this approach, the peritoneal 
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cavity is entered.
Indications are:- 
1. complex fistulae
2. if the surgeon anticipates that 
a ureteric implant may need to 
be performed (because of close 
proximity of the fistula site to 
the ureter)
3. large/high fistula where there is 
poor vaginal access
With this approach, the cave of 
Retzius is entered. A midline split 
of the dome of the bladder is 
performed and extended to the 
fistula site resulting in a racquet 
shaped incision. The bladder is 
mobilised and the fistulous tract 
excised. Layered closure is then 
performed, first closing the vaginal 
epithelium and then the bladder.
Interposition Grafts
At times, fistula repair may require 
additional tissue to provide 
support, bring in new blood supply 
to the area and to fill dead space. 
With the vaginal approach, one 
can use either a Martius graft or 
the Gracillus Muscle Graft. With 
the Martius graft, the labial fat 
pad is passed subcutaneously to 
cover the vaginal repair. This is 
particularly useful in bladder neck 
urethral fistula repair to provide 
bulk to maintain competence of 
the closure mechanism.
With the abdominal approach, 
an omental pedicle graft may be 
utilised to improve success. It is 
created by dissecting the omentum 
from the greater curve of the 
stomach and rotating it down into 
the pelvis on the gastro-epiploic 
artery. It is then secured to the 
repair site.
Postoperative Management
As a general principle, the 
best postoperative cure is a 
good intraoperative surgery. 
Furthermore, nursing care is 
critical during this period as poor 
nursing care can undermine what 
has been achieved by the surgical 
team. Important principles are as 
follows:-
1. Good fluid intake 
(approximately 3 litres/24 hours) 
and strict input and output.
2. Good bladder drainage. Free 
drainage is critical as bladder 
clots may obstruct the outflow 
resulting in distension of the 
bladder and disruption of the 
repair site.
3. The ideal is to have both a 
suprapubic and urethral catheter 
with abdominal approaches and 
a urethral 3 way catheter with 
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the vaginal approach. Following 
surgery, continuous bladder 
irrigation is instituted. Once 
the urine clears out with the 3 
way foleys, a spigot is used to 
occlude the irrigation channel 
and the catheter is left in situ.
With the Abdominal approach, 
the suprapubic is removed and 
the foleys is strapped to the 
inner thigh to avoid kinking or 
dragging of the catheter.
4. Prophylactic urinary antiseptic 
viz nitrofurantoin 100mg nocte 
is used as long as the patient has 
the catheter in situ.
5. Occasionally stool softeners 
are prescribed if the patient is 
constipated.
6. Patients are advised to be on 
bed rest during the period of 
catheterization and educated on 
catheter care.
7. With surgical fistula, 14 days of 
free drainage is recommended 
while with obstetric fistula, 25 
days is recommended.
On removal of the catheter, 
patients are counselled that they 
should void more frequently 
initially and gradually increase 
the periods between voids 
aiming to be back to normal by 4 
weeks postoperatively. Tampons, 
douching and penetrating sex must 
be avoided for at least 3 months 
postsurgery.
FIGURE I: Types and locations of 
common urogenital fistulae.  
A:  Vesicouterine,  B:  
Vesicovaginal,  C:  Urethrovaginal
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Introduction
Ever since the introduction of high-
fidelity endoscopic equipment 
in the field of gynaecological 
surgery in the early 1990’s workers 
have performed traditional 
gynaecological procedures 
using minimally invasive routes. 
Generally, the endoscopic 
approach allows the surgeon the 
advantages of:
•	 Excellent surgical view
•	 Magnification of anatomical 
structures
•	 Bloodless dissection
•	 Precise haemostasis, less blood 
loss
•	 Lower incidence of adhesions
•	 Less post operative pain, shorter 
hospitalization 
•	 Quicker return to normal 
activities
•	 Small incisions, cosmetic scars
•	 Lower incidence of infection
There is good evidence that the 
management of, for example, 
ectopic pregnancy, is superior using 
the endoscopic route, but this is 
not necessarily true for the use 
of laparoscopy in other fields of 
gynaecological surgery.
It is important that any surgeon 
using endoscopic tools:
•	 Be properly trained in the 
procedure
•	 Enjoy the use of quality 
equipment
•	 Have recourse to urological and 
surgical back-up
•	 Have an excellent appreciation 
of pelvic anatomy
•	 Counsel the patient fully in the 
spheres of surgical complications 
and the need for emergency 
laparotomy, otherwise the 
traditional approach is 
preferable
This chapter will consider the 
Chapter 23
The role of laparoscopy in 
urogynaecological procedures
Peter de Jong
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role of endoscopy in the fields of 
prolapse and incontinence surgery.
Prolapse Surgery
Apical Prolapse
Laparoscopy to repair apical 
prolapse is well described and has 
been practiced for many years. The 
procedure is identical to traditional 
sacrocolpopexy with the use of 
mesh, and offers the patient 
the advantages of endoscopy as 
mentioned above.
 
However the operation is 
technically highly demanding and 
requires extensive experience in 
endoscopic surgery. The advanced 
endoscopist completes the 
procedure in around an hour, and 
in the hands of expert surgeons 
such as Wattiez, the outcome 
enjoys comparable results to 
standard open sacrocolpopexy. In 
terms of apical repair, at present 
the ICS benchmark is still for 
conventional open sacrocolpopexy 
– but in the hands of trained 
expert endoscopists, laparoscopic 
sacrocolpopexy using mesh is 
a well described acceptable 
alternative procedure.
Anterior Compartment Prolapse
First described by Vancaille in the 
early 1990’s, in experienced hands 
the para vaginal repair may be 
performed laparoscopically by 
means of the placement of sutures 
with perfectly acceptable results. 
However it is not for the beginner, 
since suturing in this area is 
difficult laparoscopically.
Similarly, the use of mesh in the 
laparoscopic management of 
anterior or posterior compartment 
prolapse is well described, with 
acceptable long term outcomes, 
provided the surgeon is well 
trained and highly experienced in 
this art.
Urinary Stress 
Incontinence Surgery
The use of the laparoscopic 
Burch procedure was described 
in the 1990’s with placement 
of sutures similar to the open 
route. However it is difficult to 
correctly place the sutures by 
laparoscopy, and the endoscopic 
Burch was beyond the reach of 
most endoscopists. Moreover its 
use was overshadowed by the 
introduction in the late 1900’s of 
the mid urethral tapes, which were 
technically far easier to perform.
Long term results seem to be 
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equivalent to those of the 
traditional Burch, with equivalent 
cure and complication rates.
Nowadays the laparoscopic Burch 
procedure is confined to surgery 
by laparoscopic experts when 
performing prolapse operations, 
when the patient has concomitant 
stress incontinence.
Traditional Burch laparotomy 
procedures are similarly confined 
to cases where the patient 
undergoes a laparotomy for other 
reasons (for example, hysterectomy 
for large fibroids) and has 
concomitant stress incontinence.
201
Introduction
The gynaecologist is presented 
with a bewildering array of sutures 
and needles for pelvic surgery and 
wound closure. The article aims 
to narrow the choice to a few 
logical options that will meet most 
surgical requirements.
Wound Healing
Healing begins as soon as an 
incision is made, when platelets 
are activated and release a 
series of growth factors. Within 
minutes, the wound displays 
a mild inflammatory reaction 
characterised by the migration of 
neutrophils which are attracted 
by degradation products of fibrin 
and fibrinogen. During this time, 
and until the proliferative phase 
of healing begins, wound strength 
is low. Macrophages peak at 24 
hours and produce lactate. This 
promotes the release of angiogenic 
endothelial chemo-attractants 
and increases the rate of collagen 
synthesis by fibroblasts. By the fifth 
day, fibroblasts are found in high 
numbers and the formation of a 
microcirculation begins. After the 
second week, although collagen 
synthesis and angiogenesis are 
reduced, the pattern of repair is 
reorganized and the strength of 
the wound increases, although 
never to its original level. Collagen 
synthesis and lysis are delicately 
balanced. During the first 12-14 
days the rate at which wound 
strength increases is the same, 
irrespective of the type of tissue. 
Thus, relatively weak tissue, such 
as bladder mucosa, may have 
regained full strength, whereas 
fascia will only have recovered 
by 15%. Moreover, it takes three 
months for an aponeurosis to 
recover 70% of its strength and 
it probably never regains its full 
strength.
Chapter 24
Suture Options in Pelvic 
Surgery
Peter de Jong
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Factors Affecting Healing
Many factors influence healing, 
including age, nutrition, 
vascularity, sepsis and hypoxia. 
Some medical conditions, such 
as diabetes, malnutrition, use of 
steroids, uraemia, jaundice and 
anaemia effect healing adversely. 
Another factor of relevance to the 
gynaecologist is the menopause, 
since it has been shown that 
oestrogen accelerates cutaneous 
healing by increasing local 
growth factors. Postmenopausal 
women having vaginal surgery 
are therefore advised to use 
pre-operative topical oestrogen. 
Cigarette smoking can also affect 
healing adversely. 
With regard to infection, the 
main source of contamination 
is endogenous, with only about 
5% of infections being airborne. 
Most gynaecological operations 
are clean (0-2% rate of infection) 
or clean/contaminated when the 
vagina is incised (2-5% rate of 
infection). Other surgical factors in 
infection include local trauma from 
excessive retraction, over-zealous 
diathermy and operations lasting 
more than two hours.
Surgical Principles
Basic surgical principles influence 
the healing process, and the 
best sutures are useless unless 
meticulous attention to surgical 
detail is observed. There are a 
number of surgical guidelines 
which promote better outcomes of 
surgery:
The incision
A thoughtful surgeon plans the 
length, direction and position of 
the incision in such a way as to 
provide maximal exposure and 
a good cosmetic result, with a 
minimum of tissue disruption.
Maintenance of a sterile field and 
aseptic technique.
Infection deters healing, and the 
surgeon and theatre team must 
observe all proper precautions 
to avoid contamination of the 
operative field. Laparoscopic 
surgery affords a favorable 
environment to prevent 
contamination by extraneous 
debris and airborne infection. 
Gentle handling of tissue and 
precise dissection causes less tissue 
damage, with resultant fewer 
adhesions, and reduced post 
operative pain.
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Dissection Technique
A clean incision with minimal 
tissue trauma promotes speedy 
healing. Avoid careless ripping of 
tissue planes and extensive cautery 
burns. Atraumatic tissue handling 
is the hallmark of a good surgeon. 
Pressure from retractors devitalizes 
structures, causes necrosis and 
traumatizes tissue and this 
predisposes to infection. Swabs are 
remarkably abrasive, and if used to 
pack off bowel, must be soaked in 
saline.
Haemostasis
Good haemostasis allows greater 
surgical accuracy of dissection, 
prevents haematomas and 
promotes better healing. When 
clamping, tying or cauterizing 
vessels, prevent excessive tissue 
damage.
Avoid tissue dessication
Long procedures may result in 
the tissue surface drying out, 
with fibrinogen deposition and 
ultimately adhesion formation. 
Periodic flushing with Ringer’s 
lactate solution is a sound surgical 
principle.
Removal of surgical debris
Debride devitalised tissue, and 
remove blood clots, necrotic debris, 
foreign material, and charred 
tissue (secondary to cautery) to 
reduce the likelihood of scarring , 
adhesion formation and infection.
Foreign bodies
Avoid strangulating tissue with 
excessive surgical sutures. These 
represent a significant foreign 
body challenge and reduce tissue 
oxygen tension. Certain sutures 
such as chromic gut, provoke more 
inflammatory reaction than others, 
for example nylon.
Wound closure
Choice of material
The appropriate needle and suture 
combination allows atraumatic 
tension, free tissue approximation, 
with minimal reaction, and 
sufficient tensile strength.
Elimination of dead space
Separation of wound edges 
permits the collection of fluid 
which promotes infection and 
wound breakdown. Surgical drains 
help reduce fluid collections.
Stress on wounds
Postoperative activity may 
stress the wound during the 
healing phase. Coughing stresses 
abdominal fascia, and careful 
wound closure prevents disruption. 
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Excessive tension causes tissue 
necrosis, oedema and discomfort. 
The length of the suture for 
wound closure should be six times 
length of the incision to prevent 
excessive suture tension.
Choice Of Suture
Many surgeons have a personal 
preference for sutures both as a 
result of proficiency in a particular 
technique and the suitable 
handling characteristics of a 
suture and needle. Knowledge 
of the physical characteristics of 
suture material, the requirements 
of wound support, and the type 
of tissue involved, is important 
to ensure a suture used which 
will retain its strength until 
the wound heals sufficiently to 
withstand stress. While most 
suture materials cause some tissue 
reaction, synthetic materials such 
as polyglactin 910 tend to be less 
reactive than natural fibers like 
silk.
Suture Characteristics
The properties and characteristics 
of the “ideal” suture are listed in 
Table I
 
Table I: The Ideal Suture
Good handling and knotting characteristics
High tensile strength
Minimally reactive to tissue
Non capillary, non allergenic. The capillary 
action of braided material promotes infec-
tion, as opposed to non-braided sutures
Resistant to shrinkage and contraction
Complete absorption after predictable 
interval
Available in desired diameters and lenghth
Available with desired needle sizes
In general terms, the thinnest 
suture to support the healing 
tissue is best. This limits trauma 
and, as a minimum of foreign 
material is used, reduces local 
tissue reaction and speeds re-
absorption. The tensile strength of 
the material need not exceed that 
of the tissue. 
Monofilament vs. braided 
material
Monofilament sutures (for 
example nylon) are made from a 
single strand of material, and are 
less likely to harbor organisms than 
multifilament braided material 
(table II). 
Because of its composition 
monofilament material may have 
a “memory” and care should be 
taken when handling and tying 
monofilament sutures – perhaps 
a few extra throws on a proper 
surgical knot would prevent 
unravelling.
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Avoid nicking or crushing a 
monofilament strand, as this may 
create a point of weakness. They 
have a smooth surface and so pass 
easily though tissue. Nylon sutures 
have high tensile strength and very 
low tissue reactivity and degrade in 
vivo at 15% per year by hydrolysis. 
Fine nylon sutures are suitable for 
use in micro-surgery applications, 
and slightly heaver grades are 
appropriate for skin closure.
Multifilament sutures consist of 
several filaments braided together, 
affording greater tensile strength, 
pliability and flexibility with 
good handling as a result. They 
Table II: Suture Properties
Mate-
rial
Prop-
erty
Compo-
sition
Made 
from
Trade 
Name
Tissue 
Reactiv-
ity
Strength
Reten-
tion
Absorp-
tion
Natural Absorb-
able
Spun Plain gut Consid-
erable
7-10 
days
70 days
Chromic 
gut
Moder-
ate
10-14 
days
90 days
Non 
absorb-
able
Braided Silk Acute 
Inflam-
mation
6 
months
2 years
Mono-
filament
Stainless 
steel 
wire
Minimal Main-
tained
Nil
Syn-
thetic
Absorb-
able
Braided Polygla-
ctin
Vicryl* Minimal 50% at 
21 days
 70 days
Mono-
filament
Co-poly-
mer
Monocryl* Minimal 40% at 
14 days
4 
months
Co-poly-
mer
PDS II* Slight 50% at 
28 days
6 
months
Non 
absorb-
able
Braided Polyester Ethibond* 
Mersilene
Minimal Main-
tained
Nil
Mono-
filament
Nylon Minimal 20% per 
year
Years
Polypro-
pylene
Prolene* Minimal Main-
tained
Nil
* Trademark
Minimal=”very little”, Slight=”some”
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must be coated to reduce tissue 
resistance and improve handling 
characteristics. Because of their 
inherent capillarity they are 
more susceptible to harbouring 
organisms than monofilament 
sutures.
Absorbable vs. non-absorbable 
materials
Absorbable sutures are prepared 
from the collagen of animals or 
from synthetic polymers. Catgut 
is manufactured from sheep 
submucosa or bovine serosa and 
may be treated with chromium 
salts to prolong absorption time.  
Enzymes degrade the suture, with 
an inflammatory response.
The loss of tensile strength and the 
rate of absorption are separate 
phenomena. A suture can lose 
tensile strength rapidly and yet 
be absorbed slowly. If a patient is 
febrile or has a protein deficiency, 
the suture absorption process may 
accelerate, with a rapid loss of 
tensile strength.
Non-absorbable sutures may be 
processed from single or multiple 
filaments of synthetic or organic 
fibers rendered into a strand by 
spinning, twisting or braiding. 
They may be coated or uncoated, 
uncoloured or dyed.
Specific Sutures And 
Applications
Surgical gut
Absorbable surgical gut may be 
plain or chromic, and spun from 
strands of highly purified collagen. 
The non –collagenous material 
in surgical gut causes the tissue 
reaction. Ribbons of collagen are 
spun into polished strands, but 
most protein-based absorbable 
sutures have a tendency to fray 
when tied. Surgical gut may be 
used in the presence of infection, 
but will then be more rapidly 
absorbed. Surfaces may be 
irregular and so traumatise tissue 
during suturing.
Plain surgical gut is absorbed 
within 70 days, but tensile strength 
is maintained for only 7-10 days 
post operation. Chromic gut is 
collagen fiber tanned with chrome 
tanning solution before being 
spun into strands. Absorbsion is 
prolonged to over 90 days, with 
tensile strength preserved for 14 
days. Chromic sutures produce 
less tissue reaction than plain gut 
during the early stages of wound 
healing, but are unsuitable for 
certain procedures , such as in 
fertility surgery.
Recently, the use of sutures of 
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animal origin has been abandoned 
in many countries because of the 
theoretical possibility of prion 
protein transmission, thought to 
be responsible for Creutzfieldt-
Jakob disease.
Synthetic absorbable sutures
Synthetic absorbable sutures were 
developed to counter the suture 
antigenicity of surgical gut, with 
its excess tissue reaction and 
unpredictable rates of absorption.
Polyglactin 910 (i.e. Vicryl) is 
braided copolymer of lactide and 
glycolide, allowing approximation 
of tissue during wound-healing 
followed by rapid absorption. 
At 3 weeks post-surgery 50% of 
its tensile strength is retained. 
The sutures may be coated with 
a lubricant to facilitate better 
handling properties of the 
material. Absorption is minimal 
until day 40, completed about 2 
months after suture placement, 
with only a mild tissue reaction.
Occasionally it is desirable to have 
a rapid-absorbing synthetic suture, 
such as Vicryl Rapide™. The suture 
retains 50% of tensile strength 
at 5 days, and since the knot 
“falls off” in 7 to 10 days, suture 
removal is eliminated. It is only 
suitable for superficial soft tissue 
approximation where short-term 
support is desired, for example for 
episiotomy repair.
Polyglecaprone 25 (i.e. monocryl™) 
is a synthetic monofilament co-
polymer that is virtually tissue 
inert, with predictable absorption 
completed by 4 months. It has 
high tensile strength initially, 
but all strength is lost after one 
month. It is useful for subcuticular 
skin closure and soft-tissue 
approximation, for example during 
Caesarean Section. 
Polydioxanone (i.e. PDS II™) is 
absorbable and also monofilament 
composition, but has more tissue 
reaction than monocryl. It supports 
wounds for up to 6 weeks, and is 
absorbed by 6 months. Synthetic 
absorbable monofilament sutures 
are useful for subcutaneous skin 
closure since they do not require 
removal. This suture is suitable for 
sheath closure at laparotomy.
Non absorbable sutures
Surgical silk consists of filaments 
spun by silkworms, braided into a 
suture which is dyed then coated 
with wax or silicone. It loses most 
its strength after a year, and 
disappears after about 2 years. 
Although it has superior handling 
qualities, it elicits considerable 
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tissue reaction, so is seldom used in 
gynaecology nowadays.
Synthetic non absorbable 
sutures
Nylon sutures consist of a 
polyamide monofilament with very 
low tissue reactivity. Their strength 
degrades at 20% per year, and the 
sutures are absorbed after several 
years. Because of the «memory» of 
nylon, more throws of the knot are 
required to secure a monofilament 
suture than braided sutures. Nylon 
sutures in fine gauges are suitable 
for micro-surgery because of the 
properties of high tensile strength 
and low tissue reactivity.
Polyester sutures are composed of 
braided fibers in a multifilament 
strand. They are stronger than 
natural fibres and exhibit less 
tissue reaction. Mersilene* 
synthetic braided sutures last 
indefinitely, and Ethibond* is 
coated with an inert covering 
that improves suture handling, 
minimises tissue reaction and 
maintains suture strength. They 
are unsuitable for suturing vaginal 
epithelium, as they are non-
absorbable. 
Polypropylene monofilament 
sutures are synthetic polymers that 
are not degraded or weakened 
by tissue enzymes. They exhibit 
minimal tissue reactivity, and 
maintain tensile strength. 
Prolene*, for example, has better 
suture handling properties 
than nylon, and may be used in 
contaminated or infected wounds 
to minimize sinus formation and 
suture extrusion. They do not 
adhere to tissue and are easily 
removed.
Topical skin adhesions
Where skin edges appose under 
low tension, it is possible to glue 
edges together with glue, such 
as Dermabond™. It is a sterile 
liquid, and when applied onto 
the skin (not into the wound) 
seals in three minutes. It protects 
and seals out common bacteria, 
commonly associated with wound 
infections, and promotes a 
favourable, moist, wound healing 
environment, speeding the rate 
of epithelialisation. The adhesive 
gradually peels off after 5 – 10 
days with a good cosmetic result.
Subcutaneous sutures need to 
be placed to appose skin edges 
if topical skin adhesions are to 
be used. It may especially be 
used in cases of Laparoscopy to 
close several small skin incisions, 
and obviate the need for suture 
removal. Skin adhesive use 
eliminates the pain occasionally 
associated with skin sutures, but is 
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unsuitable for vaginal use.
Adhesive Tapes
Adhesive tapes are used 
approximating the edge of 
lacerations or to provide increased 
wound edge support and less 
skin tension. This is important 
if patients tend to form keloids 
during scar healing. In this 
case, the wound is closed with 
monofilament absorbable sutures, 
carefully cleaned, and sprayed 
with surgical spray to promote 
adhesive tape adhesion to the skin. 
The wound is closed with a sterile 
waterproof dressing after adhesive 
tapes are placed to provide skin 
support.   
The dressing is removed after a 
week, but the adhesive tapes are 
allowed to fall off at a later stage. 
They have minimal tissue reactivity 
and yield the lowest infection rates 
of any closure method. 
Tapes do not approximate deeper 
tissues, do not control bleeding, 
and are unsuitable for use on 
hairy areas or in the vagina. Apply 
them gently to avoid unequal 
distribution of skin tension, which 
may result in blistering.
Choosing A Surgical 
Needle
Fig 1 shows the anatomy of 
the needle. A cutting needle is 
designed to penetrate tough 
tissue such as the sheath or skin. 
Conventional cutting needles 
have an inside cutting edge on 
the concave curve of the needle, 
with the triangular cutting blade 
changing to a flattened body (See 
Fig 2).
The curvature of the body is 
flattened in the needle grasping 
area for stability in the needle 
holder, and longitudinal ridges 
may be present to reduce rocking 
or twisting in the needle holder.
Reverse cutting needles have a 
third cutting edge on the outer 
convex curvature of the needle, 
making for a strong needle able to 
penetrate very tough skin or tissue 
(See fig 3).
Taper point needles are round, and 
so pierce and spread tissue without 
cutting it. The body profile flattens 
to an oval or rectangular shape 
to prevent needle rotation in the 
needle holder. They are preferred 
for atraumatic work with the 
smallest hole being desirable, in 
easily penetrated tissue, but are 
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not suitable for stitching skin (See 
Fig 4).  
Tapercut needles combine the 
features of the reverse – cutting 
edge tip and taper point needle. 
The trochar point readily 
penetrates tough tissue, with a 
round body, moving smoothly 
through tissue without cutting 
surrounding tissue (See Fig 5).
Blunt point needles have a 
rounded, blunt point that does not 
cut through tissue. They are used 
for general closure of tissue and 
fascia especially when performing 
procedures on at-risk patients (See 
Fig 6).
Tissue trauma is increased if 
the needle bends during tissue 
penetration, and a weak needle 
damages structures and may snap. 
Reshaping a bent needle may 
make it less resistant to bending 
and breaking. Needles are not 
designed to manipulate tissue or to 
be used as retractors to lift tissue. 
Ensure the needle is stable in the 
grasp of a needle holder. The 
grasping area is usually flattened, 
and heavier needles are ribbed as 
well as flattened to resist rotating 
in the needle holder (See Fig 7).
Most sutures are attached to 
swaged needles, without the need 
for an “eye” in the needle. Eyed 
needles need to be threaded, and 
create a larger hole with greater 
tissue disruption than a swaged 
needle. The swaged end of needle 
is securely crimped over the suture 
material, and may be available 
with the controlled release option. 
This feature allows rapid suture 
placement and a slight, straight 
tug will release it from the needle 
to allow tying. Avoid grasping 
the needle holder at the swaged 
end. This may be weaker than 
the flattened body and cause 
disintegration of the needle.
Abdominal wound closure
Modern sutures are uniform and 
strong and wound dehiscence will 
only be due to suture failure in 
exceptional circumstances, with 
improper tying of knots or damage 
to the suture by instruments. The 
suture can cut through if wide 
enough bites are not taken and if 
the suture is too tight. Premature 
loss of strength only occurs with 
absorbable sutures, especially 
catgut.
The closure of low transverse 
incisions is simplified by the 
fact that they generally heal 
well, with a low incidence of 
dehiscence and hernia whatever 
suture is used. Closure of midline 
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incisions presents more problems. 
The integrity of any wound is 
completely dependant on the 
suture until reparative tissue has 
bridged the wound. First principles 
therefore indicate that rapidly 
absorbable sutures will have a 
greater tendency to fail than non-
absorbable sutures. Studies have 
shown that catgut is associated 
with an unacceptably high risk of 
evisceration and incisional hernia 
and should not be used.  
Experimental work on rats has 
shown that mass closure with 
monofilament nylon significantly 
reduces the dehiscence rate 
compared with braided suture, as 
bacteria reside in the interstices 
of infected multifilament sutures. 
However, in some patients, 
removal of suture material 
will be required due to sinus 
formation. Delayed absorbable 
sutures have been assessed 
for abdominal wound closure 
and it was found that wound 
dehiscence is similar without the 
problem of sinus formation. A 
randomised controlled trial of 
polyglyconate (Maxon™) versus 
nylon in 225 patients showed that 
polyglyconate was as effective 
at two-year follow-up. Suture 
length should be approximately 
four times  to six times the length 
of the wound to allow for the 
30% increase in abdominal 
circumference postoperatively.  
Permanent sutures should still 
be considered where the risk of 
wound failure is particularly high.
Closure of the peritoneum was 
shown in 1977 to be unnecessary, 
this was confirmed in 1990 by a 
randomised controlled trial.
Skin closure
In gynaecological practice, there 
are many options for skin closure, 
but cosmesis is more important 
than in general surgery where the 
avoidance of infection is more of a 
concern. Lower transverse incisions 
heal well because of the lack of 
tension. Full-thickness interrupted 
stitches must not be too tight as 
oedema may lead to disfiguring 
crosshatching, particularly 
if infection forms along the 
track. Very thin monofilament 
absorbable or non-absorbable 
sutures are preferable but a 
subcuticular stitch leaves less of a 
scar (Figure I). Similar assessment 
of laparoscopy scars suggests that 
subcuticular polyglactin (Vicryl™) 
is better than transdermal nylon. 
Staples are popular because there 
is less chance of bacterial migration 
into the wound, although the risk 
of infection in most gynaecological 
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surgery is low. Properly conducted 
clinical trials have shown the only 
benefit of staples to be speed, 
there is more wound pain and a 
worse cosmetic result compared 
with subcuticular sutures.
Hints And Tips
Personal preference will always 
play a part in needle and suture 
selection, but the final choice will 
depend on various factors that 
influence the healing process, 
the characteristics of the tissue 
and potential post-operative 
complications.
Close slow-healing tissues (i.e. 
fascia or sheath) with non-
absorbable or long-lasting 
absorbable material, i.e. Pds or 
vicryl.
Close fast-healing tissue such as 
a bladder with rapidly absorbed 
sutures. Non-absorbable sutures 
such as nylon form a nidus for 
stone formation. Foreign bodies 
in potentially contaminated tissue 
may convert contamination into 
infection. So avoid multifilament, 
braided sutures under these 
circumstances – rather use 
monofilament material.
Where cosmetic results are 
important, close and prolonged 
skin opposition is desired, so 
thin, inert material such as nylon 
or polypropylene is best. Close 
subcutaneously when possible, 
and use sterile skin closure strips 
to secure close opposition of skin 
edges when circumstances permit. 
Try to use the finest suture size 
commensurate with the inherent 
tissue strength to be sutured. 
Conclusion
With a little thought and 
preparation we should use the 
suture and needle best suited 
to the surgery which is being 
performed. It is essential that we 
are aware of what is available 
and how it may best be utilized. 
Surgical training should include 
the characteristics and applications 
of sutures and needles.
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When the gynaecologist decides 
that a woman requires surgery 
for prolapse or incontinence, it is 
essential that a decision be made 
as to whether she requires peri-
operative  thromboprophylaxis.
The first decision is based on the 
risk factors for  that particular 
patient.  Any patient who has had 
a previous venous thromboembolic 
(VTE) event is obviously at high 
risk.  Other important risk factors 
include an underlying malignancy, 
age more than 76 years, use of an 
estrogen containing product and 
obesity.  A relatively simple scoring 
table promoted by the Southern 
African Society of Thrombosis and 
Haemostasis has been devised.  
(See attached table). Note that 
smoking is not a risk factor.  
There is a paucity of randomized 
data on the risk of thrombosis 
after gynaecological surgery, 
especially non oncological 
gynaecological surgery.  Patients 
should be divided into open versus 
laparoscopic surgery. Patients 
undergoing “open” surgery, 
including vaginal surgery, should 
be given low molecular weight 
heparin prophylaxis routinely.  
The debate arises in laparoscopic 
surgery, which appears to have a 
very low risk of VTE.  Furthermore 
prescribing anticoagulation to 
these patients increases the risk of 
minor bleeding and this therefore 
could potentially increase the rate 
of having to convert a laparoscopic 
procedure to an open procedure.
Although there is little data to 
support the use of intermittent 
pneumatic compression devices, 
the European Association 
for Endoscopic Surgery has 
recommended that they be 
used routinely for all prolonged 
laparoscopic procedures.  The 
American guidelines mandated 
that patients undergoing 
Chapter 25
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laparoscopic procedures who do 
not have additional risk factors 
should not be offered any 
thromboprophylaxis other than 
early and frequent ambulation.
The Author suggests that the 
European recommendation should 
be followed.  All patients who 
have additional VTE risk factors 
should be offered LMWH as well 
as the graduated compression 
stockings.
So in summary, any patient having 
a laparotomy ought to receive 
LMWH thromboprophylaxis, 
generally given 6 hours after 
surgery.
Thrombosis Risk Factor Assessment
Choose All That Apply
Each Risk Factor Represents 1 point
•	 Age 41 – 60 years
•	 Minor surgery planned
•	 History of prior major surgery (< 1 month)
•	 Varicose veins (large)
•	 History of inflammatory bowel disease
•	 Swollen legs (current)
•	 Overweight (BMI >25 kg/m2)
•	 Acute myocardial infarction
•	 Congestive heart failure (CHF) (<1 month)
•	 Sepsis (< 1 month)
•	 Serious lung disease including pneumonia 
(<1 month)
•	 Abnormal pulmonary function (COPD)
•	 Medical patient currently at best rest
Each Risk Represents 3 points
•	 Age > 75 years
•	 History of DVT/PE
•	 Family history of thrombosis
•	 Positive factor V Leiden
•	 Positive prothrombin 20210A
•	 Positive lupus anticoagulant
•	 Elevated anticardiolipin antibodies
•	 Other congenital or acquired thrombophilia
Risk Factor Score
Total Risk Factor Score Incidence of DVT* Risk Level
0 – 1 < 10% Low Risk
2 10 – 20 % Moderate Risk
3 - 4 20 – 40 % High Risk
5 or more 40 – 80 % Highest Risk
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Prophylaxis Safety Considerations:  Check box if answers if “yes”
Anticoagulants:  Factors Associated with Increased Bleeding
 Is patient experiencing any active bleeding?
 Does patient have (or had a history of) HIT?
 Is patient’s platelet count < 100.000/mm 3?
 Is patient taking oral anticoagulants, platelet inhibitors (e.g. NSAIDS, Clopidogrel, salicylates)?
 Is patient’s Creatinine clearance abnormal? Please indicate value:
If any of the above boxes are checked, the patient may not be a candidate for anticoagulant 
therapy and should be considered for alternative prophylactic measure.
Intermittent Pneumatic Compression (IPC)
 Does patient have severe peripheral arterial disease?
 Does patient have CHF?
 Does patient have an acute/superficial DVT?
If any of the above boxes are checked, the patient may not be a candidate for IPC therapy and 
should be considered for alternative prophylactic measures.
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Textbook of 
Urogynaecology
The field of urogynaecology has expanded dramatically over 
the past decade with the advent of a number of new medical 
and surgical treatment modalities. The evidence base on pelvic 
floor dysfunction has also grown extensively. This multi-
contributor text, authored by a multi-disciplinary team of 
experts from around South Africa, concisely summarises the 
most up-to-date concepts and management strategies in 
urogynaecology. It will prove invaluable to gynaecology, urol-
ogy and surgery registrars and specialists. Physiotherapists and 
nurses working in the field of urogynaedcology will also find it 
extremely useful.    
